country,term,count
AL,ASTHENIA,1
AL,BETA HAEMOLYTIC STREPTOCOCCAL INFECTION,1
AL,COUGH,1
AL,EATING DISORDER,1
AL,FEBRILE NEUTROPENIA,1
AL,GENERAL PHYSICAL HEALTH DETERIORATION,1
AL,INFECTION,1
AL,OROPHARYNGEAL PAIN,1
AL,STREPTOCOCCAL URINARY TRACT INFECTION,1
AR,HYPERTENSION,3
AR,ASTHENIA,2
AR,HYPERGLYCAEMIA,2
AR,MALAISE,2
AR,ABDOMINAL PAIN UPPER,1
AR,ANAEMIA,1
AR,ANXIETY,1
AR,ARRHYTHMIA,1
AR,ARTHRALGIA,1
AR,BACK PAIN,1
AR,BLOOD GLUCOSE DECREASED,1
AR,BLOOD GLUCOSE FLUCTUATION,1
AR,BLOOD GLUCOSE INCREASED,1
AR,BONE PAIN,1
AR,BRONCHITIS,1
AR,CATARACT,1
AR,CONJUNCTIVITIS,1
AR,DIABETES MELLITUS INADEQUATE CONTROL,1
AR,DRUG DEPENDENCE,1
AR,DRUG PRESCRIBING ERROR,1
AR,DRY MOUTH,1
AR,DRY SKIN,1
AR,DYSPNOEA PAROXYSMAL NOCTURNAL,1
AR,EXPOSURE DURING PREGNANCY,1
AR,EYE DISORDER,1
AR,FATIGUE,1
AR,FLATULENCE,1
AR,FOOD INTOLERANCE,1
AR,GASTROINTESTINAL PAIN,1
AR,HAEMORRHAGE,1
AR,HEADACHE,1
AR,HEPATIC PAIN,1
AR,HEPATIC STEATOSIS,1
AR,HEPATOMEGALY,1
AR,HOT FLUSH,1
AR,HYPOACUSIS,1
AR,HYPOAESTHESIA,1
AR,INCORRECT DOSE ADMINISTERED,1
AR,INFARCTION,1
AR,INFLUENZA LIKE ILLNESS,1
AR,INJECTION SITE HAEMATOMA,1
AR,INJECTION SITE INFLAMMATION,1
AR,LETHARGY,1
AR,LIVER DISORDER,1
AR,LOSS OF CONSCIOUSNESS,1
AR,MUSCULOSKELETAL PAIN,1
AR,NON-CARDIAC CHEST PAIN,1
AR,OEDEMA PERIPHERAL,1
AR,PAIN,1
AR,PERICARDIAL EFFUSION,1
AR,POLYURIA,1
AR,PRODUCT USED FOR UNKNOWN INDICATION,1
AR,PROSTATE CANCER,1
AR,PRURITUS,1
AR,PULMONARY OEDEMA,1
AR,PYREXIA,1
AR,RASH,1
AR,SECOND PRIMARY MALIGNANCY,1
AR,SINUS TACHYCARDIA,1
AR,SPINAL DISORDER,1
AR,SPINAL PAIN,1
AR,SURGERY,1
AR,TINNITUS,1
AR,URINARY TRACT INFECTION,1
AR,URTICARIA,1
AR,VISUAL ACUITY REDUCED,1
AR,VISUAL IMPAIRMENT,1
AU,MALAISE,5
AU,DIZZINESS,4
AU,FATIGUE,4
AU,HYPOTENSION,4
AU,NEUTROPENIA,4
AU,SCHIZOPHRENIA,4
AU,ANTIPSYCHOTIC DRUG LEVEL INCREASED,3
AU,CONDITION AGGRAVATED,3
AU,DIARRHOEA,3
AU,DYSPNOEA,3
AU,HAEMATOCRIT DECREASED,3
AU,HAEMOGLOBIN DECREASED,3
AU,LYMPHOCYTE COUNT INCREASED,3
AU,PRURITUS,3
AU,RASH,3
AU,VIRAL INFECTION,3
AU,WHITE BLOOD CELL COUNT DECREASED,3
AU,ABDOMINAL PAIN,2
AU,ACIDOSIS,2
AU,ACUTE KIDNEY INJURY,2
AU,ANAEMIA,2
AU,ATYPICAL FEMUR FRACTURE,2
AU,COELIAC DISEASE,2
AU,CONSTIPATION,2
AU,DERMATITIS EXFOLIATIVE,2
AU,DIABETES MELLITUS,2
AU,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,2
AU,FALL,2
AU,HEAD INJURY,2
AU,HYPERLACTACIDAEMIA,2
AU,HYPOGLYCAEMIA,2
AU,INTENTIONAL OVERDOSE,2
AU,INTERNAL FIXATION OF FRACTURE,2
AU,ORAL CANDIDIASIS,2
AU,PAIN,2
AU,TOXICITY TO VARIOUS AGENTS,2
AU,ABDOMINAL PAIN UPPER,1
AU,ABNORMAL BEHAVIOUR,1
AU,ACQUIRED CYSTIC KIDNEY DISEASE,1
AU,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
AU,ACUTE HEPATIC FAILURE,1
AU,ADRENAL INSUFFICIENCY,1
AU,AGITATION,1
AU,ALOPECIA,1
AU,AMNESIA,1
AU,AMYLOIDOSIS,1
AU,ANTIPSYCHOTIC DRUG LEVEL DECREASED,1
AU,APPENDIX DISORDER,1
AU,ARTHRALGIA,1
AU,ARTHRITIS REACTIVE,1
AU,ATAXIA,1
AU,ATYPICAL PNEUMONIA,1
AU,BACK PAIN,1
AU,BLINDNESS,1
AU,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
AU,BLOOD CREATININE INCREASED,1
AU,C-REACTIVE PROTEIN DECREASED,1
AU,CARDIAC DISORDER,1
AU,CARDIAC FAILURE CONGESTIVE,1
AU,CARDIOMEGALY,1
AU,CELLULITIS,1
AU,CEREBRAL HAEMORRHAGE,1
AU,CHOLESTASIS,1
AU,CLEAR CELL RENAL CELL CARCINOMA,1
AU,COGNITIVE DISORDER,1
AU,COLD SWEAT,1
AU,CONTUSION,1
AU,COUGH,1
AU,DECREASED APPETITE,1
AU,DEPRESSION,1
AU,DISEASE PROGRESSION,1
AU,DRUG DEPENDENCE,1
AU,DRUG ERUPTION,1
AU,DRUG INEFFECTIVE,1
AU,DUODENAL POLYP,1
AU,DYSPHORIA,1
AU,ECZEMA,1
AU,EMOTIONAL DISTRESS,1
AU,EMPHYSEMA,1
AU,ENCEPHALOPATHY,1
AU,EPISTAXIS,1
AU,ERYTHEMA,1
AU,FACE OEDEMA,1
AU,FAECES DISCOLOURED,1
AU,GASTRIC ULCER,1
AU,GASTRITIS EROSIVE,1
AU,GENERAL PHYSICAL HEALTH DETERIORATION,1
AU,GOUTY TOPHUS,1
AU,HAEMATEMESIS,1
AU,HAEMATURIA,1
AU,HEADACHE,1
AU,HELICOBACTER INFECTION,1
AU,HEPATITIS,1
AU,HERNIA,1
AU,HYPERAMMONAEMIC ENCEPHALOPATHY,1
AU,HYPERPARATHYROIDISM,1
AU,HYPERPROLACTINAEMIA,1
AU,HYPERSENSITIVITY,1
AU,HYPOPHYSITIS,1
AU,HYPOPITUITARISM,1
AU,IMPAIRED SELF-CARE,1
AU,INTERSTITIAL LUNG DISEASE,1
AU,IRON DEFICIENCY,1
AU,JOINT STIFFNESS,1
AU,LABORATORY TEST ABNORMAL,1
AU,LACERATION,1
AU,LARGE INTESTINE POLYP,1
AU,LYMPHADENOPATHY MEDIASTINAL,1
AU,MENORRHAGIA,1
AU,METASTASES TO BONE,1
AU,MOBILITY DECREASED,1
AU,MOUTH ULCERATION,1
AU,MUCOSAL INFLAMMATION,1
AU,MUSCULOSKELETAL PAIN,1
AU,MUSCULOSKELETAL STIFFNESS,1
AU,MYALGIA,1
AU,MYELITIS TRANSVERSE,1
AU,MYOCARDITIS,1
AU,MYOPATHY,1
AU,NAUSEA,1
AU,NECK PAIN,1
AU,NECROTISING MYOSITIS,1
AU,NEURALGIA,1
AU,OEDEMA PERIPHERAL,1
AU,ORTHOSTATIC HYPOTENSION,1
AU,OSTEOARTHRITIS,1
AU,OVERDOSE,1
AU,PALPITATIONS,1
AU,PERICARDITIS,1
AU,PNEUMONIA CYTOMEGALOVIRAL,1
AU,PSORIASIS,1
AU,PULMONARY EMBOLISM,1
AU,RASH ERYTHEMATOUS,1
AU,RASH PRURITIC,1
AU,RENAL FAILURE CHRONIC,1
AU,RENAL IMPAIRMENT,1
AU,RENAL SALT-WASTING SYNDROME,1
AU,RHINORRHOEA,1
AU,SEIZURE,1
AU,SKIN DISCOLOURATION,1
AU,SKIN DISORDER,1
AU,SPLENOMEGALY,1
AU,STEVENS-JOHNSON SYNDROME,1
AU,SWELLING,1
AU,THROMBOCYTOPENIA,1
AU,TOOTHACHE,1
AU,TREATMENT FAILURE,1
AU,TREATMENT NONCOMPLIANCE,1
AU,TUBULOINTERSTITIAL NEPHRITIS,1
AU,URINARY INCONTINENCE,1
AU,URINARY TRACT INFECTION PSEUDOMONAL,1
AU,URTICARIA,1
AU,VISION BLURRED,1
AU,VITAMIN D DECREASED,1
AU,WEIGHT DECREASED,1
AU,WHEEZING,1
AU,WOUND HAEMORRHAGE,1
AT,GASTROINTESTINAL HAEMORRHAGE,4
AT,ATRIAL FIBRILLATION,3
AT,SEPSIS,3
AT,AGEUSIA,2
AT,ANOSMIA,2
AT,BRONCHITIS,2
AT,COUGH,2
AT,DECREASED APPETITE,2
AT,DELIRIUM,2
AT,DIARRHOEA,2
AT,DIZZINESS,2
AT,ECZEMA,2
AT,FUNGAL OESOPHAGITIS,2
AT,GASTROINTESTINAL INFECTION,2
AT,GENERAL PHYSICAL HEALTH DETERIORATION,2
AT,HEADACHE,2
AT,HYPONATRAEMIC ENCEPHALOPATHY,2
AT,INFLUENZA LIKE ILLNESS,2
AT,METAPNEUMOVIRUS INFECTION,2
AT,MUSCULOSKELETAL PAIN,2
AT,PALPITATIONS,2
AT,RHINOVIRUS INFECTION,2
AT,SINUS TACHYCARDIA,2
AT,SYNCOPE,2
AT,TOOTHACHE,2
AT,VISUAL FIELD DEFECT,2
AT,WATER INTOXICATION,2
AT,ANAEMIA,1
AT,APHASIA,1
AT,ATRIAL TACHYCARDIA,1
AT,BLOOD CHLORIDE DECREASED,1
AT,BLOOD OSMOLARITY DECREASED,1
AT,BLOOD POTASSIUM DECREASED,1
AT,BLOOD THYROID STIMULATING HORMONE DECREASED,1
AT,BRAIN STEM HAEMORRHAGE,1
AT,CEREBRAL INFARCTION,1
AT,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
AT,DYSARTHRIA,1
AT,HEMIPARESIS,1
AT,HYPOPHAGIA,1
AT,INCORRECT ROUTE OF DRUG ADMINISTRATION,1
AT,LEUKOPENIA,1
AT,LI-FRAUMENI SYNDROME,1
AT,LUMBAR HERNIA,1
AT,MEDULLOBLASTOMA RECURRENT,1
AT,MELAENA,1
AT,METASTASES TO LIVER,1
AT,PAIN IN EXTREMITY,1
AT,PANCYTOPENIA,1
AT,PULMONARY EMBOLISM,1
AT,PYREXIA,1
AT,SMALL INTESTINE CARCINOMA,1
AT,ULCER,1
BE,MATERNAL EXPOSURE DURING PREGNANCY,5
BE,PREMATURE DELIVERY,5
BE,URINARY TRACT INFECTION,3
BE,DECREASED APPETITE,2
BE,HYPOTENSION,2
BE,SEROTONIN SYNDROME,2
BE,ABNORMAL BEHAVIOUR,1
BE,ACUTE KIDNEY INJURY,1
BE,ACUTE MYOCARDIAL INFARCTION,1
BE,AGGRESSION,1
BE,AGITATION,1
BE,ASCITES,1
BE,ASTHENIA,1
BE,CEREBRAL HAEMORRHAGE,1
BE,CONFUSIONAL STATE,1
BE,CONVULSION,1
BE,DEATH,1
BE,DELIRIUM,1
BE,DEPRESSION,1
BE,DISORIENTATION,1
BE,DIZZINESS,1
BE,DRUG ADMINISTRATION ERROR,1
BE,DRUG WITHDRAWAL SYNDROME,1
BE,ECZEMA,1
BE,ELECTROCARDIOGRAM QT PROLONGED,1
BE,EPILEPSY,1
BE,FATIGUE,1
BE,FEBRILE NEUTROPENIA,1
BE,HERPES ZOSTER,1
BE,HYPERKALAEMIA,1
BE,HYPERREFLEXIA,1
BE,HYPERTONIA,1
BE,HYPOKALAEMIA,1
BE,IMMUNE-MEDIATED NECROTISING MYOPATHY,1
BE,KLUVER-BUCY SYNDROME,1
BE,METABOLIC ACIDOSIS,1
BE,METABOLIC ENCEPHALOPATHY,1
BE,METASTASES TO PERITONEUM,1
BE,METASTASES TO PLEURA,1
BE,NAUSEA,1
BE,OSTEOARTHRITIS,1
BE,OVARIAN CANCER,1
BE,PULMONARY EMBOLISM,1
BE,PYREXIA,1
BE,RENAL DISORDER,1
BE,RENAL TUBULAR ACIDOSIS,1
BE,RESTLESSNESS,1
BE,SEPSIS,1
BE,SOMNOLENCE,1
BE,TOXICITY TO VARIOUS AGENTS,1
BE,UNDERDOSE,1
BE,VISUAL IMPAIRMENT,1
BE,WEIGHT DECREASED,1
BA,HEART RATE DECREASED,1
BA,HYPERKALAEMIA,1
BR,PAIN,92
BR,MALAISE,85
BR,HYPERTENSION,73
BR,DRUG INEFFECTIVE,71
BR,FALL,71
BR,PAIN IN EXTREMITY,71
BR,WEIGHT DECREASED,70
BR,ARTHRALGIA,69
BR,DIZZINESS,63
BR,HEADACHE,58
BR,FATIGUE,57
BR,WEIGHT INCREASED,53
BR,URINARY TRACT INFECTION,51
BR,VOMITING,47
BR,ASTHENIA,46
BR,NAUSEA,46
BR,DIABETES MELLITUS,44
BR,DIARRHOEA,42
BR,DRUG DOSE OMISSION,42
BR,PNEUMONIA,42
BR,DYSPNOEA,41
BR,ANAEMIA,38
BR,DEPRESSION,38
BR,HYPERSENSITIVITY,38
BR,ARRHYTHMIA,37
BR,SYNCOPE,36
BR,TREMOR,36
BR,FEELING ABNORMAL,35
BR,GAIT DISTURBANCE,35
BR,INFLUENZA,33
BR,PYREXIA,33
BR,BLOOD CHOLESTEROL INCREASED,32
BR,SOMNOLENCE,31
BR,BLOOD PRESSURE INCREASED,30
BR,MATERNAL EXPOSURE DURING PREGNANCY,30
BR,CATARACT,29
BR,DECREASED APPETITE,27
BR,OSTEOARTHRITIS,27
BR,BREAST CANCER,26
BR,INSOMNIA,26
BR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,25
BR,TACHYCARDIA,25
BR,THYROID DISORDER,25
BR,CHEST PAIN,24
BR,MEMORY IMPAIRMENT,24
BR,ANXIETY,23
BR,CEREBROVASCULAR ACCIDENT,23
BR,PERIPHERAL SWELLING,23
BR,BACK PAIN,22
BR,COUGH,22
BR,IMMUNODEFICIENCY,22
BR,NERVOUSNESS,22
BR,ABDOMINAL PAIN,21
BR,ABDOMINAL PAIN UPPER,21
BR,PRODUCT USE ISSUE,21
BR,RHEUMATOID ARTHRITIS,21
BR,BLOOD PRESSURE DECREASED,20
BR,BLOOD GLUCOSE INCREASED,19
BR,CARDIAC DISORDER,19
BR,ERYTHEMA,19
BR,HYPOAESTHESIA,19
BR,ALOPECIA,18
BR,FOETAL EXPOSURE DURING PREGNANCY,18
BR,PRURITUS,18
BR,SINUSITIS,18
BR,THROMBOSIS,18
BR,THYROID CANCER,18
BR,VISUAL IMPAIRMENT,18
BR,ARTHROPATHY,17
BR,BLOOD PRESSURE FLUCTUATION,17
BR,GASTRITIS,17
BR,INCORRECT DOSE ADMINISTERED,17
BR,NASOPHARYNGITIS,17
BR,THYROID MASS,17
BR,ABORTION,16
BR,CONSTIPATION,16
BR,DRUG ADMINISTRATION ERROR,16
BR,GASTRIC DISORDER,16
BR,HYPOTENSION,16
BR,SWELLING,16
BR,AMNESIA,15
BR,DRY SKIN,15
BR,DYSPEPSIA,15
BR,HYPERGLYCAEMIA,15
BR,HYPERHIDROSIS,15
BR,INJECTION SITE PAIN,15
BR,ABDOMINAL DISTENSION,14
BR,GASTROINTESTINAL DISORDER,14
BR,MUSCLE SPASMS,14
BR,MUSCULOSKELETAL STIFFNESS,14
BR,OSTEOPOROSIS,14
BR,SEIZURE,14
BR,SPEECH DISORDER,14
BR,ARTHRITIS,13
BR,BLOOD CHOLESTEROL ABNORMAL,13
BR,CONDITION AGGRAVATED,13
BR,EXPOSURE DURING PREGNANCY,13
BR,GLAUCOMA,13
BR,LABYRINTHITIS,13
BR,MUSCULAR WEAKNESS,13
BR,PARAESTHESIA,13
BR,VISION BLURRED,13
BR,BLOOD THYROID STIMULATING HORMONE INCREASED,12
BR,CHOLELITHIASIS,12
BR,CORONARY ARTERY OCCLUSION,12
BR,DYSSTASIA,12
BR,FOETAL DEATH,12
BR,HYPOTHYROIDISM,12
BR,INTERVERTEBRAL DISC PROTRUSION,12
BR,JOINT SWELLING,12
BR,LUNG DISORDER,12
BR,MYALGIA,12
BR,MYOCARDIAL INFARCTION,12
BR,NECK PAIN,12
BR,PRODUCT QUALITY ISSUE,12
BR,THYROID NEOPLASM,12
BR,UNEVALUABLE EVENT,12
BR,VARICOSE VEIN,12
BR,WOUND,12
BR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,12
BR,CRYING,11
BR,DRY MOUTH,11
BR,EATING DISORDER,11
BR,FIBROMYALGIA,11
BR,GLUCOSE TOLERANCE IMPAIRED,11
BR,HAEMORRHAGE,11
BR,HEART RATE INCREASED,11
BR,INFECTION,11
BR,LOCAL SWELLING,11
BR,SPINAL PAIN,11
BR,STRESS,11
BR,ABASIA,10
BR,ABDOMINAL DISCOMFORT,10
BR,BLOOD THYROID STIMULATING HORMONE ABNORMAL,10
BR,CONFUSIONAL STATE,10
BR,DYSPHONIA,10
BR,FEELING HOT,10
BR,GASTROOESOPHAGEAL REFLUX DISEASE,10
BR,HYPOGLYCAEMIA,10
BR,INFLAMMATION,10
BR,OSTEOPENIA,10
BR,OVERDOSE,10
BR,RHINITIS,10
BR,SPINAL DISORDER,10
BR,THERAPY CESSATION,10
BR,THYROIDECTOMY,10
BR,BLINDNESS,9
BR,BLOOD TRIGLYCERIDES INCREASED,9
BR,BODY HEIGHT DECREASED,9
BR,BONE DISORDER,9
BR,DENGUE FEVER,9
BR,DEPRESSED MOOD,9
BR,DYSGEUSIA,9
BR,FEMUR FRACTURE,9
BR,HEAD INJURY,9
BR,HYPERTENSIVE CRISIS,9
BR,INTENTIONAL PRODUCT MISUSE,9
BR,MIGRAINE,9
BR,MUSCULOSKELETAL PAIN,9
BR,NEPHROLITHIASIS,9
BR,OEDEMA PERIPHERAL,9
BR,ORAL DISCOMFORT,9
BR,PALPITATIONS,9
BR,SKIN DISCOLOURATION,9
BR,SPINAL FRACTURE,9
BR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,9
BR,AGITATION,8
BR,ASTHMA,8
BR,BLOOD PRESSURE ABNORMAL,8
BR,BLOOD THYROID STIMULATING HORMONE DECREASED,8
BR,BRONCHITIS,8
BR,CARDIAC ARREST,8
BR,DEMENTIA ALZHEIMER^S TYPE,8
BR,DRUG HYPERSENSITIVITY,8
BR,EXPOSURE DURING BREAST FEEDING,8
BR,FLATULENCE,8
BR,FOOT DEFORMITY,8
BR,METABOLIC SURGERY,8
BR,MOBILITY DECREASED,8
BR,OCULAR HYPERAEMIA,8
BR,OROPHARYNGEAL PAIN,8
BR,RASH,8
BR,RENAL IMPAIRMENT,8
BR,SURGERY,8
BR,URTICARIA,8
BR,VITAMIN D DECREASED,8
BR,ABORTION SPONTANEOUS,7
BR,ANGINA PECTORIS,7
BR,BURNING SENSATION,7
BR,CHILLS,7
BR,COMA,7
BR,CYSTITIS,7
BR,DEHYDRATION,7
BR,FEEDING DISORDER,7
BR,FOOT FRACTURE,7
BR,HAEMATOMA,7
BR,HERNIA,7
BR,INFARCTION,7
BR,LIMB DISCOMFORT,7
BR,LOWER LIMB FRACTURE,7
BR,NEOPLASM MALIGNANT,7
BR,PARKINSON^S DISEASE,7
BR,PRURITUS GENERALISED,7
BR,RENAL DISORDER,7
BR,SJOGREN^S SYNDROME,7
BR,SWELLING FACE,7
BR,TENDON RUPTURE,7
BR,THROAT IRRITATION,7
BR,UPPER LIMB FRACTURE,7
BR,VENOUS OCCLUSION,7
BR,VERTIGO,7
BR,BALANCE DISORDER,6
BR,BENIGN NEOPLASM OF THYROID GLAND,6
BR,CONJUNCTIVITIS,6
BR,DEAFNESS,6
BR,EPISTAXIS,6
BR,FOETAL GROWTH RESTRICTION,6
BR,HEPATIC STEATOSIS,6
BR,HOSPITALISATION,6
BR,HYPERTHYROIDISM,6
BR,HYSTERECTOMY,6
BR,IMPAIRED HEALING,6
BR,INJECTION SITE ERYTHEMA,6
BR,JOINT INJURY,6
BR,LOSS OF CONSCIOUSNESS,6
BR,MOVEMENT DISORDER,6
BR,NEUROPATHY PERIPHERAL,6
BR,OESOPHAGITIS,6
BR,ORAL PAIN,6
BR,PANCREATITIS,6
BR,PANIC DISORDER,6
BR,PRODUCT PHYSICAL ISSUE,6
BR,PRODUCT USE IN UNAPPROVED INDICATION,6
BR,RENAL FAILURE,6
BR,SEPSIS,6
BR,SKIN EXFOLIATION,6
BR,SLEEP DISORDER,6
BR,STOMATITIS,6
BR,THERAPEUTIC RESPONSE UNEXPECTED,6
BR,THYROIDITIS,6
BR,TOOTH DISORDER,6
BR,WHEEZING,6
BR,ABNORMAL BEHAVIOUR,5
BR,ACTIVITIES OF DAILY LIVING IMPAIRED,5
BR,APHASIA,5
BR,APPARENT DEATH,5
BR,ARTERIAL OCCLUSIVE DISEASE,5
BR,ASCITES,5
BR,BEDRIDDEN,5
BR,BLOOD CALCIUM DECREASED,5
BR,BREAST MASS,5
BR,CAESAREAN SECTION,5
BR,CARDIOVASCULAR DISORDER,5
BR,DEATH,5
BR,DIABETES MELLITUS INADEQUATE CONTROL,5
BR,DIABETIC NEUROPATHY,5
BR,DIVERTICULITIS,5
BR,DYSENTERY,5
BR,DYSPHAGIA,5
BR,EMOTIONAL DISORDER,5
BR,ERYSIPELAS,5
BR,EYE DISORDER,5
BR,EYE IRRITATION,5
BR,EYE PAIN,5
BR,EYE SWELLING,5
BR,FEELING COLD,5
BR,GAIT INABILITY,5
BR,GASTROINTESTINAL CARCINOMA,5
BR,GASTROINTESTINAL INFECTION,5
BR,GOITRE,5
BR,HYPOACUSIS,5
BR,HYPOPHAGIA,5
BR,INJECTION SITE INDURATION,5
BR,INJECTION SITE PRURITUS,5
BR,IRRITABILITY,5
BR,ISCHAEMIA,5
BR,KNEE ARTHROPLASTY,5
BR,LACRIMATION INCREASED,5
BR,LIMB INJURY,5
BR,NERVOUS SYSTEM DISORDER,5
BR,PALLOR,5
BR,PLATELET COUNT DECREASED,5
BR,PRODUCTIVE COUGH,5
BR,PSORIASIS,5
BR,PULMONARY EMBOLISM,5
BR,RESPIRATORY DISORDER,5
BR,RETCHING,5
BR,TENDONITIS,5
BR,THROAT TIGHTNESS,5
BR,THYROID FUNCTION TEST ABNORMAL,5
BR,TINNITUS,5
BR,URINARY RETENTION,5
BR,VAGINAL HAEMORRHAGE,5
BR,VIRAL INFECTION,5
BR,VITAMIN D DEFICIENCY,5
BR,ACNE,4
BR,AGEUSIA,4
BR,AORTIC ANEURYSM,4
BR,ASTHMATIC CRISIS,4
BR,ATRIAL FIBRILLATION,4
BR,BLISTER,4
BR,BLOOD GLUCOSE ABNORMAL,4
BR,BLOOD GLUCOSE FLUCTUATION,4
BR,BLOOD PRESSURE INADEQUATELY CONTROLLED,4
BR,BLOOD SODIUM DECREASED,4
BR,BONE PAIN,4
BR,BREAST CANCER FEMALE,4
BR,CATARRH,4
BR,CELLULITIS,4
BR,CEREBRAL THROMBOSIS,4
BR,CHEST DISCOMFORT,4
BR,CHIKUNGUNYA VIRUS INFECTION,4
BR,COLD SWEAT,4
BR,COLITIS,4
BR,CONVULSION,4
BR,DECREASED IMMUNE RESPONSIVENESS,4
BR,DEMENTIA,4
BR,DISCOMFORT,4
BR,EAR DISCOMFORT,4
BR,GENERAL PHYSICAL HEALTH DETERIORATION,4
BR,GENERALISED OEDEMA,4
BR,GLOSSODYNIA,4
BR,HAEMATOCHEZIA,4
BR,HAEMORRHOIDS,4
BR,HEARING IMPAIRED,4
BR,ISCHAEMIC STROKE,4
BR,KNEE OPERATION,4
BR,LIGAMENT RUPTURE,4
BR,LIGAMENT SPRAIN,4
BR,LIVE BIRTH,4
BR,LUNG INFECTION,4
BR,LUNG NEOPLASM MALIGNANT,4
BR,MENTAL DISORDER,4
BR,MICTURITION URGENCY,4
BR,MOUTH INJURY,4
BR,MUSCLE TWITCHING,4
BR,NODULE,4
BR,NORMAL NEWBORN,4
BR,OBESITY,4
BR,OSTEONECROSIS OF JAW,4
BR,OVARIAN CANCER,4
BR,OVARIAN CYST,4
BR,PAPILLARY THYROID CANCER,4
BR,POLYP,4
BR,PREMATURE BABY,4
BR,PRESYNCOPE,4
BR,PSYCHIATRIC SYMPTOM,4
BR,RESPIRATORY FAILURE,4
BR,RIB FRACTURE,4
BR,ROAD TRAFFIC ACCIDENT,4
BR,SCIATICA,4
BR,SENSORY LOSS,4
BR,SKIN DISORDER,4
BR,SPINAL OPERATION,4
BR,THERAPEUTIC RESPONSE DECREASED,4
BR,UNDERDOSE,4
BR,UTERINE LEIOMYOMA,4
BR,VAGINAL DISCHARGE,4
BR,VISUAL ACUITY REDUCED,4
BR,ABSCESS,3
BR,ADVERSE EVENT,3
BR,AGGRESSION,3
BR,AMNIOTIC FLUID VOLUME DECREASED,3
BR,APHONIA,3
BR,BACK INJURY,3
BR,BACTERIAL INFECTION,3
BR,BLOOD GLUCOSE DECREASED,3
BR,BLOOD POTASSIUM DECREASED,3
BR,BLOOD TEST ABNORMAL,3
BR,BODY TEMPERATURE DECREASED,3
BR,BONE DENSITY DECREASED,3
BR,BONE LOSS,3
BR,BONE NEOPLASM,3
BR,BREAST ENLARGEMENT,3
BR,BRONCHOPNEUMONIA,3
BR,CANDIDA INFECTION,3
BR,CARDIAC FAILURE,3
BR,CARDIAC FAILURE CONGESTIVE,3
BR,CARDIAC FIBRILLATION,3
BR,CARDIAC PACEMAKER INSERTION,3
BR,CATARACT OPERATION,3
BR,CHOKING,3
BR,CHROMATURIA,3
BR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,3
BR,COLON CANCER,3
BR,CONCOMITANT DISEASE AGGRAVATED,3
BR,COORDINATION ABNORMAL,3
BR,CYST,3
BR,DEPRESSED LEVEL OF CONSCIOUSNESS,3
BR,DEVICE FAILURE,3
BR,DEVICE MALFUNCTION,3
BR,DISORIENTATION,3
BR,DISTURBANCE IN ATTENTION,3
BR,DRUG DEPENDENCE,3
BR,DRUG EFFECT DECREASED,3
BR,DRUG EFFECT INCOMPLETE,3
BR,DRUG INTOLERANCE,3
BR,DRUG PRESCRIBING ERROR,3
BR,DRY EYE,3
BR,EAR INFECTION,3
BR,EMOTIONAL DISTRESS,3
BR,EMPHYSEMA,3
BR,EYE HAEMORRHAGE,3
BR,EYE PRURITUS,3
BR,FEAR,3
BR,FIBROSIS,3
BR,FORMICATION,3
BR,GALLBLADDER DISORDER,3
BR,GASTRIC HAEMORRHAGE,3
BR,GASTROINTESTINAL MOTILITY DISORDER,3
BR,GASTROINTESTINAL NEOPLASM,3
BR,GLYCOSYLATED HAEMOGLOBIN INCREASED,3
BR,HALLUCINATION,3
BR,HEAD DISCOMFORT,3
BR,HEPATITIS,3
BR,HERPES VIRUS INFECTION,3
BR,HERPES ZOSTER,3
BR,HIATUS HERNIA,3
BR,HUNGER,3
BR,HYPERAESTHESIA,3
BR,HYPERCHLORHYDRIA,3
BR,HYPERSOMNIA,3
BR,HYPOKINESIA,3
BR,HYPONATRAEMIA,3
BR,HYPOVITAMINOSIS,3
BR,ILL-DEFINED DISORDER,3
BR,INCORRECT PRODUCT STORAGE,3
BR,INCREASED APPETITE,3
BR,INGUINAL HERNIA,3
BR,INJECTION SITE MASS,3
BR,INJECTION SITE WARMTH,3
BR,IRON DEFICIENCY,3
BR,JAW FRACTURE,3
BR,KYPHOSIS,3
BR,LARYNGEAL OEDEMA,3
BR,LEIOMYOMA,3
BR,LIVER DISORDER,3
BR,LOCALISED INFECTION,3
BR,MASS,3
BR,MENOPAUSE,3
BR,MOOD ALTERED,3
BR,MULTIPLE SCLEROSIS RELAPSE,3
BR,NAIL DISORDER,3
BR,NASAL DRYNESS,3
BR,NEUTROPENIA,3
BR,ONYCHOCLASIS,3
BR,ORAL CANDIDIASIS,3
BR,OSTEOMYELITIS,3
BR,PANCREATIC DISORDER,3
BR,PHARYNGITIS,3
BR,POOR QUALITY SLEEP,3
BR,POST PROCEDURAL COMPLICATION,3
BR,PROSTATOMEGALY,3
BR,PULMONARY OEDEMA,3
BR,PYELONEPHRITIS,3
BR,RENAL CANCER,3
BR,RESTLESSNESS,3
BR,RHINORRHOEA,3
BR,ROTATOR CUFF SYNDROME,3
BR,SENSORY DISTURBANCE,3
BR,SKIN IRRITATION,3
BR,SLUGGISHNESS,3
BR,SNEEZING,3
BR,SPINAL OSTEOARTHRITIS,3
BR,SUICIDAL IDEATION,3
BR,SUICIDE ATTEMPT,3
BR,SYSTEMIC LUPUS ERYTHEMATOSUS,3
BR,THIRST,3
BR,THYROID HORMONES INCREASED,3
BR,THYROXINE ABNORMAL,3
BR,THYROXINE DECREASED,3
BR,TONGUE DISORDER,3
BR,TOOTH FRACTURE,3
BR,TOOTH INFECTION,3
BR,TYPE 2 DIABETES MELLITUS,3
BR,ULCER,3
BR,UTERINE CYST,3
BR,WALKING AID USER,3
BR,WEIGHT LOSS POOR,3
BR,WHITE BLOOD CELL COUNT DECREASED,3
BR,ABDOMINAL HERNIA,2
BR,ABDOMINAL INFECTION,2
BR,ABNORMAL SENSATION IN EYE,2
BR,ACCIDENT,2
BR,ACCIDENTAL EXPOSURE TO PRODUCT,2
BR,AFFECTIVE DISORDER,2
BR,AMNIOTIC FLUID VOLUME INCREASED,2
BR,ANEURYSM,2
BR,ANGIOPATHY,2
BR,ANKLE FRACTURE,2
BR,ANKYLOSING SPONDYLITIS,2
BR,ANORECTAL DISCOMFORT,2
BR,APPENDICITIS,2
BR,ARTERIAL INJURY,2
BR,ARTERIAL STENOSIS,2
BR,ASPARTATE AMINOTRANSFERASE INCREASED,2
BR,ASPIRATION,2
BR,ASPIRATION BRONCHIAL,2
BR,ATROPHY,2
BR,BLADDER DISORDER,2
BR,BLINDNESS UNILATERAL,2
BR,BLOOD CALCIUM INCREASED,2
BR,BLOOD CHOLESTEROL DECREASED,2
BR,BLOOD GROWTH HORMONE INCREASED,2
BR,BLOOD INSULIN INCREASED,2
BR,BLOOD TESTOSTERONE DECREASED,2
BR,BLOOD URIC ACID INCREASED,2
BR,BRADYCARDIA,2
BR,BRADYPHRENIA,2
BR,BREAST DISORDER,2
BR,BREECH PRESENTATION,2
BR,BRONCHIECTASIS,2
BR,BURSITIS,2
BR,CANCER PAIN,2
BR,CARDIAC VALVE DISEASE,2
BR,CARDIOMEGALY,2
BR,CENTRAL NERVOUS SYSTEM LESION,2
BR,CEREBRAL ISCHAEMIA,2
BR,CERVICAL VERTEBRAL FRACTURE,2
BR,CERVIX CARCINOMA,2
BR,CHOLECYSTITIS,2
BR,CLAVICLE FRACTURE,2
BR,COMPLICATION OF PREGNANCY,2
BR,CONTUSION,2
BR,DENTAL IMPLANTATION,2
BR,DERMATITIS,2
BR,DEVICE DISLOCATION,2
BR,DEVICE LOOSENING,2
BR,DEVICE OCCLUSION,2
BR,DIPLOPIA,2
BR,DISEASE PROGRESSION,2
BR,DRUG ADMINISTERED AT INAPPROPRIATE SITE,2
BR,DRUG DISPENSING ERROR,2
BR,DYSARTHRIA,2
BR,DYSMENORRHOEA,2
BR,EAR DISORDER,2
BR,EAR PAIN,2
BR,EMBOLISM,2
BR,ENDOMETRIOSIS,2
BR,EPILEPSY,2
BR,EUPHORIC MOOD,2
BR,EXOSTOSIS,2
BR,EXPIRED DRUG ADMINISTERED,2
BR,EXPIRED PRODUCT ADMINISTERED,2
BR,EYE INFLAMMATION,2
BR,FAECES DISCOLOURED,2
BR,FEBRILE NEUTROPENIA,2
BR,FEELING DRUNK,2
BR,FEELING JITTERY,2
BR,FINGER DEFORMITY,2
BR,FLUID RETENTION,2
BR,GASTRIC POLYPS,2
BR,GASTROINTESTINAL PAIN,2
BR,GASTROINTESTINAL TRACT ADENOMA,2
BR,GINGIVAL BLEEDING,2
BR,GINGIVAL DISORDER,2
BR,GLUTEN SENSITIVITY,2
BR,GROIN PAIN,2
BR,HAEMATURIA,2
BR,HAEMOGLOBIN DECREASED,2
BR,HALLUCINATION_ VISUAL,2
BR,HEART RATE DECREASED,2
BR,HEART RATE IRREGULAR,2
BR,HEPATIC CIRRHOSIS,2
BR,HEPATIC PAIN,2
BR,HOT FLUSH,2
BR,HYPERAEMIA,2
BR,HYPERCHOLESTEROLAEMIA,2
BR,HYPOAESTHESIA ORAL,2
BR,HYPOPNOEA,2
BR,IMMUNE SYSTEM DISORDER,2
BR,INCORRECT ROUTE OF DRUG ADMINISTRATION,2
BR,INJECTION SITE BRUISING,2
BR,INJECTION SITE HAEMATOMA,2
BR,INJECTION SITE SWELLING,2
BR,INJURY,2
BR,INSULIN RESISTANCE,2
BR,INTENTIONAL DRUG MISUSE,2
BR,INTENTIONAL PRODUCT USE ISSUE,2
BR,INTERVERTEBRAL DISC DISORDER,2
BR,INTESTINAL OBSTRUCTION,2
BR,INTESTINAL PERFORATION,2
BR,INVESTIGATION ABNORMAL,2
BR,JAUNDICE NEONATAL,2
BR,JAW DISORDER,2
BR,JOINT DISLOCATION,2
BR,JOINT STIFFNESS,2
BR,KNEE DEFORMITY,2
BR,LACTOSE INTOLERANCE,2
BR,LEUKAEMIA,2
BR,LIMB OPERATION,2
BR,LIPODYSTROPHY ACQUIRED,2
BR,LIVER INJURY,2
BR,LUMBAR VERTEBRAL FRACTURE,2
BR,LYMPHADENOPATHY,2
BR,LYMPHOMA,2
BR,MALNUTRITION,2
BR,MATERNAL EXPOSURE BEFORE PREGNANCY,2
BR,MEDICATION ERROR,2
BR,MEDICATION RESIDUE PRESENT,2
BR,MENISCUS INJURY,2
BR,MENORRHAGIA,2
BR,MENSTRUAL DISORDER,2
BR,MENTAL IMPAIRMENT,2
BR,METASTASES TO SPINE,2
BR,METASTASIS,2
BR,MITRAL VALVE INCOMPETENCE,2
BR,MONOPLEGIA,2
BR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
BR,MUSCLE HAEMORRHAGE,2
BR,MUSCLE RIGIDITY,2
BR,MUSCULOSKELETAL CHEST PAIN,2
BR,MYOPIA,2
BR,NASAL CONGESTION,2
BR,NEEDLE ISSUE,2
BR,NEOPLASM PROGRESSION,2
BR,NEPHROTIC SYNDROME,2
BR,NERVE COMPRESSION,2
BR,NIGHTMARE,2
BR,NOSOCOMIAL INFECTION,2
BR,OLIGOHYDRAMNIOS,2
BR,ORAL DISORDER,2
BR,OROPHARYNGEAL DISCOMFORT,2
BR,OVARIAN NEOPLASM,2
BR,OXYGEN SATURATION DECREASED,2
BR,PANCREATIC CARCINOMA,2
BR,PANCREATOLITHIASIS,2
BR,PANIC REACTION,2
BR,PATHOLOGICAL FRACTURE,2
BR,PERICARDIAL EFFUSION,2
BR,PERIPHERAL COLDNESS,2
BR,PHARYNGEAL DISORDER,2
BR,PHARYNGEAL INFLAMMATION,2
BR,PLATELET COUNT ABNORMAL,2
BR,PLEURAL EFFUSION,2
BR,PNEUMOTHORAX,2
BR,POST PROCEDURAL DISCHARGE,2
BR,PRE-ECLAMPSIA,2
BR,PRE-EXISTING CONDITION IMPROVED,2
BR,PREGNANCY,2
BR,PREMATURE DELIVERY,2
BR,PREMATURE RUPTURE OF MEMBRANES,2
BR,PRODUCT BLISTER PACKAGING ISSUE,2
BR,PRODUCT SUBSTITUTION ISSUE,2
BR,PRODUCT TASTE ABNORMAL,2
BR,PROSTATIC DISORDER,2
BR,PSORIATIC ARTHROPATHY,2
BR,PULMONARY MASS,2
BR,RASH ERYTHEMATOUS,2
BR,RED BLOOD CELL COUNT DECREASED,2
BR,RENAL INJURY,2
BR,RENAL PAIN,2
BR,RESPIRATION ABNORMAL,2
BR,RHEUMATIC DISORDER,2
BR,SCAR,2
BR,SCIATIC NERVE INJURY,2
BR,SELF ESTEEM DECREASED,2
BR,SEPTIC SHOCK,2
BR,SHOCK,2
BR,SKIN DEPIGMENTATION,2
BR,SKIN FISSURES,2
BR,SKIN HYPERTROPHY,2
BR,SKIN PLAQUE,2
BR,SKIN SENSITISATION,2
BR,SKIN ULCER,2
BR,SPINAL DEFORMITY,2
BR,SPLENOMEGALY,2
BR,SWOLLEN TONGUE,2
BR,SYNOVIAL CYST,2
BR,TENSION HEADACHE,2
BR,THROMBOCYTOPENIA,2
BR,THYROID CYST,2
BR,THYROID NODULE REMOVAL,2
BR,THYROID OPERATION,2
BR,THYROXINE INCREASED,2
BR,TOOTHACHE,2
BR,TRANSIENT ISCHAEMIC ATTACK,2
BR,TRI-IODOTHYRONINE DECREASED,2
BR,TUMOUR PAIN,2
BR,URETHRAL PAIN,2
BR,URINARY INCONTINENCE,2
BR,URINARY TRACT INFECTION BACTERIAL,2
BR,UTERINE DISORDER,2
BR,UTERINE HAEMORRHAGE,2
BR,UTERINE PAIN,2
BR,UTERINE POLYP,2
BR,VARICES OESOPHAGEAL,2
BR,VASCULAR OCCLUSION,2
BR,VASCULITIS,2
BR,VEIN DISORDER,2
BR,VISUAL FIELD DEFECT,2
BR,VITAMIN B12 DEFICIENCY,2
BR,VULVOVAGINAL PRURITUS,2
BR,WHITE BLOOD CELL COUNT INCREASED,2
BR,WOUND SECRETION,2
BR,YELLOW SKIN,2
BR,ABDOMINAL ADHESIONS,1
BR,ABDOMINAL PAIN LOWER,1
BR,ABDOMINAL RIGIDITY,1
BR,ABDOMINAL WALL CYST,1
BR,ABDOMINAL WALL WOUND,1
BR,ABORTION INCOMPLETE,1
BR,ABSTAINS FROM ALCOHOL,1
BR,ACCIDENTAL OVERDOSE,1
BR,ACQUIRED HAEMOPHILIA,1
BR,ACUTE KIDNEY INJURY,1
BR,ACUTE MYOCARDIAL INFARCTION,1
BR,ACUTE PULMONARY OEDEMA,1
BR,ADENOIDECTOMY,1
BR,ADRENAL ADENOMA,1
BR,ADRENAL DISORDER,1
BR,AFFECT LABILITY,1
BR,ALANINE AMINOTRANSFERASE ABNORMAL,1
BR,ALANINE AMINOTRANSFERASE INCREASED,1
BR,ALLERGIC COUGH,1
BR,ALLERGY TO CHEMICALS,1
BR,ALPHA 1 FOETOPROTEIN INCREASED,1
BR,AMENORRHOEA,1
BR,AMERICAN TRYPANOSOMIASIS,1
BR,AMNIORRHOEA,1
BR,AMYLASE INCREASED,1
BR,AMYOTROPHIC LATERAL SCLEROSIS,1
BR,ANAL FISSURE,1
BR,ANAL HAEMORRHAGE,1
BR,ANAPHYLACTIC SHOCK,1
BR,ANEURYSM REPAIR,1
BR,ANGER,1
BR,ANGINA UNSTABLE,1
BR,ANIMAL SCRATCH,1
BR,ANTI-THYROID ANTIBODY POSITIVE,1
BR,ANURIA,1
BR,AORTIC VALVE STENOSIS,1
BR,APALLIC SYNDROME,1
BR,APATHY,1
BR,APHAGIA,1
BR,APPLICATION SITE ERYTHEMA,1
BR,APPLICATION SITE REACTION,1
BR,ARTERIOSCLEROSIS,1
BR,ARTHROPOD STING,1
BR,ASPARTATE AMINOTRANSFERASE ABNORMAL,1
BR,ASPHYXIA,1
BR,ASTHENOPIA,1
BR,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
BR,ATRIOVENTRICULAR BLOCK SECOND DEGREE,1
BR,ATROPHIC GLOSSITIS,1
BR,AUTISM SPECTRUM DISORDER,1
BR,AUTOIMMUNE HEPATITIS,1
BR,AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME,1
BR,AUTOIMMUNE THYROIDITIS,1
BR,BACK DISORDER,1
BR,BENIGN HEPATIC NEOPLASM,1
BR,BIPOLAR DISORDER,1
BR,BLADDER CANCER,1
BR,BLADDER DILATATION,1
BR,BLADDER NEOPLASM,1
BR,BLADDER OPERATION,1
BR,BLADDER PROLAPSE,1
BR,BLEPHARITIS,1
BR,BLOOD COUNT ABNORMAL,1
BR,BLOOD CREATININE ABNORMAL,1
BR,BLOOD ELECTROLYTES DECREASED,1
BR,BLOOD FOLATE DECREASED,1
BR,BLOOD IMMUNOGLOBULIN A DECREASED,1
BR,BLOOD IMMUNOGLOBULIN G DECREASED,1
BR,BLOOD OESTROGEN ABNORMAL,1
BR,BLOOD PROLACTIN DECREASED,1
BR,BLOOD SODIUM ABNORMAL,1
BR,BLOOD TRIGLYCERIDES ABNORMAL,1
BR,BLOOD URIC ACID,1
BR,BLOOD URINE,1
BR,BLOOD URINE PRESENT,1
BR,BONE CYST,1
BR,BONE DECALCIFICATION,1
BR,BONE FISSURE,1
BR,BONE MARROW DISORDER,1
BR,BONE MARROW OEDEMA,1
BR,BORDERLINE SEROUS TUMOUR OF OVARY,1
BR,BOREDOM,1
BR,BRADYARRHYTHMIA,1
BR,BRAIN INJURY,1
BR,BRAIN NEOPLASM MALIGNANT,1
BR,BREAST CALCIFICATIONS,1
BR,BREAST CANCER RECURRENT,1
BR,BREAST CANCER STAGE IV,1
BR,BREAST CYST,1
BR,BREAST HYPERPLASIA,1
BR,BREAST INDURATION,1
BR,BREAST INJURY,1
BR,BREAST PAIN,1
BR,BREAST RECONSTRUCTION,1
BR,BREAST SWELLING,1
BR,BREATH ODOUR,1
BR,BRONCHIOLITIS,1
BR,BRONCHOSPASM,1
BR,BUDD-CHIARI SYNDROME,1
BR,BUTTOCK CRUSHING,1
BR,C-REACTIVE PROTEIN ABNORMAL,1
BR,C-REACTIVE PROTEIN INCREASED,1
BR,CARBOHYDRATE ANTIGEN 125,1
BR,CARDIAC ANEURYSM,1
BR,CARDIAC ASSISTANCE DEVICE USER,1
BR,CARDIAC DISCOMFORT,1
BR,CARDIAC HYPERTROPHY,1
BR,CARDIAC OPERATION,1
BR,CAROTID ARTERIOSCLEROSIS,1
BR,CAROTID ARTERY OCCLUSION,1
BR,CARTILAGE ATROPHY,1
BR,CARTILAGE INJURY,1
BR,CATARACT DIABETIC,1
BR,CAUDA EQUINA SYNDROME,1
BR,CEREBELLAR ATROPHY,1
BR,CEREBRAL DISORDER,1
BR,CEREBROVASCULAR INSUFFICIENCY,1
BR,CERVICAL CONISATION,1
BR,CHOLECYSTITIS CHRONIC,1
BR,CHONDROPATHY,1
BR,CHROMOSOME ANALYSIS ABNORMAL,1
BR,CHRONIC GASTRITIS,1
BR,COAGULOPATHY,1
BR,COGNITIVE DISORDER,1
BR,COMPLICATION OF DELIVERY,1
BR,CONGENITAL ANAEMIA,1
BR,CONGENITAL CYSTIC KIDNEY DISEASE,1
BR,CONGENITAL TORTICOLLIS,1
BR,CONTRAINDICATION TO MEDICAL TREATMENT,1
BR,CORNEAL DECOMPENSATION,1
BR,CORNEAL DISORDER,1
BR,CORNEAL PERFORATION,1
BR,CREPITATIONS,1
BR,CRYSTAL ARTHROPATHY,1
BR,CRYSTAL URINE PRESENT,1
BR,CYSTITIS NONINFECTIVE,1
BR,DARK CIRCLES UNDER EYES,1
BR,DAYDREAMING,1
BR,DEEP VEIN THROMBOSIS,1
BR,DELIRIUM,1
BR,DELUSION,1
BR,DENTAL OPERATION,1
BR,DEPENDENCE,1
BR,DERMATITIS BULLOUS,1
BR,DEVELOPMENTAL DELAY,1
BR,DEVICE ISSUE,1
BR,DIABETIC COMA,1
BR,DIABETIC EYE DISEASE,1
BR,DIABETIC FOOT,1
BR,DIABETIC KETOACIDOSIS,1
BR,DIABETIC RETINOPATHY,1
BR,DISSOCIATION,1
BR,DROOLING,1
BR,DRUG-INDUCED LIVER INJURY,1
BR,DYSBACTERIOSIS,1
BR,DYSLIPIDAEMIA,1
BR,DYSPLASIA,1
BR,DYSPNOEA EXERTIONAL,1
BR,DYSTONIA,1
BR,DYSURIA,1
BR,ECTOPIC PREGNANCY,1
BR,ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY,1
BR,ELECTROENCEPHALOGRAM ABNORMAL,1
BR,ENTERITIS,1
BR,ENURESIS,1
BR,ERUCTATION,1
BR,ERYTHEMA NODOSUM,1
BR,ESCHERICHIA INFECTION,1
BR,EXERCISE LACK OF,1
BR,EXPOSURE VIA BREAST MILK,1
BR,EXTRA DOSE ADMINISTERED,1
BR,EXTRASYSTOLES,1
BR,EYE ALLERGY,1
BR,EYE DISCHARGE,1
BR,EYE INFECTION,1
BR,EYE INJURY,1
BR,EYE OPERATION,1
BR,EYE PENETRATION,1
BR,EYELID DERMATOCHALASIS,1
BR,EYELID OEDEMA,1
BR,EYELID PTOSIS,1
BR,FACE OEDEMA,1
BR,FACIAL BONES FRACTURE,1
BR,FALLOPIAN TUBE OPERATION,1
BR,FEELING OF DESPAIR,1
BR,FEELING OF RELAXATION,1
BR,FEMORAL NECK FRACTURE,1
BR,FISTULA,1
BR,FLUID INTAKE REDUCED,1
BR,FOETAL DISTRESS SYNDROME,1
BR,FOETAL MALPOSITION,1
BR,FOETAL PLACENTAL THROMBOSIS,1
BR,FOOD ALLERGY,1
BR,FOOD CRAVING,1
BR,FOOD INTOLERANCE,1
BR,FOOD POISONING,1
BR,FRACTURE,1
BR,FRACTURE NONUNION,1
BR,FRACTURE PAIN,1
BR,FREQUENT BOWEL MOVEMENTS,1
BR,FRUSTRATION TOLERANCE DECREASED,1
BR,FURUNCLE,1
BR,GALLBLADDER INJURY,1
BR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
BR,GASTRECTOMY,1
BR,GASTRIC CANCER,1
BR,GASTRIC OPERATION,1
BR,GASTROINTESTINAL BACTERIAL INFECTION,1
BR,GASTROINTESTINAL HAEMORRHAGE,1
BR,GASTROINTESTINAL INFLAMMATION,1
BR,GASTROINTESTINAL INJURY,1
BR,GASTROINTESTINAL SURGERY,1
BR,GASTROINTESTINAL TRACT IRRITATION,1
BR,GASTROINTESTINAL ULCER,1
BR,GENERAL PHYSICAL CONDITION ABNORMAL,1
BR,GENERALISED ANXIETY DISORDER,1
BR,GENITAL DISCOMFORT,1
BR,GENITAL PAIN,1
BR,GENITAL RASH,1
BR,GESTATIONAL HYPERTENSION,1
BR,GINGIVAL ERYTHEMA,1
BR,GINGIVAL SWELLING,1
BR,GINGIVITIS,1
BR,GOUT,1
BR,GRANULOMA,1
BR,H1N1 INFLUENZA,1
BR,HAEMOGLOBIN ABNORMAL,1
BR,HAEMORRHAGE IN PREGNANCY,1
BR,HAIR DISORDER,1
BR,HAIR TEXTURE ABNORMAL,1
BR,HALLUCINATION_ AUDITORY,1
BR,HAND FRACTURE,1
BR,HEART DISEASE CONGENITAL,1
BR,HEART INJURY,1
BR,HEART RATE ABNORMAL,1
BR,HEAT ILLNESS,1
BR,HELICOBACTER INFECTION,1
BR,HELMINTHIC INFECTION,1
BR,HEPATIC CANCER,1
BR,HEPATIC ENZYME INCREASED,1
BR,HEPATIC NEOPLASM,1
BR,HEPATITIS C,1
BR,HEPATOMEGALY,1
BR,HERNIA PAIN,1
BR,HERNIA PERFORATION,1
BR,HICCUPS,1
BR,HIGH DENSITY LIPOPROTEIN DECREASED,1
BR,HIP FRACTURE,1
BR,HOOKWORM INFECTION,1
BR,HORMONE LEVEL ABNORMAL,1
BR,HYDROCEPHALUS,1
BR,HYPERACUSIS,1
BR,HYPERCALCAEMIA,1
BR,HYPERKALAEMIA,1
BR,HYPERPYREXIA,1
BR,HYPERTHERMIA,1
BR,HYPERTRICHOSIS,1
BR,HYPOCALCAEMIA,1
BR,HYPOGAMMAGLOBULINAEMIA,1
BR,HYPOGLOBULINAEMIA,1
BR,HYPOTHERMIA,1
BR,HYPOVOLAEMIC SHOCK,1
BR,IDIOPATHIC PULMONARY FIBROSIS,1
BR,IIIRD NERVE PARALYSIS,1
BR,ILEUS,1
BR,IMMUNOGLOBULINS ABNORMAL,1
BR,IMMUNOSUPPRESSION,1
BR,IMPATIENCE,1
BR,INADEQUATE LUBRICATION,1
BR,INCISIONAL HERNIA,1
BR,INCOHERENT,1
BR,INCONTINENCE,1
BR,INCORRECT DOSAGE ADMINISTERED,1
BR,INCORRECT DRUG ADMINISTRATION DURATION,1
BR,INCREASED BRONCHIAL SECRETION,1
BR,INCREASED UPPER AIRWAY SECRETION,1
BR,INFLAMMATORY BOWEL DISEASE,1
BR,INFLAMMATORY MARKER INCREASED,1
BR,INFLAMMATORY PAIN,1
BR,INFLUENZA LIKE ILLNESS,1
BR,INFUSION RELATED REACTION,1
BR,INGROWN HAIR,1
BR,INJECTION SITE DISCOLOURATION,1
BR,INJECTION SITE HYPERSENSITIVITY,1
BR,INJECTION SITE LACERATION,1
BR,INJECTION SITE URTICARIA,1
BR,INJECTION SITE VESICLES,1
BR,INTENTIONAL UNDERDOSE,1
BR,INTERSTITIAL LUNG DISEASE,1
BR,INTESTINAL HAEMORRHAGE,1
BR,INTESTINAL PSEUDO-OBSTRUCTION,1
BR,INTESTINAL RESECTION,1
BR,INTRAOCULAR PRESSURE INCREASED,1
BR,IRON DEFICIENCY ANAEMIA,1
BR,IRRITABLE BOWEL SYNDROME,1
BR,JOINT EFFUSION,1
BR,JOINT NEOPLASM,1
BR,JOINT RANGE OF MOTION DECREASED,1
BR,KIDNEY INFECTION,1
BR,KLEBSIELLA INFECTION,1
BR,KYPHOSIS POSTOPERATIVE,1
BR,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,1
CA,FATIGUE,565
CA,DRUG INEFFECTIVE,463
CA,NAUSEA,443
CA,ARTHRALGIA,386
CA,PAIN,382
CA,DIARRHOEA,355
CA,DYSPNOEA,342
CA,HEADACHE,321
CA,BLOOD PRESSURE INCREASED,276
CA,PAIN IN EXTREMITY,272
CA,WEIGHT DECREASED,272
CA,ASTHENIA,271
CA,DIZZINESS,268
CA,MALAISE,268
CA,VOMITING,261
CA,FALL,260
CA,NASOPHARYNGITIS,246
CA,PNEUMONIA,237
CA,COUGH,227
CA,RHEUMATOID ARTHRITIS,222
CA,PERIPHERAL SWELLING,199
CA,PYREXIA,199
CA,JOINT SWELLING,198
CA,WEIGHT INCREASED,192
CA,DEATH,186
CA,BACK PAIN,178
CA,GAIT DISTURBANCE,178
CA,ABDOMINAL PAIN,165
CA,INFUSION RELATED REACTION,163
CA,HYPOTENSION,159
CA,RASH,159
CA,CONDITION AGGRAVATED,155
CA,PRURITUS,154
CA,ARTHRITIS,150
CA,URINARY TRACT INFECTION,146
CA,DECREASED APPETITE,144
CA,CHEST PAIN,135
CA,HAEMOGLOBIN DECREASED,134
CA,HERPES ZOSTER,131
CA,INFECTION,131
CA,ANAEMIA,125
CA,HYPERTENSION,124
CA,BRONCHITIS,123
CA,INFLUENZA,122
CA,DRUG INTOLERANCE,119
CA,INSOMNIA,117
CA,ERYTHEMA,114
CA,BLOOD PRESSURE SYSTOLIC INCREASED,113
CA,MUSCLE SPASMS,113
CA,OROPHARYNGEAL PAIN,109
CA,MYALGIA,108
CA,CONSTIPATION,106
CA,SOMNOLENCE,104
CA,SINUSITIS,103
CA,HYPOAESTHESIA,100
CA,HEART RATE INCREASED,98
CA,OXYGEN SATURATION DECREASED,97
CA,MUSCULOSKELETAL PAIN,96
CA,SYNOVITIS,96
CA,CONTUSION,95
CA,ABDOMINAL PAIN UPPER,92
CA,HYPERSENSITIVITY,91
CA,ABDOMINAL DISCOMFORT,90
CA,DEHYDRATION,90
CA,HEPATIC ENZYME INCREASED,89
CA,FEELING ABNORMAL,88
CA,CHEST DISCOMFORT,85
CA,HEART RATE DECREASED,85
CA,OEDEMA PERIPHERAL,85
CA,PALPITATIONS,85
CA,ANXIETY,84
CA,SWELLING,83
CA,MUSCULOSKELETAL STIFFNESS,81
CA,MUSCULAR WEAKNESS,80
CA,PARAESTHESIA,78
CA,TREMOR,78
CA,DEPRESSION,77
CA,OSTEOARTHRITIS,76
CA,ABDOMINAL DISTENSION,75
CA,CHILLS,75
CA,LOSS OF CONSCIOUSNESS,75
CA,BLOOD CHOLESTEROL INCREASED,74
CA,INJECTION SITE PAIN,74
CA,PRODUCTIVE COUGH,74
CA,DYSPEPSIA,73
CA,PRODUCT USE ISSUE,72
CA,ASTHMA,70
CA,CEREBROVASCULAR ACCIDENT,70
CA,GENERAL PHYSICAL HEALTH DETERIORATION,70
CA,HYPERHIDROSIS,68
CA,URTICARIA,68
CA,FIBROMYALGIA,67
CA,LOWER RESPIRATORY TRACT INFECTION,67
CA,ARTHROPATHY,66
CA,CONFUSIONAL STATE,65
CA,BLOOD PRESSURE DECREASED,64
CA,CATARACT,63
CA,STRESS,63
CA,LUNG INFECTION,62
CA,NASAL CONGESTION,62
CA,HOT FLUSH,61
CA,MIGRAINE,61
CA,HYPOTHYROIDISM,60
CA,MYOCARDIAL INFARCTION,60
CA,BODY TEMPERATURE DECREASED,59
CA,DYSPHAGIA,59
CA,VISION BLURRED,59
CA,ATRIAL FIBRILLATION,58
CA,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,58
CA,BLOOD GLUCOSE INCREASED,57
CA,FLUSHING,56
CA,BLOOD PRESSURE FLUCTUATION,55
CA,LEUKOPENIA,55
CA,MOBILITY DECREASED,55
CA,RHINORRHOEA,55
CA,BONE PAIN,52
CA,FEELING HOT,52
CA,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,52
CA,PLATELET COUNT DECREASED,52
CA,SYNCOPE,52
CA,ALOPECIA,51
CA,DRUG DOSE OMISSION,51
CA,DRUG HYPERSENSITIVITY,51
CA,DRY MOUTH,51
CA,HAEMORRHAGE,51
CA,WHITE BLOOD CELL COUNT DECREASED,51
CA,BALANCE DISORDER,49
CA,CELLULITIS,49
CA,VISUAL IMPAIRMENT,49
CA,PSORIASIS,48
CA,PULMONARY OEDEMA,48
CA,PLEURAL EFFUSION,47
CA,EPISTAXIS,46
CA,MALIGNANT MELANOMA,46
CA,CYSTITIS,45
CA,DYSPHONIA,45
CA,HAEMATOCHEZIA,45
CA,INFLUENZA LIKE ILLNESS,45
CA,LIVER FUNCTION TEST ABNORMAL,45
CA,NEPHROLITHIASIS,45
CA,RED BLOOD CELL SEDIMENTATION RATE INCREASED,45
CA,RENAL FAILURE,45
CA,BLOOD CREATININE INCREASED,44
CA,DISEASE PROGRESSION,43
CA,DRUG EFFECT DECREASED,43
CA,AMNESIA,42
CA,NECK PAIN,42
CA,PNEUMONIA VIRAL,42
CA,BLOOD PRESSURE DIASTOLIC DECREASED,41
CA,INFLAMMATION,41
CA,MALIGNANT NEOPLASM PROGRESSION,41
CA,WHEEZING,41
CA,BURNING SENSATION,40
CA,LUNG DISORDER,40
CA,SPEECH DISORDER,40
CA,STOMATITIS,40
CA,DRY SKIN,39
CA,LOCAL SWELLING,39
CA,RENAL IMPAIRMENT,39
CA,THROMBOSIS,39
CA,WOUND,39
CA,CARDIAC FAILURE CONGESTIVE,38
CA,INJECTION SITE ERYTHEMA,38
CA,SWELLING FACE,38
CA,ACTIVITIES OF DAILY LIVING IMPAIRED,37
CA,CHOLELITHIASIS,37
CA,FREQUENT BOWEL MOVEMENTS,37
CA,GASTROOESOPHAGEAL REFLUX DISEASE,37
CA,NERVOUSNESS,37
CA,OEDEMA,37
CA,TENDERNESS,37
CA,VERTIGO,37
CA,BREAST CANCER,36
CA,C-REACTIVE PROTEIN INCREASED,36
CA,FEELING COLD,36
CA,SEPSIS,36
CA,C-REACTIVE PROTEIN ABNORMAL,35
CA,CARDIAC DISORDER,35
CA,INTESTINAL OBSTRUCTION,35
CA,MEMORY IMPAIRMENT,35
CA,FLATULENCE,34
CA,FUNGAL INFECTION,34
CA,GASTROENTERITIS VIRAL,34
CA,LOCALISED INFECTION,34
CA,SEIZURE,34
CA,TACHYCARDIA,34
CA,TOOTH DISORDER,34
CA,ACNE,33
CA,ADVERSE DRUG REACTION,33
CA,ARTERIOSCLEROSIS CORONARY ARTERY,33
CA,GASTROINTESTINAL DISORDER,33
CA,SOFT TISSUE DISORDER,33
CA,TREATMENT FAILURE,33
CA,DRUG EFFECT INCOMPLETE,32
CA,HYPERSOMNIA,32
CA,INJECTION SITE MASS,32
CA,POLLAKIURIA,32
CA,DIVERTICULITIS,31
CA,EYE PAIN,31
CA,LIVER DISORDER,31
CA,PELVIC FRACTURE,31
CA,POOR VENOUS ACCESS,31
CA,THROAT IRRITATION,31
CA,ASPHYXIA,30
CA,CARPAL TUNNEL SYNDROME,30
CA,CROHN^S DISEASE,30
CA,DIABETES MELLITUS,30
CA,HYPERGLYCAEMIA,30
CA,ORAL PAIN,30
CA,PANCREATITIS,30
CA,PHARYNGEAL OEDEMA,30
CA,TOXICITY TO VARIOUS AGENTS,30
CA,CARDIAC FAILURE,29
CA,DISCOMFORT,29
CA,HEART RATE IRREGULAR,29
CA,LACRIMATION INCREASED,29
CA,PRODUCT SUBSTITUTION ISSUE,29
CA,PRODUCT USE IN UNAPPROVED INDICATION,29
CA,SKIN DISORDER,29
CA,SWOLLEN TONGUE,29
CA,DEPRESSED MOOD,28
CA,DYSPNOEA EXERTIONAL,28
CA,EAR INFECTION,28
CA,ORAL HERPES,28
CA,SLEEP DISORDER,28
CA,THYROID DISORDER,28
CA,ANGINA PECTORIS,27
CA,BLOOD PRESSURE DIASTOLIC INCREASED,27
CA,COLITIS ULCERATIVE,27
CA,IMPAIRED HEALING,27
CA,INCORRECT DOSE ADMINISTERED,27
CA,LYMPHADENOPATHY,27
CA,PULMONARY EMBOLISM,27
CA,SPINAL COLUMN STENOSIS,27
CA,WHITE BLOOD CELL COUNT INCREASED,27
CA,ACUTE KIDNEY INJURY,26
CA,APHASIA,26
CA,DYSURIA,26
CA,FLUID RETENTION,26
CA,LIMB INJURY,26
CA,NEUTROPENIA,26
CA,SURGERY,26
CA,TRANSIENT ISCHAEMIC ATTACK,26
CA,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,25
CA,FAECES DISCOLOURED,25
CA,HOSPITALISATION,25
CA,KIDNEY INFECTION,25
CA,MASS,25
CA,MOVEMENT DISORDER,25
CA,MUSCULOSKELETAL DISCOMFORT,25
CA,NEOPLASM MALIGNANT,25
CA,RENAL DISORDER,25
CA,SKIN DISCOLOURATION,25
CA,ABASIA,24
CA,CRYING,24
CA,GASTROENTERITIS,24
CA,HYPOGLYCAEMIA,24
CA,INJECTION SITE REACTION,24
CA,INJECTION SITE SWELLING,24
CA,LIP SWELLING,24
CA,UPPER LIMB FRACTURE,24
CA,VIRAL UPPER RESPIRATORY TRACT INFECTION,24
CA,ARRHYTHMIA,23
CA,BLOOD IRON DECREASED,23
CA,BONE EROSION,23
CA,GASTRIC DISORDER,23
CA,GROIN PAIN,23
CA,HIP FRACTURE,23
CA,ILL-DEFINED DISORDER,23
CA,LACERATION,23
CA,RASH GENERALISED,23
CA,RECTAL HAEMORRHAGE,23
CA,RESPIRATORY RATE INCREASED,23
CA,CLOSTRIDIUM DIFFICILE INFECTION,22
CA,COGNITIVE DISORDER,22
CA,DEPRESSED LEVEL OF CONSCIOUSNESS,22
CA,DIABETIC KETOACIDOSIS,22
CA,DISORIENTATION,22
CA,DYSGEUSIA,22
CA,EYE INFECTION,22
CA,INJECTION SITE BRUISING,22
CA,INTERNATIONAL NORMALISED RATIO INCREASED,22
CA,MUSCLE FATIGUE,22
CA,NIGHT SWEATS,22
CA,PRODUCT QUALITY ISSUE,22
CA,PULMONARY MASS,22
CA,SKIN LESION,22
CA,THERAPEUTIC RESPONSE UNEXPECTED,22
CA,UPPER RESPIRATORY TRACT INFECTION,22
CA,ABDOMINAL PAIN LOWER,21
CA,BLISTER,21
CA,DRY EYE,21
CA,GASTROINTESTINAL HAEMORRHAGE,21
CA,JOINT STIFFNESS,21
CA,MOUTH ULCERATION,21
CA,NEEDLE ISSUE,21
CA,OSTEOMYELITIS,21
CA,POST PROCEDURAL INFECTION,21
CA,RESPIRATORY FAILURE,21
CA,SKIN EXFOLIATION,21
CA,THERAPEUTIC RESPONSE DECREASED,21
CA,ANGIOEDEMA,20
CA,BLINDNESS,20
CA,BLOOD GLUCOSE DECREASED,20
CA,BRADYCARDIA,20
CA,CORONARY ARTERY OCCLUSION,20
CA,EMOTIONAL DISORDER,20
CA,FEMUR FRACTURE,20
CA,HALLUCINATION,20
CA,HEPATIC STEATOSIS,20
CA,JOINT RANGE OF MOTION DECREASED,20
CA,LIMB DISCOMFORT,20
CA,OSTEOPOROSIS,20
CA,PALLOR,20
CA,RASH ERYTHEMATOUS,20
CA,VIRAL INFECTION,20
CA,WOUND INFECTION,20
CA,ALANINE AMINOTRANSFERASE INCREASED,19
CA,BODY TEMPERATURE INCREASED,19
CA,DEEP VEIN THROMBOSIS,19
CA,DELIRIUM,19
CA,DENTAL CARIES,19
CA,EAR PAIN,19
CA,EXPOSURE DURING PREGNANCY,19
CA,EYE DISORDER,19
CA,EYE HAEMORRHAGE,19
CA,FEBRILE NEUTROPENIA,19
CA,HYPERAESTHESIA,19
CA,HYPONATRAEMIA,19
CA,INJECTION SITE PRURITUS,19
CA,INJURY,19
CA,LUNG NEOPLASM MALIGNANT,19
CA,PERIPHERAL COLDNESS,19
CA,RESPIRATORY TRACT INFECTION,19
CA,THROMBOCYTOPENIA,19
CA,TINNITUS,19
CA,TOOTH ABSCESS,19
CA,APHONIA,18
CA,BLOOD POTASSIUM DECREASED,18
CA,BURSITIS,18
CA,HAEMOPTYSIS,18
CA,INCREASED APPETITE,18
CA,KNEE ARTHROPLASTY,18
CA,LETHARGY,18
CA,PAIN IN JAW,18
CA,RASH PRURITIC,18
CA,RENAL FAILURE ACUTE,18
CA,SCAR,18
CA,TOOTHACHE,18
CA,WRIST FRACTURE,18
CA,ADVERSE EVENT,17
CA,AGITATION,17
CA,BLOOD URINE PRESENT,17
CA,CYST,17
CA,DYSARTHRIA,17
CA,EYE PRURITUS,17
CA,FOOT DEFORMITY,17
CA,FOOT FRACTURE,17
CA,HEAD INJURY,17
CA,IMMOBILE,17
CA,IRRITABILITY,17
CA,MULTIPLE SCLEROSIS RELAPSE,17
CA,PULMONARY FIBROSIS,17
CA,RED BLOOD CELL COUNT DECREASED,17
CA,RIB FRACTURE,17
CA,SCIATICA,17
CA,TOOTH EXTRACTION,17
CA,URINARY INCONTINENCE,17
CA,BLOOD POTASSIUM INCREASED,16
CA,BLOOD THYROID STIMULATING HORMONE INCREASED,16
CA,BONE DISORDER,16
CA,DRUG EFFECT VARIABLE,16
CA,DRY THROAT,16
CA,DYSKINESIA,16
CA,GLOMERULAR FILTRATION RATE DECREASED,16
CA,GROWTH HORMONE DEFICIENCY,16
CA,INJECTION SITE HAEMORRHAGE,16
CA,LYMPHOCYTE COUNT DECREASED,16
CA,MEDICATION ERROR,16
CA,POST PROCEDURAL COMPLICATION,16
CA,RENAL PAIN,16
CA,RESPIRATORY TRACT CONGESTION,16
CA,ROAD TRAFFIC ACCIDENT,16
CA,SECRETION DISCHARGE,16
CA,SUICIDAL IDEATION,16
CA,THROAT TIGHTNESS,16
CA,VAGINAL HAEMORRHAGE,16
CA,ABSCESS,15
CA,BACTERIAL INFECTION,15
CA,BLOOD PRESSURE ABNORMAL,15
CA,BRONCHOSPASM,15
CA,CARDIAC ARREST,15
CA,ECZEMA,15
CA,EXTREMITY CONTRACTURE,15
CA,GINGIVAL PAIN,15
CA,HAEMORRHOIDS,15
CA,HIP ARTHROPLASTY,15
CA,JOINT INJURY,15
CA,LYMPHOMA,15
CA,NEOPLASM PROGRESSION,15
CA,OVERDOSE,15
CA,PARKINSON^S DISEASE,15
CA,PHARYNGITIS,15
CA,PITUITARY TUMOUR BENIGN,15
CA,PRURITUS GENERALISED,15
CA,PULMONARY FUNCTION TEST DECREASED,15
CA,PUSTULAR PSORIASIS,15
CA,RED BLOOD CELL SEDIMENTATION RATE ABNORMAL,15
CA,RESPIRATORY DISORDER,15
CA,SEPTIC SHOCK,15
CA,SINUS CONGESTION,15
CA,THYROID CANCER,15
CA,BLOOD MAGNESIUM DECREASED,14
CA,BREAST MASS,14
CA,DISTURBANCE IN ATTENTION,14
CA,EATING DISORDER,14
CA,EYE SWELLING,14
CA,GASTROINTESTINAL INFECTION,14
CA,GLAUCOMA,14
CA,GRIP STRENGTH DECREASED,14
CA,MIDDLE INSOMNIA,14
CA,NEURALGIA,14
CA,PHOTOSENSITIVITY REACTION,14
CA,PRESYNCOPE,14
CA,RED CELL DISTRIBUTION WIDTH INCREASED,14
CA,SPINAL FRACTURE,14
CA,STEVENS-JOHNSON SYNDROME,14
CA,SYSTEMIC LUPUS ERYTHEMATOSUS,14
CA,THYROID FUNCTION TEST ABNORMAL,14
CA,TOOTH INFECTION,14
CA,UNEVALUABLE EVENT,14
CA,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,14
CA,ANAPHYLACTIC REACTION,13
CA,ASCITES,13
CA,BLOOD PRESSURE SYSTOLIC DECREASED,13
CA,COLITIS,13
CA,ECCHYMOSIS,13
CA,FOETAL EXPOSURE DURING PREGNANCY,13
CA,GASTROINTESTINAL INFLAMMATION,13
CA,GOUT,13
CA,HAEMATURIA,13
CA,INTERSTITIAL LUNG DISEASE,13
CA,MENTAL IMPAIRMENT,13
CA,NODULE,13
CA,OCULAR HYPERAEMIA,13
CA,OSTEONECROSIS OF JAW,13
CA,PRE-EXISTING CONDITION IMPROVED,13
CA,SKIN CANCER,13
CA,SKIN INFECTION,13
CA,SKIN IRRITATION,13
CA,SLEEP APNOEA SYNDROME,13
CA,SPINAL PAIN,13
CA,SPLENOMEGALY,13
CA,UNDERDOSE,13
CA,ARTERIAL OCCLUSIVE DISEASE,12
CA,ASPARTATE AMINOTRANSFERASE INCREASED,12
CA,BLOOD CALCIUM DECREASED,12
CA,BLOOD PRESSURE DIASTOLIC ABNORMAL,12
CA,CATARACT OPERATION,12
CA,CHROMATURIA,12
CA,CHRONIC KIDNEY DISEASE,12
CA,EYE IRRITATION,12
CA,GASTRIC ULCER,12
CA,GENERALISED OEDEMA,12
CA,HAEMATOMA,12
CA,HEPATIC CIRRHOSIS,12
CA,HERNIA,12
CA,HIATUS HERNIA,12
CA,HYPOACUSIS,12
CA,HYPOKINESIA,12
CA,IMMUNE SYSTEM DISORDER,12
CA,INJECTION SITE INDURATION,12
CA,INTENTIONAL OVERDOSE,12
CA,LIGAMENT SPRAIN,12
CA,LIVER FUNCTION TEST INCREASED,12
CA,LOWER LIMB FRACTURE,12
CA,MENTAL DISORDER,12
CA,METASTASES TO BONE,12
CA,MUSCLE TIGHTNESS,12
CA,NEUROPATHY PERIPHERAL,12
CA,OBESITY,12
CA,PANCYTOPENIA,12
CA,PANIC ATTACK,12
CA,PERICARDITIS,12
CA,POLYP,12
CA,RESPIRATORY DISTRESS,12
CA,SEDATION,12
CA,SKIN ULCER,12
CA,SPUTUM DISCOLOURED,12
CA,SUICIDE ATTEMPT,12
CA,TENDONITIS,12
CA,ABORTION SPONTANEOUS,11
CA,ACUTE MYOCARDIAL INFARCTION,11
CA,ANAPHYLACTIC SHOCK,11
CA,ANKLE FRACTURE,11
CA,APHAGIA,11
CA,BASAL CELL CARCINOMA,11
CA,BLADDER PAIN,11
CA,CONVULSION,11
CA,CORONARY ARTERY DISEASE,11
CA,ELECTROLYTE IMBALANCE,11
CA,GASTRITIS,11
CA,HAEMATOCRIT DECREASED,11
CA,HYPOPHAGIA,11
CA,JAUNDICE,11
CA,JOINT DISLOCATION,11
CA,METASTASES TO LIVER,11
CA,MUSCULOSKELETAL CHEST PAIN,11
CA,NERVOUS SYSTEM DISORDER,11
CA,NEUTROPHIL COUNT DECREASED,11
CA,PULMONARY HYPERTENSION,11
CA,ROTATOR CUFF REPAIR,11
CA,SPINAL DISORDER,11
CA,STAPHYLOCOCCAL INFECTION,11
CA,THYROID MASS,11
CA,TYPE 2 DIABETES MELLITUS,11
CA,ULCER,11
CA,URINARY RETENTION,11
CA,VISUAL ACUITY REDUCED,11
CA,VITAMIN B12 DECREASED,11
CA,CAESAREAN SECTION,10
CA,COMA,10
CA,DEAFNESS,10
CA,DIPLOPIA,10
CA,DRUG ADMINISTRATION ERROR,10
CA,DYSSTASIA,10
CA,EAR DISCOMFORT,10
CA,FORCED EXPIRATORY VOLUME DECREASED,10
CA,GALLBLADDER DISORDER,10
CA,HEPATITIS,10
CA,IMPAIRED WORK ABILITY,10
CA,INGUINAL HERNIA,10
CA,INTENTIONAL PRODUCT MISUSE,10
CA,INTERVERTEBRAL DISC PROTRUSION,10
CA,LARYNGITIS,10
CA,LYMPHADENECTOMY,10
CA,MUSCLE STRAIN,10
CA,MUSCULOSKELETAL DISORDER,10
CA,ORAL CANDIDIASIS,10
CA,PAPILLARY THYROID CANCER,10
CA,PERIPHERAL VENOUS DISEASE,10
CA,PNEUMOTHORAX,10
CA,PROCEDURAL PAIN,10
CA,PULMONARY CONGESTION,10
CA,QUALITY OF LIFE DECREASED,10
CA,RASH PAPULAR,10
CA,RESTLESSNESS,10
CA,SECOND PRIMARY MALIGNANCY,10
CA,SENSORY LOSS,10
CA,SERUM FERRITIN INCREASED,10
CA,TOE AMPUTATION,10
CA,VAGINAL INFECTION,10
CA,ATYPICAL FEMUR FRACTURE,9
CA,BACK INJURY,9
CA,BILE DUCT OBSTRUCTION,9
CA,BLOOD GLUCOSE ABNORMAL,9
CA,BLOOD SODIUM DECREASED,9
CA,BLOOD TEST ABNORMAL,9
CA,CHOLECYSTITIS ACUTE,9
CA,COLD SWEAT,9
CA,CONCOMITANT DISEASE AGGRAVATED,9
CA,GAIT INABILITY,9
CA,GASTROINTESTINAL PAIN,9
CA,HEPATIC PAIN,9
CA,INCREASED UPPER AIRWAY SECRETION,9
CA,INJECTION SITE EXTRAVASATION,9
CA,INTESTINAL PERFORATION,9
CA,MACULAR DEGENERATION,9
CA,METASTASES TO LUNG,9
CA,MOOD ALTERED,9
CA,MUSCLE TWITCHING,9
CA,NECK MASS,9
CA,OVARIAN CYST,9
CA,PANCREATIC CARCINOMA,9
CA,PHLEBITIS,9
CA,PSYCHOTIC DISORDER,9
CA,RESTLESS LEGS SYNDROME,9
CA,RHEUMATOID NODULE,9
CA,SCRATCH,9
CA,SEASONAL ALLERGY,9
CA,SINUS DISORDER,9
CA,SKIN ABRASION,9
CA,SQUAMOUS CELL CARCINOMA,9
CA,UPPER-AIRWAY COUGH SYNDROME,9
CA,VASCULITIS,9
CA,WALKING AID USER,9
CA,APPENDICITIS,8
CA,ARTHRITIS INFECTIVE,8
CA,BLOOD ALKALINE PHOSPHATASE INCREASED,8
CA,CONJUNCTIVITIS,8
CA,DEMENTIA,8
CA,DEVICE RELATED INFECTION,8
CA,DIARRHOEA HAEMORRHAGIC,8
CA,DISTURBANCE IN SOCIAL BEHAVIOUR,8
CA,ELECTROCARDIOGRAM QT PROLONGED,8
CA,EOSINOPHIL COUNT INCREASED,8
CA,EYE DISCHARGE,8
CA,FACE OEDEMA,8
CA,FISTULA,8
CA,GAMMA-GLUTAMYLTRANSFERASE INCREASED,8
CA,HEAD DISCOMFORT,8
CA,HYPERTHYROIDISM,8
CA,HYPOXIA,8
CA,INJECTION SITE WARMTH,8
CA,LIP DRY,8
CA,METABOLIC ACIDOSIS,8
CA,MOOD SWINGS,8
CA,NEOPLASM,8
CA,NEUTROPHIL COUNT INCREASED,8
CA,PANCREATITIS ACUTE,8
CA,PARAESTHESIA ORAL,8
CA,PERICARDIAL EFFUSION,8
CA,PLASMA CELL MYELOMA,8
CA,POOR QUALITY SLEEP,8
CA,PROCTALGIA,8
CA,PULMONARY FUNCTION TEST ABNORMAL,8
CA,RASH MACULAR,8
CA,RECURRENT CANCER,8
CA,RENAL CYST,8
CA,RHINITIS,8
CA,SENSITIVITY TO WEATHER CHANGE,8
CA,SYNOVIAL CYST,8
CA,SYRINGE ISSUE,8
CA,THERAPY NON-RESPONDER,8
CA,TOOTH FRACTURE,8
CA,TRANSFUSION,8
CA,UNRESPONSIVE TO STIMULI,8
CA,UVEITIS,8
CA,VULVOVAGINAL MYCOTIC INFECTION,8
CA,ABNORMAL FAECES,7
CA,AGEUSIA,7
CA,AGGRESSION,7
CA,ANKYLOSING SPONDYLITIS,7
CA,ATELECTASIS,7
CA,BLADDER DISORDER,7
CA,BLOOD COUNT ABNORMAL,7
CA,BLOOD GROWTH HORMONE INCREASED,7
CA,BLOOD IMMUNOGLOBULIN E INCREASED,7
CA,BLOOD THYROID STIMULATING HORMONE DECREASED,7
CA,BONE DENSITY DECREASED,7
CA,BRAIN INJURY,7
CA,BRAIN NEOPLASM,7
CA,CARDIAC FLUTTER,7
CA,CARDIAC OPERATION,7
CA,CARDIAC VALVE DISEASE,7
CA,CARDIOMEGALY,7
CA,CENTRAL NERVOUS SYSTEM LESION,7
CA,CEREBRAL HAEMORRHAGE,7
CA,CHOLECYSTECTOMY,7
CA,CHOLECYSTITIS,7
CA,COELIAC DISEASE,7
CA,CONTRAINDICATED PRODUCT ADMINISTERED,7
CA,DEFAECATION URGENCY,7
CA,DEVICE FAILURE,7
CA,DIABETES MELLITUS INADEQUATE CONTROL,7
CA,DRUG LEVEL INCREASED,7
CA,EAR DISORDER,7
CA,EMOTIONAL DISTRESS,7
CA,EPILEPSY,7
CA,ESCHERICHIA INFECTION,7
CA,EYE INFLAMMATION,7
CA,FLANK PAIN,7
CA,FRACTURE,7
CA,FULL BLOOD COUNT DECREASED,7
CA,GINGIVAL SWELLING,7
CA,GRAND MAL CONVULSION,7
CA,HAEMORRHOIDAL HAEMORRHAGE,7
CA,HEART RATE ABNORMAL,7
CA,HELICOBACTER INFECTION,7
CA,HEPATIC FAILURE,7
CA,HIP SURGERY,7
CA,HUNGER,7
CA,INTERVERTEBRAL DISC DEGENERATION,7
CA,INTESTINAL RESECTION,7
CA,JAW DISORDER,7
CA,JOINT ARTHROPLASTY,7
CA,LIPOMA,7
CA,LUNG INFILTRATION,7
CA,MALLORY-WEISS SYNDROME,7
CA,MELAENA,7
CA,METASTASES TO CENTRAL NERVOUS SYSTEM,7
CA,MICTURITION URGENCY,7
CA,MIXED DEMENTIA,7
CA,NOCTURIA,7
CA,ORAL DISORDER,7
CA,OSTEONECROSIS,7
CA,PERSONALITY CHANGE,7
CA,PHOTOPHOBIA,7
CA,PNEUMONITIS,7
CA,PRESCRIBED UNDERDOSE,7
CA,PULMONARY ARTERIAL HYPERTENSION,7
CA,SKIN FRAGILITY,7
CA,SKIN HAEMORRHAGE,7
CA,SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION_ INSOMNIA TYPE,7
CA,SPINAL OSTEOARTHRITIS,7
CA,SUBDURAL HAEMATOMA,7
CA,THIRST,7
CA,THROMBOPHLEBITIS,7
CA,UTERINE LEIOMYOMA,7
CA,VEIN DISORDER,7
CA,WEIGHT FLUCTUATION,7
CA,ABDOMINAL HERNIA,6
CA,ABDOMINAL MASS,6
CA,APHTHOUS ULCER,6
CA,ARTHRITIS BACTERIAL,6
CA,BACK DISORDER,6
CA,BLADDER CANCER,6
CA,BLOOD BILIRUBIN INCREASED,6
CA,BLOOD CREATINE PHOSPHOKINASE INCREASED,6
CA,BLOOD DISORDER,6
CA,BLOOD UREA INCREASED,6
CA,BODY HEIGHT DECREASED,6
CA,BONE MARROW FAILURE,6
CA,BREATH SOUNDS ABNORMAL,6
CA,CHOKING,6
CA,COAGULOPATHY,6
CA,COLON CANCER,6
CA,COMPLICATION ASSOCIATED WITH DEVICE,6
CA,COMPRESSION FRACTURE,6
CA,CONCUSSION,6
CA,DEVICE BREAKAGE,6
CA,EPIGASTRIC DISCOMFORT,6
CA,ERUCTATION,6
CA,EXPOSURE DURING BREAST FEEDING,6
CA,FEEDING DISORDER,6
CA,FINGER DEFORMITY,6
CA,FOOD POISONING,6
CA,FURUNCLE,6
CA,GASTRIC INFECTION,6
CA,GASTROINTESTINAL OBSTRUCTION,6
CA,HAEMORRHAGE INTRACRANIAL,6
CA,HEMIPARESIS,6
CA,HEPATIC LESION,6
CA,HEPATOMEGALY,6
CA,HERPES VIRUS INFECTION,6
CA,HYPERTENSIVE CRISIS,6
CA,HYPOCALCAEMIA,6
CA,HYPOVOLAEMIA,6
CA,HYPOVOLAEMIC SHOCK,6
CA,HYSTERECTOMY,6
CA,INJECTION SITE DISCOLOURATION,6
CA,INSULIN-LIKE GROWTH FACTOR INCREASED,6
CA,INVASIVE DUCTAL BREAST CARCINOMA,6
CA,IRON DEFICIENCY,6
CA,KNEE OPERATION,6
CA,LYME DISEASE,6
CA,LYMPHOPENIA,6
CA,MANIA,6
CA,METAMORPHOPSIA,6
CA,METASTASES TO SPINE,6
CA,MONOCYTE COUNT INCREASED,6
CA,MOUTH HAEMORRHAGE,6
CA,MULTIPLE SCLEROSIS,6
CA,MYDRIASIS,6
CA,MYOCLONUS,6
CA,NEURODERMATITIS,6
CA,NIGHTMARE,6
CA,OBSESSIVE-COMPULSIVE DISORDER,6
CA,OBSTRUCTIVE AIRWAYS DISORDER,6
CA,OESOPHAGEAL DISORDER,6
CA,OESOPHAGEAL SPASM,6
CA,ORAL DISCOMFORT,6
CA,ORTHOSTATIC HYPOTENSION,6
CA,OSTEITIS,6
CA,PAINFUL RESPIRATION,6
CA,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,6
CA,PARALYSIS,6
CA,PLEURISY,6
CA,PSYCHOMOTOR HYPERACTIVITY,6
CA,PYELONEPHRITIS,6
CA,RENAL CANCER,6
CA,RENAL FUNCTION TEST ABNORMAL,6
CA,RETCHING,6
CA,SCAB,6
CA,SKIN ATROPHY,6
CA,SKIN BURNING SENSATION,6
CA,SKIN PLAQUE,6
CA,SPINA BIFIDA,6
CA,TENDON PAIN,6
CA,TENDON RUPTURE,6
CA,THERAPEUTIC PRODUCT INEFFECTIVE,6
CA,THERAPEUTIC REACTION TIME DECREASED,6
CA,THERMAL BURN,6
CA,THORACIC VERTEBRAL FRACTURE,6
CA,TRACHEITIS,6
CA,TUBERCULOSIS,6
CA,VARICOSE VEIN,6
CA,ABNORMAL DREAMS,5
CA,ABNORMAL SLEEP-RELATED EVENT,5
CA,ACCIDENT,5
CA,AMYOTROPHIC LATERAL SCLEROSIS,5
CA,AORTIC ANEURYSM,5
CA,ARTHROPOD BITE,5
CA,ATAXIA,5
CA,ATRIOVENTRICULAR BLOCK,5
CA,AUTONOMIC NERVOUS SYSTEM IMBALANCE,5
CA,BLADDER TRANSITIONAL CELL CARCINOMA,5
CA,BLOOD CALCIUM INCREASED,5
CA,BLOOD PRESSURE INADEQUATELY CONTROLLED,5
CA,BLOOD PRESSURE SYSTOLIC ABNORMAL,5
CA,BREAST CYST,5
CA,CANDIDA INFECTION,5
CA,CARDIAC MURMUR,5
CA,CHOKING SENSATION,5
CA,COORDINATION ABNORMAL,5
CA,CYANOSIS,5
CA,DENTAL RESTORATION FAILURE,5
CA,DERMATITIS,5
CA,DEVICE OCCLUSION,5
CA,DIVERTICULUM INTESTINAL,5
CA,DIZZINESS POSTURAL,5
CA,DRUG EFFECT INCREASED,5
CA,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,5
CA,DRUG-INDUCED LIVER INJURY,5
CA,DUODENAL ULCER,5
CA,EAR CONGESTION,5
CA,EJECTION FRACTION DECREASED,5
CA,ELECTROCARDIOGRAM ABNORMAL,5
CA,ERECTILE DYSFUNCTION,5
CA,ESCHERICHIA SEPSIS,5
CA,EYE OPERATION,5
CA,FACIAL PARALYSIS,5
CA,FEAR,5
CA,FIBRIN D DIMER INCREASED,5
CA,FRUSTRATION,5
CA,GENERALISED TONIC-CLONIC SEIZURE,5
CA,GINGIVAL BLEEDING,5
CA,GINGIVAL DISORDER,5
CA,GLOSSODYNIA,5
CA,GRANULOMATOSIS WITH POLYANGIITIS,5
CA,HAND DEFORMITY,5
CA,HEART VALVE INCOMPETENCE,5
CA,HEPATOTOXICITY,5
CA,HEREDITARY ANGIOEDEMA,5
CA,HICCUPS,5
CA,HUMERUS FRACTURE,5
CA,HUMIDITY INTOLERANCE,5
CA,HYPERKALAEMIA,5
CA,HYPERNATRAEMIA,5
CA,IMMUNODEFICIENCY,5
CA,IMPAIRED GASTRIC EMPTYING,5
CA,IMPAIRED SELF-CARE,5
CA,INCORRECT DRUG ADMINISTRATION DURATION,5
CA,INFARCTION,5
CA,INFUSION SITE PAIN,5
CA,INGROWING NAIL,5
CA,INITIAL INSOMNIA,5
CA,INTENTIONAL DRUG MISUSE,5
CA,INTENTIONAL PRODUCT USE ISSUE,5
CA,LACTIC ACIDOSIS,5
CA,LUMBAR VERTEBRAL FRACTURE,5
CA,MALNUTRITION,5
CA,MEAN PLATELET VOLUME DECREASED,5
CA,MENINGITIS,5
CA,MENORRHAGIA,5
CA,MICTURITION DISORDER,5
CA,MOUTH SWELLING,5
CA,MULTIPLE ALLERGIES,5
CA,MUSCLE ATROPHY,5
CA,MYELODYSPLASTIC SYNDROME,5
CA,NAIL INFECTION,5
CA,NERVE INJURY,5
CA,NEUROLEPTIC MALIGNANT SYNDROME,5
CA,NO THERAPEUTIC RESPONSE,5
CA,OCULAR DISCOMFORT,5
CA,ORAL FUNGAL INFECTION,5
CA,OSTEOPENIA,5
CA,PAIN OF SKIN,5
CA,PANCREATIC DISORDER,5
CA,PARANASAL SINUS DISCOMFORT,5
CA,PHARYNGITIS STREPTOCOCCAL,5
CA,PHOTOPSIA,5
CA,PLATELET COUNT INCREASED,5
CA,POSTOPERATIVE WOUND INFECTION,5
CA,PREGNANCY,5
CA,PROSTATE CANCER METASTATIC,5
CA,PULMONARY THROMBOSIS,5
CA,RALES,5
CA,RECTAL ADENOCARCINOMA,5
CA,RENAL FAILURE CHRONIC,5
CA,RETINAL DETACHMENT,5
CA,ROTATOR CUFF SYNDROME,5
CA,SENSATION OF HEAVINESS,5
CA,SHOCK,5
CA,SINUS HEADACHE,5
CA,SINUS PAIN,5
CA,SKIN FISSURES,5
CA,SKIN REACTION,5
CA,SNEEZING,5
CA,STENT PLACEMENT,5
CA,SUPRAVENTRICULAR TACHYCARDIA,5
CA,TEMPERATURE INTOLERANCE,5
CA,THERAPY CESSATION,5
CA,THERAPY PARTIAL RESPONDER,5
CA,TONGUE DISORDER,5
CA,TOOTH LOSS,5
CA,URINARY TRACT INFECTION BACTERIAL,5
CA,URINE ABNORMALITY,5
CA,URINE ODOUR ABNORMAL,5
CA,UROSEPSIS,5
CA,VASCULAR OCCLUSION,5
CA,WHITE BLOOD CELLS URINE POSITIVE,5
CA,WRONG TECHNIQUE IN DRUG USAGE PROCESS,5
CA,ABDOMINAL ADHESIONS,4
CA,ABNORMAL BEHAVIOUR,4
CA,ACUTE CORONARY SYNDROME,4
CA,ACUTE MYELOID LEUKAEMIA,4
CA,ACUTE PULMONARY OEDEMA,4
CA,ADDISON^S DISEASE,4
CA,ADENOCARCINOMA OF COLON,4
CA,ADRENAL INSUFFICIENCY,4
CA,ADRENOCORTICAL INSUFFICIENCY ACUTE,4
CA,ALTERED STATE OF CONSCIOUSNESS,4
CA,AMENORRHOEA,4
CA,ANAL FISSURE,4
CA,ANAL INCONTINENCE,4
CA,ANIMAL BITE,4
CA,ANORECTAL DISCOMFORT,4
CA,ANTICONVULSANT DRUG LEVEL DECREASED,4
CA,ANTICONVULSANT DRUG LEVEL INCREASED,4
CA,AORTIC STENOSIS,4
CA,APPARENT DEATH,4
CA,APPENDICITIS PERFORATED,4
CA,AREFLEXIA,4
CA,AUTOIMMUNE THYROIDITIS,4
CA,BENIGN BREAST NEOPLASM,4
CA,BLOOD ALBUMIN DECREASED,4
CA,BLOOD CHOLESTEROL ABNORMAL,4
CA,BLOOD GLUCOSE FLUCTUATION,4
CA,BLOOD THYROID STIMULATING HORMONE ABNORMAL,4
CA,BLOOD TRIGLYCERIDES INCREASED,4
CA,BOWEL MOVEMENT IRREGULARITY,4
CA,BRADYPHRENIA,4
CA,BREAST CANCER METASTATIC,4
CA,BREAST PAIN,4
CA,C-REACTIVE PROTEIN,4
CA,CARDIAC FIBRILLATION,4
CA,CATHETER SITE HAEMORRHAGE,4
CA,CERVIX CARCINOMA,4
CA,CHEST X-RAY ABNORMAL,4
CA,CHOLECYSTITIS INFECTIVE,4
CA,CHRONIC SINUSITIS,4
CA,CLOSTRIDIUM DIFFICILE COLITIS,4
CA,CREATININE RENAL CLEARANCE DECREASED,4
CA,CYSTITIS KLEBSIELLA,4
CA,DEAFNESS UNILATERAL,4
CA,DECUBITUS ULCER,4
CA,DEVICE DISLOCATION,4
CA,DEVICE MALFUNCTION,4
CA,DISEASE RECURRENCE,4
CA,DROP ATTACKS,4
CA,DRUG LEVEL DECREASED,4
CA,DRUG WITHDRAWAL SYNDROME,4
CA,DYSLIPIDAEMIA,4
CA,EOSINOPHILIA,4
CA,ERYTHEMA MULTIFORME,4
CA,EXOSTOSIS,4
CA,EXTREMITY NECROSIS,4
CA,EYELID OEDEMA,4
CA,FACIAL PAIN,4
CA,FAECES PALE,4
CA,FAILURE TO THRIVE,4
CA,FEAR OF INJECTION,4
CA,FEELING JITTERY,4
CA,FEELING OF BODY TEMPERATURE CHANGE,4
CA,FOOD ALLERGY,4
CA,FOOT OPERATION,4
CA,FORCED VITAL CAPACITY DECREASED,4
CA,FUNGAL SKIN INFECTION,4
CA,GANGRENE,4
CA,GASTROINTESTINAL CARCINOMA,4
CA,GENITAL HERPES,4
CA,GENITAL SWELLING,4
CA,GLYCOSYLATED HAEMOGLOBIN INCREASED,4
CA,GRAFT VERSUS HOST DISEASE,4
CA,HAEMATEMESIS,4
CA,HAEMOGLOBIN ABNORMAL,4
CA,HAEMOLYSIS,4
CA,HAEMORRHAGE URINARY TRACT,4
CA,HAEMORRHAGIC STROKE,4
CA,HAIR DISORDER,4
CA,HAIR TEXTURE ABNORMAL,4
CA,HAND FRACTURE,4
CA,HEART VALVE STENOSIS,4
CA,HEPATIC NEOPLASM,4
CA,HEPATITIS ACUTE,4
CA,HYDRONEPHROSIS,4
CA,HYPERCALCAEMIA,4
CA,HYPERCHOLESTEROLAEMIA,4
CA,HYPERKERATOSIS,4
CA,HYPERPLASIA,4
CA,HYPERTHERMIA,4
CA,HYPOAESTHESIA ORAL,4
CA,HYPOPITUITARISM,4
CA,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,4
CA,INCISION SITE INFECTION,4
CA,INCOHERENT,4
CA,INCORRECT PRODUCT STORAGE,4
CL,ANAEMIA,2
CL,FATIGUE,2
CL,PYREXIA,2
CL,ABDOMINAL DISCOMFORT,1
CL,ACTIVITIES OF DAILY LIVING IMPAIRED,1
CL,ASTHENIA,1
CL,BACK PAIN,1
CL,BOREDOM,1
CL,CHILLS,1
CL,COUGH,1
CL,DANDRUFF,1
CL,DECREASED APPETITE,1
CL,DEPRESSED MOOD,1
CL,DIARRHOEA,1
CL,EATING DISORDER,1
CL,FEELING ABNORMAL,1
CL,FEELING COLD,1
CL,HAEMATOCRIT DECREASED,1
CL,HAEMATOLOGY TEST ABNORMAL,1
CL,HYPERTRIGLYCERIDAEMIA,1
CL,MENTAL IMPAIRMENT,1
CL,MYALGIA,1
CL,NASAL DRYNESS,1
CL,NAUSEA,1
CL,PNEUMONIA,1
CL,PROTEINURIA,1
CL,RENAL IMPAIRMENT,1
CL,VOMITING,1
CL,YELLOW SKIN,1
CN,BRAIN OEDEMA,5
CN,FOETAL EXPOSURE DURING PREGNANCY,5
CN,DRUG INEFFECTIVE,4
CN,HEPATIC FUNCTION ABNORMAL,3
CN,HYPOGLYCAEMIC COMA,3
CN,HYPOSPADIAS,3
CN,LUNG INFECTION,3
CN,BLOOD GLUCOSE INCREASED,2
CN,CEREBRAL PALSY,2
CN,ELECTROLYTE IMBALANCE,2
CN,HYPONATRAEMIA,2
CN,RENAL IMPAIRMENT,2
CN,ABORTION INDUCED,1
CN,ACUTE MYOCARDIAL INFARCTION,1
CN,ASTHMA,1
CN,ATRIAL FIBRILLATION,1
CN,BLOOD ALBUMIN DECREASED,1
CN,BLOOD CHOLESTEROL INCREASED,1
CN,BLOOD CREATININE INCREASED,1
CN,BLOOD TRIGLYCERIDES INCREASED,1
CN,BLOOD UREA INCREASED,1
CN,BONE MARROW FAILURE,1
CN,CEREBRAL HAEMORRHAGE,1
CN,CHEST DISCOMFORT,1
CN,CHOLECYSTECTOMY,1
CN,DEATH,1
CN,DIZZINESS,1
CN,ELECTROCARDIOGRAM ABNORMAL,1
CN,EYE SWELLING,1
CN,GASTROINTESTINAL HAEMORRHAGE,1
CN,HAEMOGLOBIN DECREASED,1
CN,HEAD DISCOMFORT,1
CN,HYPOTHYROIDISM,1
CN,IMMUNE THROMBOCYTOPENIC PURPURA,1
CN,LARYNGEAL INFLAMMATION,1
CN,LIVER INJURY,1
CN,LOW DENSITY LIPOPROTEIN INCREASED,1
CN,LYMPHOCYTE COUNT DECREASED,1
CN,MATERNAL EXPOSURE DURING PREGNANCY,1
CN,MELAENA,1
CN,MULTI-ORGAN FAILURE,1
CN,NEUTROPENIA,1
CN,NEUTROPHIL COUNT INCREASED,1
CN,NORMAL NEWBORN,1
CN,OVERDOSE,1
CN,PNEUMONIA,1
CN,POLYCYSTIC OVARIES,1
CN,PREGNANCY,1
CN,PROTEIN URINE PRESENT,1
CN,RASH,1
CN,SYSTEMIC LUPUS ERYTHEMATOSUS,1
CN,THROMBOCYTOPENIA,1
CN,THYROID NEOPLASM,1
CN,VENTRICULAR TACHYCARDIA,1
CN,WHITE BLOOD CELL COUNT INCREASED,1
CO,ABDOMINAL PAIN,4
CO,ANXIETY,4
CO,DIARRHOEA,4
CO,FATIGUE,4
CO,HAEMOGLOBIN DECREASED,4
CO,DECREASED APPETITE,3
CO,DEPRESSION,3
CO,DRUG INEFFECTIVE,3
CO,PAIN,3
CO,URINARY TRACT INFECTION,3
CO,VOMITING,3
CO,ALOPECIA,2
CO,ARTHROPATHY,2
CO,ASTHENIA,2
CO,FOETAL EXPOSURE DURING PREGNANCY,2
CO,HEART DISEASE CONGENITAL,2
CO,HEPATIC LESION,2
CO,HYPERTENSION,2
CO,HYPOGLYCAEMIA,2
CO,INFLAMMATION,2
CO,INSOMNIA,2
CO,MALAISE,2
CO,MALIGNANT NEOPLASM PROGRESSION,2
CO,MUCOSAL INFLAMMATION,2
CO,NEUTROPENIA,2
CO,OEDEMA PERIPHERAL,2
CO,PANCREATITIS,2
CO,PANCYTOPENIA,2
CO,PLATELET COUNT DECREASED,2
CO,PRURITUS GENERALISED,2
CO,PYREXIA,2
CO,RASH,2
CO,THROMBOCYTOPENIA,2
CO,TOOTH ABSCESS,2
CO,ABDOMINAL DISCOMFORT,1
CO,ABDOMINAL PAIN LOWER,1
CO,ACUTE RESPIRATORY DISTRESS SYNDROME,1
CO,ADHESION,1
CO,AGEUSIA,1
CO,AGGRESSION,1
CO,ANAEMIA,1
CO,ANGINA PECTORIS,1
CO,APPENDICECTOMY,1
CO,APPENDICITIS,1
CO,ARRHYTHMIA,1
CO,ARTERIAL DISORDER,1
CO,ARTHRALGIA,1
CO,BACK PAIN,1
CO,BILE DUCT STONE,1
CO,BLISTER,1
CO,BLOOD CREATININE INCREASED,1
CO,BLOOD GLUCOSE INCREASED,1
CO,BLOOD PRESSURE FLUCTUATION,1
CO,BLOOD SODIUM DECREASED,1
CO,BRONCHIOLITIS,1
CO,BRONCHITIS,1
CO,BURNING SENSATION,1
CO,CALCULUS BLADDER,1
CO,CARDIAC DISORDER,1
CO,CARDIAC FAILURE,1
CO,CHILLS,1
CO,CHOLECYSTITIS,1
CO,CONJUNCTIVITIS,1
CO,CORONARY ARTERY DISEASE,1
CO,COUGH,1
CO,CYTOMEGALOVIRUS INFECTION,1
CO,DIABETES MELLITUS,1
CO,DISORIENTATION,1
CO,DRUG DISPENSING ERROR,1
CO,ECTROPION,1
CO,FALL,1
CO,FLUID RETENTION,1
CO,GAIT DISTURBANCE,1
CO,GASTRITIS,1
CO,GENERAL PHYSICAL HEALTH DETERIORATION,1
CO,GINGIVAL PAIN,1
CO,GROIN PAIN,1
CO,HAEMATOLOGY TEST ABNORMAL,1
CO,HAEMATOTOXICITY,1
CO,HAEMATURIA,1
CO,HAIR COLOUR CHANGES,1
CO,HALLUCINATION,1
CO,HEADACHE,1
CO,HEPATIC CIRRHOSIS,1
CO,HEPATIC ENZYME INCREASED,1
CO,HEPATOTOXICITY,1
CO,HIATUS HERNIA,1
CO,HYPERSENSITIVITY,1
CO,HYPERTHYROIDISM,1
CO,HYPOTHYROIDISM,1
CO,IMMUNODEFICIENCY,1
CO,INCORRECT DOSE ADMINISTERED,1
CO,INFLUENZA,1
CO,INJECTION SITE DISCOMFORT,1
CO,INJECTION SITE PAIN,1
CO,INTERVERTEBRAL DISC PROTRUSION,1
CO,INVESTIGATION ABNORMAL,1
CO,IRRITABILITY,1
CO,JAUNDICE,1
CO,LARYNGITIS,1
CO,LEUKOPENIA,1
CO,LUNG DISORDER,1
CO,MYOCARDIAL INFARCTION,1
CO,NAUSEA,1
CO,NEPHROPATHY,1
CO,NERVOUSNESS,1
CO,NEUTROPHIL COUNT DECREASED,1
CO,NODULE,1
CO,ONYCHOMADESIS,1
CO,PAIN IN EXTREMITY,1
CO,PALLOR,1
CO,PANCREATIC MASS,1
CO,PANCREATIC NECROSIS,1
CO,PERIPHERAL SWELLING,1
CO,PNEUMONIA,1
CO,PROSTATE CANCER,1
CO,PROSTATIC DISORDER,1
CO,PROTEIN TOTAL DECREASED,1
CO,PRURITUS,1
CO,PULMONARY HYPERTENSION,1
CO,RESPIRATORY ARREST,1
CO,RESTLESSNESS,1
CO,SENSORY DISTURBANCE,1
CO,SJOGREN^S SYNDROME,1
CO,SKIN DEPIGMENTATION,1
CO,SKIN LESION,1
CO,SOFT TISSUE SARCOMA,1
CO,SWELLING,1
CO,SYNCOPE,1
CO,THERAPY NON-RESPONDER,1
CO,THROMBOSIS,1
CO,TONGUE NEOPLASM MALIGNANT STAGE UNSPECIFIED,1
CO,ULCER,1
CO,UPPER LIMB FRACTURE,1
CO,VEIN DISORDER,1
CO,WEIGHT DECREASED,1
CR,ARRHYTHMIA,1
CR,ASTHENIA,1
CR,ATRIOVENTRICULAR BLOCK,1
CR,BLOOD CHOLESTEROL INCREASED,1
CR,FATIGUE,1
CR,HEART RATE DECREASED,1
CR,HYPOTENSION,1
CR,MYOCARDIAL INFARCTION,1
CI,OCULAR DISCOMFORT,1
CI,VISUAL FIELD DEFECT,1
CZ,POLYMYOSITIS,2
CZ,STEVENS-JOHNSON SYNDROME,2
CZ,BREAST CANCER,1
CZ,CONJUNCTIVITIS,1
CZ,DEPRESSED LEVEL OF CONSCIOUSNESS,1
CZ,DRUG INEFFECTIVE,1
CZ,FATIGUE,1
CZ,HEPATIC FUNCTION ABNORMAL,1
CZ,LACERATION,1
CZ,MUSCULAR WEAKNESS,1
CZ,NEUROPATHY PERIPHERAL,1
CZ,PNEUMONIA,1
CZ,RASH,1
CZ,SECOND PRIMARY MALIGNANCY,1
CZ,SOPOR,1
CZ,STATUS EPILEPTICUS,1
CZ,STOMATITIS,1
CZ,VERTIGO,1
DK,ABSCESS,1
DK,ADRENAL INSUFFICIENCY,1
DK,ALTERED STATE OF CONSCIOUSNESS,1
DK,ARTHRALGIA,1
DK,CARDIAC FAILURE,1
DK,COLITIS,1
DK,CONFUSIONAL STATE,1
DK,CONSCIOUSNESS FLUCTUATING,1
DK,CONTRAST MEDIA ALLERGY,1
DK,DEHYDRATION,1
DK,DISORIENTATION,1
DK,DYSPNOEA,1
DK,FATIGUE,1
DK,HYPOPHYSITIS,1
DK,HYPOPITUITARISM,1
DK,HYPOTHYROIDISM,1
DK,INFECTION,1
DK,LIP SWELLING,1
DK,LUNG ADENOCARCINOMA,1
DK,LUNG LOBECTOMY,1
DK,MYALGIA,1
DK,MYOCARDITIS,1
DK,NAUSEA,1
DK,PLEURAL EFFUSION,1
DK,POOR PERIPHERAL CIRCULATION,1
DK,QUALITY OF LIFE DECREASED,1
DK,SEPSIS,1
DK,SWOLLEN TONGUE,1
DK,VISUAL IMPAIRMENT,1
EC,OSMOTIC DEMYELINATION SYNDROME,1
EC,PARKINSONISM,1
EG,BONE MARROW FAILURE,1
EG,LEUKOPENIA,1
EG,THROMBOCYTOPENIA,1
FI,DYSPNOEA,2
FI,NAUSEA,2
FI,PYREXIA,2
FI,VOMITING,2
FI,APHAGIA,1
FI,AUTOIMMUNE HEPATITIS,1
FI,COUGH,1
FI,DECREASED APPETITE,1
FI,DIARRHOEA,1
FI,DRUG CLEARANCE DECREASED,1
FI,DRUG INEFFECTIVE,1
FI,ELECTROLYTE IMBALANCE,1
FI,ERYTHEMA,1
FI,ESCHERICHIA PYELONEPHRITIS,1
FI,FATIGUE,1
FI,GAIT DISTURBANCE,1
FI,GENERAL PHYSICAL HEALTH DETERIORATION,1
FI,HYPERTHYROIDISM,1
FI,LIP PAIN,1
FI,MOUTH ULCERATION,1
FI,MUSCULAR WEAKNESS,1
FI,MYALGIA,1
FI,MYOPATHY,1
FI,NEUTROPENIA,1
FI,ORAL CANDIDIASIS,1
FI,PAIN IN EXTREMITY,1
FI,PARAESTHESIA,1
FI,PNEUMONIA,1
FI,RADIUS FRACTURE,1
FI,RESTLESS LEGS SYNDROME,1
FR,FATIGUE,152
FR,HEADACHE,82
FR,BLOOD THYROID STIMULATING HORMONE INCREASED,79
FR,INSOMNIA,79
FR,MUSCLE SPASMS,65
FR,VERTIGO,60
FR,PALPITATIONS,52
FR,WEIGHT INCREASED,51
FR,DIZZINESS,50
FR,NAUSEA,46
FR,MYALGIA,44
FR,ASTHENIA,43
FR,DIARRHOEA,43
FR,ARTHRALGIA,36
FR,BLOOD THYROID STIMULATING HORMONE DECREASED,36
FR,ALOPECIA,33
FR,DISTURBANCE IN ATTENTION,31
FR,DEPRESSION,29
FR,DIFFUSE ALOPECIA,29
FR,IRRITABILITY,29
FR,DYSPNOEA,27
FR,HYPERHIDROSIS,25
FR,ABDOMINAL PAIN,24
FR,TACHYCARDIA,23
FR,AMNESIA,21
FR,PRODUCT FORMULATION ISSUE,21
FR,BLOOD THYROID STIMULATING HORMONE NORMAL,20
FR,GASTROINTESTINAL DISORDER,19
FR,HOT FLUSH,19
FR,MIGRAINE,19
FR,VISION BLURRED,19
FR,MALAISE,18
FR,ANXIETY,17
FR,PAIN,17
FR,SLEEP DISORDER,17
FR,PARAESTHESIA,15
FR,ABDOMINAL PAIN UPPER,14
FR,ARRHYTHMIA,14
FR,BLOOD THYROID STIMULATING HORMONE,14
FR,CONSTIPATION,14
FR,MEMORY IMPAIRMENT,14
FR,ACUTE KIDNEY INJURY,13
FR,HYPERTHYROIDISM,13
FR,VOMITING,13
FR,PAIN IN EXTREMITY,12
FR,WEIGHT DECREASED,12
FR,DECREASED APPETITE,11
FR,HYPERTENSION,11
FR,RENAL FAILURE,11
FR,AFFECTIVE DISORDER,10
FR,BALANCE DISORDER,10
FR,GAIT DISTURBANCE,10
FR,MUSCULAR WEAKNESS,10
FR,TREMOR,10
FR,DRY SKIN,9
FR,BLOOD THYROID STIMULATING HORMONE ABNORMAL,8
FR,DYSPEPSIA,8
FR,HYPOTHYROIDISM,8
FR,NERVOUSNESS,8
FR,CARDIAC FAILURE,7
FR,CRYING,7
FR,HYPOTENSION,7
FR,LACTIC ACIDOSIS,7
FR,SOMNOLENCE,7
FR,TINNITUS,7
FR,URTICARIA,7
FR,VISUAL IMPAIRMENT,7
FR,CONDITION AGGRAVATED,6
FR,CONFUSIONAL STATE,6
FR,DRY MOUTH,6
FR,FALL,6
FR,HYPERKALAEMIA,6
FR,MUSCULOSKELETAL STIFFNESS,6
FR,OEDEMA PERIPHERAL,6
FR,PRURITUS,6
FR,RASH,6
FR,ABDOMINAL DISTENSION,5
FR,AGITATION,5
FR,ATRIAL FIBRILLATION,5
FR,BRADYCARDIA,5
FR,DEPRESSED MOOD,5
FR,FEELING JITTERY,5
FR,MOOD ALTERED,5
FR,POOR QUALITY SLEEP,5
FR,AGGRESSION,4
FR,ANAEMIA,4
FR,CHEST PAIN,4
FR,CHILLS,4
FR,DYSPNOEA EXERTIONAL,4
FR,FEELING COLD,4
FR,GENERAL PHYSICAL HEALTH DETERIORATION,4
FR,HENOCH-SCHONLEIN PURPURA,4
FR,HYPONATRAEMIA,4
FR,LIBIDO DECREASED,4
FR,LIMB DISCOMFORT,4
FR,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,4
FR,LUNG DISORDER,4
FR,MULTIPLE ORGAN DYSFUNCTION SYNDROME,4
FR,SEPSIS,4
FR,THYROXINE INCREASED,4
FR,ABDOMINAL DISCOMFORT,3
FR,ACNE,3
FR,ANGINA PECTORIS,3
FR,BACK PAIN,3
FR,CHOLESTASIS,3
FR,COLITIS,3
FR,DEPRESSIVE SYMPTOM,3
FR,DIABETES MELLITUS,3
FR,ELECTROCARDIOGRAM QT PROLONGED,3
FR,EYE PAIN,3
FR,FEELING HOT,3
FR,FORMICATION,3
FR,HEPATIC FAILURE,3
FR,HEPATITIS CHOLESTATIC,3
FR,HYPERSENSITIVITY,3
FR,MIDDLE INSOMNIA,3
FR,MOOD SWINGS,3
FR,NECK PAIN,3
FR,NIGHT SWEATS,3
FR,OEDEMA,3
FR,PEMPHIGOID,3
FR,RECTAL HAEMORRHAGE,3
FR,RENAL FAILURE ACUTE,3
FR,SENSE OF OPPRESSION,3
FR,SUICIDAL IDEATION,3
FR,SYNCOPE,3
FR,THROAT TIGHTNESS,3
FR,THROMBOCYTOPENIA,3
FR,TOXICITY TO VARIOUS AGENTS,3
FR,VASCULAR PURPURA,3
FR,VISUAL ACUITY REDUCED,3
FR,AFFECT LABILITY,2
FR,APATHY,2
FR,BLOOD ALKALINE PHOSPHATASE INCREASED,2
FR,BLOOD PRESSURE DECREASED,2
FR,C-REACTIVE PROTEIN INCREASED,2
FR,CARDIO-RESPIRATORY ARREST,2
FR,COLITIS ISCHAEMIC,2
FR,DEHYDRATION,2
FR,DIPLOPIA,2
FR,DRUG INEFFECTIVE,2
FR,DRUG-INDUCED LIVER INJURY,2
FR,DYSPHAGIA,2
FR,DYSSTASIA,2
FR,EPILEPSY,2
FR,EYE BURNS,2
FR,FEELING ABNORMAL,2
FR,FUNCTIONAL GASTROINTESTINAL DISORDER,2
FR,GAIT INABILITY,2
FR,GASTROOESOPHAGEAL REFLUX DISEASE,2
FR,HAEMATURIA,2
FR,HAEMORRHAGE,2
FR,HALLUCINATION_ VISUAL,2
FR,HEAD DISCOMFORT,2
FR,HEART RATE INCREASED,2
FR,HEPATIC ENZYME INCREASED,2
FR,HEPATITIS,2
FR,HEPATOCELLULAR INJURY,2
FR,HYPERTENSIVE CRISIS,2
FR,HYPOGLYCAEMIA,2
FR,HYPOKALAEMIA,2
FR,INFECTION,2
FR,INITIAL INSOMNIA,2
FR,INTERNATIONAL NORMALISED RATIO INCREASED,2
FR,INTERSTITIAL LUNG DISEASE,2
FR,LOSS OF CONSCIOUSNESS,2
FR,MALNUTRITION,2
FR,MIGRAINE WITH AURA,2
FR,MUSCLE FATIGUE,2
FR,NASAL DRYNESS,2
FR,OPTIC NEURITIS,2
FR,ORGANISING PNEUMONIA,2
FR,OVERDOSE,2
FR,OXYGEN SATURATION DECREASED,2
FR,PANCYTOPENIA,2
FR,PERIPHERAL SWELLING,2
FR,PRERENAL FAILURE,2
FR,PRODUCT USE ISSUE,2
FR,PROTEINURIA,2
FR,PYREXIA,2
FR,RASH MORBILLIFORM,2
FR,RENAL IMPAIRMENT,2
FR,RENAL VASCULITIS,2
FR,RESPIRATORY DISORDER,2
FR,RESPIRATORY DISTRESS,2
FR,SHOCK,2
FR,SINUS BRADYCARDIA,2
FR,SINUS NODE DYSFUNCTION,2
FR,SPEECH DISORDER,2
FR,STATUS EPILEPTICUS,2
FR,STRESS,2
FR,SUPRAVENTRICULAR TACHYCARDIA,2
FR,TENDONITIS,2
FR,THYROID FUNCTION TEST ABNORMAL,2
FR,THYROXINE DECREASED,2
FR,TRANSAMINASES INCREASED,2
FR,TRI-IODOTHYRONINE DECREASED,2
FR,VASCULITIS NECROTISING,2
FR,ABNORMAL BEHAVIOUR,1
FR,ABNORMAL FAECES,1
FR,ABNORMAL WEIGHT GAIN,1
FR,ABORTION SPONTANEOUS,1
FR,ABSCESS,1
FR,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,1
FR,ACUTE HEPATIC FAILURE,1
FR,ACUTE PULMONARY OEDEMA,1
FR,ACUTE RESPIRATORY FAILURE,1
FR,ADRENAL HAEMATOMA,1
FR,ADRENAL INSUFFICIENCY,1
FR,ADRENOCORTICAL INSUFFICIENCY ACUTE,1
FR,ADRENOMEGALY,1
FR,AGE-RELATED MACULAR DEGENERATION,1
FR,AIR EMBOLISM,1
FR,ALCOHOLISM,1
FR,ANALGESIC DRUG LEVEL INCREASED,1
FR,ANGIOEDEMA,1
FR,ANKYLOSING SPONDYLITIS,1
FR,ANTIPSYCHOTIC DRUG LEVEL INCREASED,1
FR,AORTIC VALVE INCOMPETENCE,1
FR,APLASIA PURE RED CELL,1
FR,APPENDICITIS,1
FR,APPLICATION SITE VESICLES,1
FR,ARTERIAL DISORDER,1
FR,ARTERIAL THROMBOSIS,1
FR,ARTHROPATHY,1
FR,ASTHENOPIA,1
FR,ASTHMA,1
FR,ASTHMATIC CRISIS,1
FR,AUTOIMMUNE HEPATITIS,1
FR,AUTOIMMUNE THYROIDITIS,1
FR,AXILLARY PAIN,1
FR,BACTERIAL SEPSIS,1
FR,BILOMA,1
FR,BLEEDING TIME PROLONGED,1
FR,BLINDNESS,1
FR,BLOOD BILIRUBIN INCREASED,1
FR,BONE CANCER,1
FR,BRAIN NATRIURETIC PEPTIDE INCREASED,1
FR,BREAST ABSCESS,1
FR,BREAST CANCER,1
FR,BREAST PAIN,1
FR,BRONCHIAL OBSTRUCTION,1
FR,BRONCHITIS CHRONIC,1
FR,BUNDLE BRANCH BLOCK RIGHT,1
FR,BURNING SENSATION,1
FR,CARDIAC DISORDER,1
FR,CARDIAC MURMUR,1
FR,CARDIAC VALVE DISEASE,1
FR,CARDIAC VALVE REPLACEMENT COMPLICATION,1
FR,CARDIOACTIVE DRUG LEVEL INCREASED,1
FR,CARDIOGENIC SHOCK,1
FR,CARDIOMEGALY,1
FR,CAROTID ARTERY STENOSIS,1
FR,CEREBROVASCULAR ACCIDENT,1
FR,CHANGE OF BOWEL HABIT,1
FR,CHEST DISCOMFORT,1
FR,CHOLECYSTECTOMY,1
FR,CHOLELITHIASIS,1
FR,CHROMATURIA,1
FR,CIRCULATORY COLLAPSE,1
FR,COAGULATION FACTOR V LEVEL DECREASED,1
FR,COGNITIVE DISORDER,1
FR,COLD SWEAT,1
FR,COLITIS ULCERATIVE,1
FR,COUGH,1
FR,CYANOSIS,1
FR,DEAFNESS,1
FR,DEAFNESS BILATERAL,1
FR,DEATH,1
FR,DEPERSONALISATION/DEREALISATION DISORDER,1
FR,DEPRESSED LEVEL OF CONSCIOUSNESS,1
FR,DIABETES MELLITUS INADEQUATE CONTROL,1
FR,DIARRHOEA INFECTIOUS,1
FR,DISCOMFORT,1
FR,DISEASE PROGRESSION,1
FR,DIVERTICULAR PERFORATION,1
FR,DRUG DOSE OMISSION,1
FR,DRUG TOLERANCE,1
FR,DRUG WITHDRAWAL SYNDROME,1
FR,DRY EYE,1
FR,DYSAESTHESIA,1
FR,DYSGRAPHIA,1
FR,DYSPHONIA,1
FR,ECZEMA,1
FR,ELECTRIC SHOCK,1
FR,ELECTROCARDIOGRAM CHANGE,1
FR,ELECTROCARDIOGRAM QRS COMPLEX ABNORMAL,1
FR,ELECTROCARDIOGRAM REPOLARISATION ABNORMALITY,1
FR,ELECTROCARDIOGRAM ST SEGMENT ABNORMAL,1
FR,ENCEPHALOPATHY,1
FR,EOSINOPHILIA,1
FR,EPISTAXIS,1
FR,ERYTHEMA,1
FR,EXPOSED BONE IN JAW,1
FR,EXTRADURAL HAEMATOMA,1
FR,EXTRASYSTOLES,1
FR,EYE DISORDER,1
FR,EYE IRRITATION,1
FR,EYELID OEDEMA,1
FR,FACE OEDEMA,1
FR,FACIAL PAIN,1
FR,FAECES SOFT,1
FR,FEAR,1
FR,FEAR OF DEATH,1
FR,FEAR OF FALLING,1
FR,FEBRILE BONE MARROW APLASIA,1
FR,FEELING DRUNK,1
FR,FINE MOTOR SKILL DYSFUNCTION,1
FR,FLATULENCE,1
FR,FLUID RETENTION,1
FR,FOETAL EXPOSURE DURING PREGNANCY,1
FR,FOETAL HEART RATE DISORDER,1
FR,FOLLICULITIS,1
FR,FRACTURE,1
FR,GALLBLADDER DISORDER,1
FR,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
FR,GASTRECTOMY,1
FR,GASTRIC DISORDER,1
FR,GASTRITIS,1
FR,GASTROENTERITIS EOSINOPHILIC,1
FR,GASTROINTESTINAL MOTILITY DISORDER,1
FR,GASTROINTESTINAL PAIN,1
FR,GENERAL PHYSICAL CONDITION ABNORMAL,1
FR,GINGIVITIS,1
FR,GLOMERULONEPHRITIS MEMBRANOUS,1
FR,GLOSSODYNIA,1
FR,HAEMATOMA,1
FR,HAEMODYNAMIC INSTABILITY,1
FR,HALLUCINATION_ AUDITORY,1
FR,HEAD INJURY,1
FR,HEART RATE DECREASED,1
FR,HEPARIN-INDUCED THROMBOCYTOPENIA,1
FR,HICCUPS,1
FR,HISTIOCYTOSIS HAEMATOPHAGIC,1
FR,HUNGER,1
FR,HYPERACUSIS,1
FR,HYPERGLYCAEMIA,1
FR,HYPERSENSITIVITY VASCULITIS,1
FR,HYPERTHERMIA,1
FR,HYPERTRICHOSIS,1
FR,HYPOACUSIS,1
FR,HYPOAESTHESIA,1
FR,HYPOAESTHESIA ORAL,1
FR,HYPOCALCAEMIA,1
FR,HYPOGLYCAEMIC COMA,1
FR,HYPOXIA,1
FR,IGA NEPHROPATHY,1
FR,ILEUS PARALYTIC,1
FR,IMPAIRED HEALING,1
FR,IMPAIRED WORK ABILITY,1
FR,INCOHERENT,1
FR,INFLAMMATION,1
FR,INSULIN-REQUIRING TYPE 2 DIABETES MELLITUS,1
FR,INTENTIONAL OVERDOSE,1
FR,INTERNATIONAL NORMALISED RATIO DECREASED,1
FR,IRRITABLE BOWEL SYNDROME,1
FR,ISCHAEMIC CARDIOMYOPATHY,1
FR,ISCHAEMIC STROKE,1
FR,JAUNDICE,1
FR,JAW DISORDER,1
FR,LARYNGITIS,1
FR,LEFT VENTRICULAR FAILURE,1
FR,LEUKOCYTOCLASTIC VASCULITIS,1
FR,LEUKOENCEPHALOPATHY,1
FR,LICHEN PLANUS,1
FR,LIVER DISORDER,1
FR,LIVER TRANSPLANT REJECTION,1
FR,LOSS OF LIBIDO,1
FR,LUNG INFECTION,1
FR,MAJOR DEPRESSION,1
FR,MALIGNANT NEOPLASM PROGRESSION,1
FR,MEDICATION ERROR,1
FR,MELAENA,1
FR,MENINGIOMA,1
FR,MENORRHAGIA,1
FR,MENTAL FATIGUE,1
FR,METABOLIC DISORDER,1
FR,METASTASIS,1
FR,MICTURITION DISORDER,1
FR,MUCOSAL INFLAMMATION,1
FR,MUCOUS STOOLS,1
FR,MUSCLE DISORDER,1
FR,MUSCLE HAEMORRHAGE,1
FR,MUSCLE RUPTURE,1
FR,MUSCLE TIGHTNESS,1
FR,MUSCULOSKELETAL PAIN,1
FR,MYOCARDIAL INFARCTION,1
FR,NAIL TOXICITY,1
FR,NECK INJURY,1
FR,NERVOUS SYSTEM DISORDER,1
FR,NEURALGIA,1
FR,NEUROLEPTIC MALIGNANT SYNDROME,1
FR,NEUROPATHY PERIPHERAL,1
FR,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
FR,OBLITERATIVE BRONCHIOLITIS,1
FR,OESOPHAGITIS,1
FR,ONYCHOCLASIS,1
FR,ORAL DISCOMFORT,1
FR,ORAL FUNGAL INFECTION,1
FR,ORAL MUCOSAL EXFOLIATION,1
FR,OROPHARYNGEAL PAIN,1
FR,OSTEONECROSIS OF JAW,1
FR,OSTEOPOROSIS,1
FR,PAIN IN JAW,1
FR,PALLOR,1
FR,PANCREATITIS ACUTE,1
FR,PARAPLEGIA,1
FR,PARKINSONISM,1
FR,PERICARDIAL EFFUSION,1
FR,PERIPHERAL T-CELL LYMPHOMA UNSPECIFIED,1
FR,PERITONITIS,1
FR,PHLEBITIS,1
FR,PHOTOSENSITIVITY REACTION,1
FR,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
FR,PNEUMONIA,1
FR,PNEUMONIA LEGIONELLA,1
FR,PO2 DECREASED,1
FR,POISONING,1
FR,POLLAKIURIA,1
FR,POLYCYTHAEMIA,1
FR,POLYMENORRHOEA,1
FR,POLYURIA,1
FR,PRESYNCOPE,1
FR,PRINZMETAL ANGINA,1
FR,PRODUCT QUALITY ISSUE,1
FR,PROTHROMBIN LEVEL ABNORMAL,1
FR,PROTHROMBIN TIME RATIO DECREASED,1
FR,PRURITUS GENERALISED,1
FR,PSYCHIATRIC SYMPTOM,1
FR,PULMONARY EMBOLISM,1
FR,PULMONARY FIBROSIS,1
FR,PULMONARY HYPERTENSION,1
FR,PURPURA,1
FR,PYELONEPHRITIS,1
FR,QUALITY OF LIFE DECREASED,1
FR,RASH GENERALISED,1
FR,RASH MACULAR,1
FR,RASH MACULO-PAPULAR,1
FR,REFLEXES ABNORMAL,1
FR,RENAL ARTERY OCCLUSION,1
FR,RENAL ARTERY THROMBOSIS,1
FR,RENAL DISORDER,1
FR,RENAL FAILURE CHRONIC,1
FR,RENAL TUBULAR DISORDER,1
FR,RESPIRATORY FAILURE,1
FR,ROAD TRAFFIC ACCIDENT,1
FR,SALIVA ALTERED,1
FR,SEPTIC SHOCK,1
FR,SJOGREN^S SYNDROME,1
FR,SKIN ULCER,1
FR,SLEEP APNOEA SYNDROME,1
FR,SPINAL CORD COMPRESSION,1
FR,SPINAL PAIN,1
FR,STRESS AT WORK,1
FR,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,1
FR,SUBCUTANEOUS HAEMATOMA,1
FR,SUBDURAL HAEMATOMA,1
FR,SUICIDE ATTEMPT,1
FR,SURGERY,1
FR,SWOLLEN TONGUE,1
FR,TACHYPNOEA,1
FR,TENDON RUPTURE,1
FR,TENSION,1
FR,TENSION HEADACHE,1
FR,TERMINAL INSOMNIA,1
FR,TETANY,1
FR,THINKING ABNORMAL,1
FR,THIRST,1
FR,THROMBOTIC CEREBRAL INFARCTION,1
FR,THYROID CANCER,1
FR,THYROID CYST,1
FR,THYROID MASS,1
FR,TONGUE DRY,1
FR,TONGUE HAEMATOMA,1
FR,TONGUE OEDEMA,1
FR,TONGUE PARALYSIS,1
FR,TOOTH DISORDER,1
FR,TOXIC SKIN ERUPTION,1
FR,TRANSAMINASES DECREASED,1
FR,TRI-IODOTHYRONINE INCREASED,1
FR,TUBULOINTERSTITIAL NEPHRITIS,1
FR,TUMOUR LYSIS SYNDROME,1
FR,TYPE 2 DIABETES MELLITUS,1
FR,URINARY INCONTINENCE,1
FR,URINARY RETENTION,1
FR,URINARY TRACT DISORDER,1
FR,URINARY TRACT INFECTION,1
FR,VENTRICULAR EXTRASYSTOLES,1
FR,VENTRICULAR TACHYCARDIA,1
FR,VOGT-KOYANAGI-HARADA SYNDROME,1
FR,VULVOVAGINAL BURNING SENSATION,1
FR,WEIGHT ABNORMAL,1
FR,WRIST FRACTURE,1
FR,WRONG PATIENT RECEIVED MEDICATION,1
FR,ZYGOMYCOSIS,1
DE,FOETAL EXPOSURE DURING PREGNANCY,48
DE,EXPOSURE DURING PREGNANCY,31
DE,FEBRILE NEUTROPENIA,20
DE,PYREXIA,18
DE,HYPONATRAEMIA,16
DE,HYPOTENSION,13
DE,RESPIRATORY DISORDER NEONATAL,13
DE,AGITATION,11
DE,AGITATION NEONATAL,11
DE,ATRIAL SEPTAL DEFECT,11
DE,PRODUCT USE IN UNAPPROVED INDICATION,10
DE,SMALL FOR DATES BABY,10
DE,SYNCOPE,10
DE,URINARY TRACT INFECTION,10
DE,DYSPNOEA,9
DE,GESTATIONAL DIABETES,9
DE,CAESAREAN SECTION,8
DE,DEPRESSION,8
DE,DIARRHOEA,8
DE,FATIGUE,8
DE,GAIT DISTURBANCE,8
DE,GENERAL PHYSICAL HEALTH DETERIORATION,8
DE,RENAL FAILURE ACUTE,8
DE,ALANINE AMINOTRANSFERASE INCREASED,7
DE,ASPARTATE AMINOTRANSFERASE INCREASED,7
DE,BLOOD CREATINE PHOSPHOKINASE INCREASED,7
DE,MYALGIA,7
DE,RESTLESSNESS,7
DE,VOMITING,7
DE,BLOOD LACTATE DEHYDROGENASE INCREASED,6
DE,GAMMA-GLUTAMYLTRANSFERASE INCREASED,6
DE,HEADACHE,6
DE,NAUSEA,6
DE,NEONATAL RESPIRATORY DISTRESS SYNDROME,6
DE,PREMATURE LABOUR,6
DE,PRURITUS,6
DE,PULMONARY EMBOLISM,6
DE,STOMATITIS,6
DE,THROMBOCYTOPENIA,6
DE,ASTHENIA,5
DE,DEHYDRATION,5
DE,FALL,5
DE,FEEDING DISORDER NEONATAL,5
DE,HEPATIC FAILURE,5
DE,INTENTIONAL SELF-INJURY,5
DE,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,5
DE,PATENT DUCTUS ARTERIOSUS,5
DE,PERSONALITY DISORDER,5
DE,PRE-ECLAMPSIA,5
DE,PREMATURE RUPTURE OF MEMBRANES,5
DE,RENAL FAILURE,5
DE,RESPIRATORY FAILURE,5
DE,SEPSIS,5
DE,SOMNOLENCE,5
DE,ABDOMINAL PAIN,4
DE,ACUTE KIDNEY INJURY,4
DE,ALTERED STATE OF CONSCIOUSNESS,4
DE,BACK PAIN,4
DE,CARDIAC FAILURE,4
DE,CHILLS,4
DE,CONGENITAL MITRAL VALVE INCOMPETENCE,4
DE,DELIRIUM,4
DE,DEVELOPMENTAL HIP DYSPLASIA,4
DE,DISORIENTATION,4
DE,DRUG-INDUCED LIVER INJURY,4
DE,FEBRILE INFECTION,4
DE,FOETAL HEART RATE DECELERATION ABNORMALITY,4
DE,GASTROINTESTINAL INFLAMMATION,4
DE,HYPERTENSION,4
DE,HYPERTHYROIDISM,4
DE,HYPOSPADIAS,4
DE,HYPOTHERMIA,4
DE,LARGE FOR DATES BABY,4
DE,MECONIUM IN AMNIOTIC FLUID,4
DE,MYOCLONUS,4
DE,NEUTROPENIA,4
DE,PAIN OF SKIN,4
DE,PANCREATITIS,4
DE,PNEUMOTHORAX,4
DE,URINARY INCONTINENCE,4
DE,ABDOMINAL PAIN UPPER,3
DE,AMNIOTIC FLUID VOLUME INCREASED,3
DE,ATRIAL FIBRILLATION,3
DE,BLOOD CREATININE INCREASED,3
DE,CIRCULATORY COLLAPSE,3
DE,COGNITIVE DISORDER,3
DE,CONFUSIONAL STATE,3
DE,CONGENITAL TRICUSPID VALVE INCOMPETENCE,3
DE,DEATH,3
DE,DEVICE RELATED INFECTION,3
DE,DIZZINESS,3
DE,ELECTROCARDIOGRAM QT PROLONGED,3
DE,ENTERITIS,3
DE,FLATULENCE,3
DE,GASTROINTESTINAL DISORDER,3
DE,GASTROINTESTINAL HAEMORRHAGE,3
DE,HAEMANGIOMA CONGENITAL,3
DE,HAEMOLYSIS,3
DE,HEPATIC ENZYME INCREASED,3
DE,HYPOKALAEMIA,3
DE,INTERSTITIAL LUNG DISEASE,3
DE,LOGORRHOEA,3
DE,MONOPARESIS,3
DE,MYOCARDIAL INFARCTION,3
DE,POTENTIATING DRUG INTERACTION,3
DE,PREMATURE BABY,3
DE,PRETERM PREMATURE RUPTURE OF MEMBRANES,3
DE,PULMONARY HYPERTENSION,3
DE,PULMONARY VALVE STENOSIS CONGENITAL,3
DE,RHABDOMYOLYSIS,3
DE,SEROMA,3
DE,SLEEP DISORDER,3
DE,SOMNAMBULISM,3
DE,TACHYARRHYTHMIA,3
DE,WEIGHT DECREASED,3
DE,ANAEMIA,2
DE,ANXIETY,2
DE,BRADYCARDIA NEONATAL,2
DE,C-REACTIVE PROTEIN INCREASED,2
DE,CEREBRAL INFARCTION,2
DE,COLITIS,2
DE,COMPARTMENT SYNDROME,2
DE,CONDITION AGGRAVATED,2
DE,CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY,2
DE,CONGENITAL CYSTIC LUNG,2
DE,CONGESTIVE CARDIOMYOPATHY,2
DE,CONVULSION,2
DE,CONVULSION NEONATAL,2
DE,COORDINATION ABNORMAL,2
DE,COUGH,2
DE,DEEP VEIN THROMBOSIS,2
DE,DIABETES MELLITUS,2
DE,DIABETIC GASTROPARESIS,2
DE,DIASTOLIC DYSFUNCTION,2
DE,DRUG EFFECT INCOMPLETE,2
DE,DRUG INEFFECTIVE,2
DE,DRUG LEVEL FLUCTUATING,2
DE,DRUG WITHDRAWAL SYNDROME,2
DE,DRUG WITHDRAWAL SYNDROME NEONATAL,2
DE,DYSARTHRIA,2
DE,DYSPHONIA,2
DE,DYSPNOEA EXERTIONAL,2
DE,EJECTION FRACTION DECREASED,2
DE,FOETAL GROWTH RESTRICTION,2
DE,GASTROINTESTINAL INFECTION,2
DE,HAEMATOMA,2
DE,HAEMOGLOBIN DECREASED,2
DE,HAEMOPTYSIS,2
DE,HAEMORRHAGE INTRACRANIAL,2
DE,HYDROPS FOETALIS,2
DE,HYPERBILIRUBINAEMIA NEONATAL,2
DE,HYPERCALCAEMIA,2
DE,HYPERHIDROSIS,2
DE,HYPERSENSITIVITY,2
DE,HYPERTONIA NEONATAL,2
DE,HYPOGLYCAEMIA NEONATAL,2
DE,HYPOMAGNESAEMIA,2
DE,INAPPROPRIATE AFFECT,2
DE,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,2
DE,INDUCED LABOUR,2
DE,INFECTION,2
DE,INSOMNIA,2
DE,LACTIC ACIDOSIS,2
DE,LEUKOENCEPHALOPATHY,2
DE,LOSS OF CONSCIOUSNESS,2
DE,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,2
DE,MALAISE,2
DE,MALIGNANT NEOPLASM PROGRESSION,2
DE,MATERNAL DRUGS AFFECTING FOETUS,2
DE,MEMORY IMPAIRMENT,2
DE,NEONATAL ASPHYXIA,2
DE,ORAL PAIN,2
DE,OSTEONECROSIS,2
DE,OVERDOSE,2
DE,PAIN,2
DE,PAIN IN EXTREMITY,2
DE,PERSISTENT FOETAL CIRCULATION,2
DE,PERSONALITY CHANGE,2
DE,POISONING,2
DE,POLYHYDRAMNIOS,2
DE,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,2
DE,PULMONARY OEDEMA,2
DE,RENAL APLASIA,2
DE,ROAD TRAFFIC ACCIDENT,2
DE,SEDATION,2
DE,SEIZURE,2
DE,SELECTIVE EATING DISORDER,2
DE,SEROTONIN SYNDROME,2
DE,SUBILEUS,2
DE,SUICIDAL IDEATION,2
DE,SUPRAVENTRICULAR TACHYCARDIA,2
DE,THROMBOSIS,2
DE,TOXICITY TO VARIOUS AGENTS,2
DE,TRANSAMINASES INCREASED,2
DE,TREMOR NEONATAL,2
DE,VENTRICULAR SEPTAL DEFECT,2
DE,VENTRICULAR TACHYARRHYTHMIA,2
DE,VERTIGO,2
DE,WITHDRAWAL HYPERTENSION,2
DE,ABDOMINAL DISTENSION,1
DE,ABDOMINAL PAIN LOWER,1
DE,ABORTION MISSED,1
DE,ACCIDENTAL OVERDOSE,1
DE,ACIDOSIS,1
DE,ACTIVITIES OF DAILY LIVING IMPAIRED,1
DE,ACUTE HEPATIC FAILURE,1
DE,ACUTE MYOCARDIAL INFARCTION,1
DE,ACUTE RESPIRATORY FAILURE,1
DE,ADRENAL INSUFFICIENCY,1
DE,AGGRESSION,1
DE,AGRANULOCYTOSIS,1
DE,AMNESIA,1
DE,ANGIOEDEMA,1
DE,APHASIA,1
DE,APNOEA NEONATAL,1
DE,APPARENT DEATH,1
DE,ARTHRALGIA,1
DE,ARTHROPATHY,1
DE,ASCITES,1
DE,ASPIRATION,1
DE,ATRIAL FLUTTER,1
DE,ATRIAL THROMBOSIS,1
DE,BACTERIAL VAGINOSIS,1
DE,BASAL GANGLIA HAEMORRHAGE,1
DE,BICYTOPENIA,1
DE,BILE DUCT STENOSIS,1
DE,BLINDNESS CORTICAL,1
DE,BLOOD BILIRUBIN INCREASED,1
DE,BLOOD CREATINE INCREASED,1
DE,BLOOD INSULIN DECREASED,1
DE,BLOOD PRESSURE DECREASED,1
DE,BLOOD THYROID STIMULATING HORMONE ABNORMAL,1
DE,BODY TEMPERATURE INCREASED,1
DE,BONE DISORDER,1
DE,BONE MARROW FAILURE,1
DE,BONE PAIN,1
DE,BRADYCARDIA,1
DE,BRAIN ABSCESS,1
DE,BRAIN OEDEMA,1
DE,BREAST CANCER,1
DE,BRONCHOPNEUMONIA,1
DE,BRONCHOSPASM,1
DE,BURNING SENSATION,1
DE,CARDIAC ARREST,1
DE,CARDIAC DISORDER,1
DE,CARDIOGENIC SHOCK,1
DE,CARDIOMYOPATHY,1
DE,CARDIOVASCULAR DISORDER,1
DE,CEREBRAL HAEMORRHAGE,1
DE,CEREBRAL ISCHAEMIA,1
DE,CEREBROVASCULAR ACCIDENT,1
DE,CHEST DISCOMFORT,1
DE,CHEST PAIN,1
DE,CHOLECYSTITIS,1
DE,CHOLELITHIASIS,1
DE,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
DE,COAGULATION TIME PROLONGED,1
DE,COELIAC DISEASE,1
DE,COLITIS ULCERATIVE,1
DE,COLON CANCER,1
DE,COMA,1
DE,COMPLETED SUICIDE,1
DE,CONGENITAL CHOROID PLEXUS CYST,1
DE,CONGENITAL LARGE INTESTINAL ATRESIA,1
DE,CONGENITAL MUSCULOSKELETAL ANOMALY,1
DE,CONGENITAL NAEVUS,1
DE,CONSTIPATION,1
DE,CORRECTED TRANSPOSITION OF GREAT VESSELS,1
DE,CRANIAL NERVE DISORDER,1
DE,CRANIAL SUTURES WIDENING,1
DE,CREATININE RENAL CLEARANCE DECREASED,1
DE,CRUSH SYNDROME,1
DE,CSF PROTEIN INCREASED,1
DE,CYANOSIS NEONATAL,1
DE,CYSTITIS,1
DE,CYSTITIS NONINFECTIVE,1
DE,DANDY-WALKER SYNDROME,1
DE,DARK CIRCLES UNDER EYES,1
DE,DEAFNESS CONGENITAL,1
DE,DECREASED APPETITE,1
DE,DELUSION,1
DE,DEPRESSED LEVEL OF CONSCIOUSNESS,1
DE,DERMATITIS,1
DE,DEVELOPMENTAL COORDINATION DISORDER,1
DE,DIABETIC FOETOPATHY,1
DE,DISEASE PROGRESSION,1
DE,DISTURBANCE IN ATTENTION,1
DE,DRUG ERUPTION,1
DE,DRUG LEVEL INCREASED,1
DE,DRY MOUTH,1
DE,DYSAESTHESIA,1
DE,DYSKINESIA,1
DE,DYSMORPHISM,1
DE,DYSPEPSIA,1
DE,DYSPHAGIA,1
DE,DYSPHORIA,1
DE,DYSTONIA,1
DE,ELECTROENCEPHALOGRAM ABNORMAL,1
DE,ENCEPHALITIS,1
DE,ENCEPHALOPATHY,1
DE,EPISTAXIS,1
DE,ERUCTATION,1
DE,EXTREMITY CONTRACTURE,1
DE,FAECAL INCONTINENCE,1
DE,FAECES DISCOLOURED,1
DE,FLOPPY INFANT,1
DE,FOETAL MACROSOMIA,1
DE,FOOD ALLERGY,1
DE,FUNGAL INFECTION,1
DE,GAMBLING DISORDER,1
DE,GAMMA-GLUTAMYLTRANSFERASE ABNORMAL,1
DE,GASTROINTESTINAL NECROSIS,1
DE,GASTROINTESTINAL TRACT ADENOMA,1
DE,GASTROOESOPHAGEAL REFLUX DISEASE,1
DE,GENERAL PHYSICAL CONDITION ABNORMAL,1
DE,GENERALISED TONIC-CLONIC SEIZURE,1
DE,GOITRE,1
DE,GRAND MAL CONVULSION,1
DE,HAEMATURIA,1
DE,HAEMOLYTIC ANAEMIA,1
DE,HAEMORRHAGE,1
DE,HAEMORRHAGIC DISORDER,1
DE,HAEMORRHAGIC STROKE,1
DE,HAEMORRHOIDS,1
DE,HALLUCINATION,1
DE,HEART RATE INCREASED,1
DE,HELLP SYNDROME,1
DE,HEPATITIS,1
DE,HEPATITIS CHOLESTATIC,1
DE,HEPATOTOXICITY,1
DE,HERPES SIMPLEX,1
DE,HOT FLUSH,1
DE,HUNGER,1
DE,HYDROCELE,1
DE,HYDRONEPHROSIS,1
DE,HYPERGLYCAEMIA,1
DE,HYPERPARATHYROIDISM,1
DE,HYPERTENSIVE CRISIS,1
DE,HYPERTONIA,1
DE,HYPERTRICHOSIS,1
DE,HYPOACUSIS,1
DE,HYPOCALCAEMIA,1
DE,HYPOGLYCAEMIA,1
DE,HYPOPHAGIA,1
DE,HYPOTHERMIA NEONATAL,1
DE,HYPOTONIA,1
DE,HYPOTONIA NEONATAL,1
DE,ILL-DEFINED DISORDER,1
DE,IMMUNISATION REACTION,1
DE,IMMUNOSUPPRESSION,1
DE,IMPAIRED DRIVING ABILITY,1
DE,INCREASED APPETITE,1
DE,INFANTILE APNOEA,1
DE,INFANTILE HAEMANGIOMA,1
DE,INFLAMMATORY MARKER INCREASED,1
DE,INFLUENZA LIKE ILLNESS,1
DE,INJECTION SITE ERYTHEMA,1
DE,INJECTION SITE SWELLING,1
DE,INTENTIONAL OVERDOSE,1
DE,INTESTINAL FISTULA,1
DE,INTESTINAL ISCHAEMIA,1
DE,IRRITABILITY,1
DE,JAUNDICE,1
DE,JOINT STIFFNESS,1
DE,LABILE BLOOD PRESSURE,1
DE,LEFT VENTRICULAR DYSFUNCTION,1
DE,LEUKOPENIA,1
DE,LIPIDOSIS,1
DE,LIVER ABSCESS,1
DE,LIVER FUNCTION TEST ABNORMAL,1
DE,LUNG INFECTION,1
DE,MATERNAL EXPOSURE TIMING UNSPECIFIED,1
DE,MECONIUM ILEUS,1
DE,MEDICAL DEVICE COMPLICATION,1
DE,MELAENA,1
DE,MENINGOENCEPHALITIS VIRAL,1
DE,MENSTRUAL DISORDER,1
DE,METABOLIC ACIDOSIS,1
DE,METASTASES TO BONE,1
DE,METASTASES TO LIVER,1
DE,METASTATIC BRONCHIAL CARCINOMA,1
DE,MICROCEPHALY,1
DE,MICROPHTHALMOS,1
DE,MITRAL VALVE INCOMPETENCE,1
DE,MOOD SWINGS,1
DE,MOVEMENT DISORDER,1
DE,MUCOSAL INFLAMMATION,1
DE,MULTI-ORGAN FAILURE,1
DE,MUSCLE HAEMORRHAGE,1
DE,MUSCLE SPASMS,1
DE,MUSCLE TWITCHING,1
DE,MUSCULAR WEAKNESS,1
DE,MYELITIS,1
DE,NAEVUS FLAMMEUS,1
DE,NASOPHARYNGITIS,1
DE,NEONATAL ANURIA,1
DE,NEONATAL INFECTION,1
DE,NEONATAL PNEUMONIA,1
DE,NEPHROCALCINOSIS,1
DE,NEPHROTIC SYNDROME,1
DE,NEUROLOGIC NEGLECT SYNDROME,1
DE,NEUTROPHIL FUNCTION DISORDER,1
DE,NORMOCHROMIC NORMOCYTIC ANAEMIA,1
DE,NYSTAGMUS,1
DE,OBSTRUCTIVE AIRWAYS DISORDER,1
DE,OCULOGYRIC CRISIS,1
DE,OSTEOPOROTIC FRACTURE,1
DE,OXYGEN SATURATION DECREASED,1
DE,PANCREATIC CARCINOMA,1
DE,PANCREATIC PSEUDOCYST,1
DE,PANCYTOPENIA,1
DE,PARAESTHESIA,1
DE,PARAPLEGIA,1
DE,PARKINSON^S DISEASE,1
DE,PARTIAL SEIZURES,1
DE,PEPTIC ULCER,1
DE,PERIPHERAL MOTOR NEUROPATHY,1
DE,PERIPHERAL NERVE PARESIS,1
DE,PERIPHERAL SWELLING,1
DE,PERONEAL NERVE PALSY,1
DE,PERSISTENT DEPRESSIVE DISORDER,1
DE,PHOTOPHOBIA,1
DE,PHOTOPSIA,1
DE,PHYSICAL EXAMINATION ABNORMAL,1
DE,PITUITARY TUMOUR BENIGN,1
DE,PLAGIOCEPHALY,1
DE,PLASMA CELL MYELOMA,1
DE,PLASMODIUM FALCIPARUM INFECTION,1
DE,PLATELET AGGREGATION DECREASED,1
DE,PLEURAL EFFUSION,1
DE,PNEUMONIA,1
DE,PNEUMONIA ASPIRATION,1
DE,POOR SUCKING REFLEX,1
DE,PREMATURE BABY DEATH,1
DE,PRESCRIBED UNDERDOSE,1
DE,PRESYNCOPE,1
DE,PRODUCT QUALITY ISSUE,1
DE,PROSTATE CANCER,1
DE,PROSTATE CANCER METASTATIC,1
DE,PROTEIN URINE PRESENT,1
DE,PROTRUSION TONGUE,1
DE,PSORIASIS,1
DE,PSYCHOTIC BEHAVIOUR,1
DE,PULMONARY ALVEOLAR HAEMORRHAGE,1
DE,PULMONARY ARTERIAL PRESSURE,1
DE,PULMONARY ARTERY STENOSIS CONGENITAL,1
DE,PULMONARY FIBROSIS,1
DE,PULMONARY HAEMORRHAGE,1
DE,PULMONARY MALFORMATION,1
DE,RASH,1
DE,RAYNAUD^S PHENOMENON,1
DE,RENAL DISORDER,1
DE,RENAL HYPERTROPHY,1
DE,RENAL PAIN,1
DE,RESPIRATORY DEPRESSION,1
DE,RETROPLACENTAL HAEMATOMA,1
DE,RIB FRACTURE,1
DE,RIGHT VENTRICULAR HYPERTROPHY,1
DE,SALIVARY HYPERSECRETION,1
DE,SECONDARY HYPOTHYROIDISM,1
DE,SELECTIVE ABORTION,1
DE,SENSORY LEVEL ABNORMAL,1
DE,SINUSITIS,1
DE,SJOGREN^S SYNDROME,1
DE,SKIN DISCOLOURATION,1
DE,SKIN DISORDER,1
DE,SKIN HAEMORRHAGE,1
DE,SKIN ULCER,1
DE,SKULL FRACTURE,1
DE,SPINAL FRACTURE,1
DE,SPONTANEOUS HAEMATOMA,1
DE,STREPTOCOCCUS TEST POSITIVE,1
DE,SUBARACHNOID HAEMORRHAGE,1
DE,SUBDURAL HAEMATOMA,1
DE,SUDDEN UNEXPLAINED DEATH IN EPILEPSY,1
DE,SWOLLEN TONGUE,1
DE,SYSTEMIC LUPUS ERYTHEMATOSUS,1
DE,TACHYCARDIA,1
DE,TEMPERATURE REGULATION DISORDER,1
DE,TEMPORAL ARTERITIS,1
DE,TENSION,1
DE,THORACIC VERTEBRAL FRACTURE,1
DE,THROMBOCYTOSIS,1
DE,THYROID FUNCTION TEST ABNORMAL,1
DE,TONSILLAR DISORDER,1
DE,TRACHEAL OBSTRUCTION,1
DE,TRACHEOBRONCHITIS,1
DE,TREATMENT NONCOMPLIANCE,1
DE,TREMOR,1
DE,TRICUSPID VALVE INCOMPETENCE,1
DE,TYPE 2 DIABETES MELLITUS,1
DE,URINARY HESITATION,1
DE,URINARY RETENTION,1
DE,URINE SODIUM INCREASED,1
DE,URTICARIA,1
DE,VAGINAL HAEMORRHAGE,1
DE,VASCULITIS,1
DE,VENTRICULAR EXTRASYSTOLES,1
DE,VIROLOGIC FAILURE,1
DE,VISION BLURRED,1
DE,VISUAL ACUITY REDUCED,1
DE,VISUAL IMPAIRMENT,1
DE,VULVOVAGINAL MYCOTIC INFECTION,1
DE,WEIGHT INCREASED,1
DE,WEIGHT LOSS POOR,1
DE,WITHDRAWAL SYNDROME,1
GR,ATRIAL FIBRILLATION,2
GR,HYPOTENSION,2
GR,LYMPHOPENIA,2
GR,NEUTROPENIA,2
GR,ABDOMINAL PAIN,1
GR,ABDOMINAL PAIN LOWER,1
GR,AGRANULOCYTOSIS,1
GR,ANAEMIA,1
GR,BACTERAEMIA,1
GR,BLOOD BILIRUBIN INCREASED,1
GR,BLOOD PRESSURE INCREASED,1
GR,BRAIN HERNIATION,1
GR,CARDIAC ARREST,1
GR,CHEST PAIN,1
GR,CLOSTRIDIUM DIFFICILE INFECTION,1
GR,COGNITIVE DISORDER,1
GR,DEPRESSED MOOD,1
GR,DERMATITIS ALLERGIC,1
GR,DIARRHOEA,1
GR,DRUG INEFFECTIVE,1
GR,EMBOLISM,1
GR,ERYTHEMA,1
GR,FEELING HOT,1
GR,GAIT DISTURBANCE,1
GR,GASTROINTESTINAL HAEMORRHAGE,1
GR,HAEMATURIA,1
GR,HAEMORRHAGIC STROKE,1
GR,HYPERSENSITIVITY VASCULITIS,1
GR,HYPERTRANSAMINASAEMIA,1
GR,HYPOTHYROIDISM,1
GR,INFECTION,1
GR,INFLUENZA LIKE ILLNESS,1
GR,INJECTION SITE EXTRAVASATION,1
GR,JAUNDICE,1
GR,LEUKOPENIA,1
GR,LOWER RESPIRATORY TRACT INFECTION,1
GR,LUNG CANCER METASTATIC,1
GR,MALIGNANT MELANOMA IN SITU,1
GR,MILK-ALKALI SYNDROME,1
GR,NASOPHARYNGITIS,1
GR,OEDEMA,1
GR,OEDEMA PERIPHERAL,1
GR,ORGANIC BRAIN SYNDROME,1
GR,PAIN IN EXTREMITY,1
GR,PAIN OF SKIN,1
GR,PELVIC VENOUS THROMBOSIS,1
GR,PNEUMONIA,1
GR,PNEUMONIA PNEUMOCOCCAL,1
GR,PNEUMONITIS,1
GR,PRODUCT USE ISSUE,1
GR,PRODUCTIVE COUGH,1
GR,PURPURA,1
GR,PYREXIA,1
GR,RASH ERYTHEMATOUS,1
GR,RESPIRATORY FAILURE,1
GR,RHEUMATOID ARTHRITIS,1
GR,SCIATICA,1
GR,SEPTIC SHOCK,1
GR,SOMNOLENCE,1
GR,VEIN RUPTURE,1
GR,WHITE BLOOD CELL COUNT DECREASED,1
GT,CANDIDA INFECTION,1
GT,CYSTITIS,1
GT,ESCHERICHIA URINARY TRACT INFECTION,1
GT,GENERAL PHYSICAL HEALTH DETERIORATION,1
GT,HAEMATURIA,1
GT,TONSILLAR EXUDATE,1
GT,TONSILLITIS BACTERIAL,1
HN,BACK PAIN,1
HN,CARDIAC ARREST,1
HN,CONDITION AGGRAVATED,1
HN,DEMENTIA ALZHEIMER^S TYPE,1
HN,DYSPHAGIA,1
HN,EATING DISORDER,1
HN,FEELING ABNORMAL,1
HN,FLUID RETENTION,1
HN,MALAISE,1
HN,MASTICATION DISORDER,1
HN,PNEUMONIA,1
HN,PREMATURE DELIVERY,1
HN,PRODUCTIVE COUGH,1
HN,RESPIRATORY ARREST,1
HK,CARDIAC ARREST,1
HK,DERMATITIS,1
HK,INABILITY TO AFFORD MEDICATION,1
HK,OVERDOSE,1
HK,T-CELL LYMPHOMA,1
HU,HYPONATRAEMIA,2
HU,ALTERED STATE OF CONSCIOUSNESS,1
HU,AUTOIMMUNE HEPATITIS,1
HU,DISORIENTATION,1
HU,DRUG DEPENDENCE,1
HU,DRUG INEFFECTIVE,1
HU,DRUG WITHDRAWAL SYNDROME,1
HU,DYSPNOEA,1
HU,ENDOTRACHEAL INTUBATION,1
HU,FATIGUE,1
HU,LATENT TUBERCULOSIS,1
HU,LOSS OF CONSCIOUSNESS,1
HU,MYOPATHY TOXIC,1
HU,NAUSEA,1
HU,PARAPARESIS,1
HU,PSEUDOPHAEOCHROMOCYTOMA,1
HU,PSYCHOMOTOR SKILLS IMPAIRED,1
HU,SINUS ARRHYTHMIA,1
HU,SOMNOLENCE,1
IN,BRADYCARDIA,7
IN,ANAPHYLACTIC SHOCK,6
IN,TOXICITY TO VARIOUS AGENTS,3
IN,ATAXIA,2
IN,ATRIAL FIBRILLATION,2
IN,ATRIOVENTRICULAR BLOCK COMPLETE,2
IN,DRUG ABUSE,2
IN,HYPOTENSION,2
IN,MEDICATION ERROR,2
IN,NODAL RHYTHM,2
IN,SPLENIC INFARCTION,2
IN,TREMOR,2
IN,ALLERGIC GRANULOMATOUS ANGIITIS,1
IN,ANGIOEDEMA,1
IN,ASPERGILLUS INFECTION,1
IN,ATRIOVENTRICULAR BLOCK FIRST DEGREE,1
IN,BASILAR ARTERY ANEURYSM,1
IN,BASILAR ARTERY THROMBOSIS,1
IN,BRONCHOSPASM,1
IN,CENTRAL NERVOUS SYSTEM INFECTION,1
IN,COMPARTMENT SYNDROME,1
IN,DIABETES MELLITUS,1
IN,DIARRHOEA,1
IN,DISSEMINATED TUBERCULOSIS,1
IN,DIZZINESS,1
IN,DYSARTHRIA,1
IN,DYSKINESIA,1
IN,ELECTROLYTE IMBALANCE,1
IN,GAIT DISTURBANCE,1
IN,HAEMATEMESIS,1
IN,HAEMORRHAGIC CEREBRAL INFARCTION,1
IN,HEPATITIS A,1
IN,HYPERTHYROIDISM,1
IN,HYPONATRAEMIA,1
IN,HYPOTHYROIDISM,1
IN,INFECTION,1
IN,INFECTIVE ANEURYSM,1
IN,INSOMNIA,1
IN,INTENTIONAL PRODUCT MISUSE,1
IN,MONONEUROPATHY MULTIPLEX,1
IN,OROMANDIBULAR DYSTONIA,1
IN,ORTHOSTATIC HYPOTENSION,1
IN,OVERDOSE,1
IN,PANCREATITIS,1
IN,PERONEAL NERVE PALSY,1
IN,RHABDOMYOLYSIS,1
IN,SEPSIS,1
IN,SEPTIC SHOCK,1
IN,SINUS BRADYCARDIA,1
IN,SOMNOLENCE,1
IN,STEVENS-JOHNSON SYNDROME,1
IN,SUBARACHNOID HAEMORRHAGE,1
IN,SUICIDE ATTEMPT,1
IN,THYROTOXIC CRISIS,1
IN,THYROTOXIC PERIODIC PARALYSIS,1
IN,TOXIC EPIDERMAL NECROLYSIS,1
IN,TRANSAMINASES INCREASED,1
IN,URINARY TRACT INFECTION,1
IN,VENOUS PRESSURE JUGULAR INCREASED,1
IE,URTICARIA,2
IE,ABDOMINAL PAIN UPPER,1
IE,ANGIOEDEMA,1
IE,ATRIAL FIBRILLATION,1
IE,BACK PAIN,1
IE,BLOOD TEST ABNORMAL,1
IE,CHILLS,1
IE,COLD SWEAT,1
IE,DECREASED APPETITE,1
IE,LETHARGY,1
IE,MYALGIA,1
IE,NEUTROPENIA,1
IE,PANCREATIC DISORDER,1
IE,RASH PRURITIC,1
IE,SLEEP APNOEA SYNDROME,1
IE,TONSILLAR HYPERTROPHY,1
IE,WHITE BLOOD CELL DISORDER,1
IL,HYPERTENSION,3
IL,CONGENITAL HYPOTHYROIDISM,2
IL,DIZZINESS,2
IL,ERYTHEMA,2
IL,FALL,2
IL,FOETAL EXPOSURE DURING PREGNANCY,2
IL,ABDOMINAL PAIN,1
IL,ABDOMINAL PAIN UPPER,1
IL,ACUTE MYOCARDIAL INFARCTION,1
IL,ADDISON^S DISEASE,1
IL,AMNESIA,1
IL,C-REACTIVE PROTEIN INCREASED,1
IL,CHILLS,1
IL,CONCUSSION,1
IL,DISTURBANCE IN ATTENTION,1
IL,DRUG INEFFECTIVE,1
IL,FATIGUE,1
IL,FEMUR FRACTURE,1
IL,FOOT DEFORMITY,1
IL,FOOT FRACTURE,1
IL,GAIT DISTURBANCE,1
IL,GRAFT VERSUS HOST DISEASE,1
IL,HAEMATURIA,1
IL,HAEMORRHAGIC STROKE,1
IL,HEAD DISCOMFORT,1
IL,HEADACHE,1
IL,HYPERHIDROSIS,1
IL,HYPOTHYROIDISM,1
IL,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,1
IL,INTESTINAL OBSTRUCTION,1
IL,LOSS OF CONSCIOUSNESS,1
IL,LOW DENSITY LIPOPROTEIN DECREASED,1
IL,MALIGNANT NEOPLASM PROGRESSION,1
IL,MATERNAL EXPOSURE DURING PREGNANCY,1
IL,MEMORY IMPAIRMENT,1
IL,MUCOSAL INFLAMMATION,1
IL,MUSCULOSKELETAL STIFFNESS,1
IL,NORMAL NEWBORN,1
IL,OSTEOPOROSIS,1
IL,PAIN IN EXTREMITY,1
IL,PAIN OF SKIN,1
IL,PANCYTOPENIA,1
IL,PEMPHIGOID,1
IL,PERIORBITAL OEDEMA,1
IL,PERIPHERAL SWELLING,1
IL,PLANTAR FASCIITIS,1
IL,PRESCRIBED UNDERDOSE,1
IL,PRURITUS,1
IL,PYREXIA,1
IL,SKIN EXFOLIATION,1
IL,SPEECH DISORDER,1
IL,TOXICITY TO VARIOUS AGENTS,1
IL,VISION BLURRED,1
IL,VITAMIN D DEFICIENCY,1
IT,ELECTROCARDIOGRAM QT PROLONGED,24
IT,DYSPNOEA,15
IT,COMA,13
IT,SUICIDE ATTEMPT,13
IT,ELECTROCARDIOGRAM T WAVE INVERSION,12
IT,HYPOTHYROIDISM,12
IT,MALAISE,12
IT,MYOCARDIAL ISCHAEMIA,12
IT,FEELING COLD,11
IT,WEIGHT INCREASED,11
IT,ASTHENIA,10
IT,FATIGUE,10
IT,BRADYKINESIA,9
IT,ACUTE KIDNEY INJURY,8
IT,ERYTHEMA,8
IT,DISCOMFORT,7
IT,DRUG ABUSE,7
IT,HYPOGLYCAEMIA,7
IT,PULMONARY EMBOLISM,7
IT,RENAL FAILURE,7
IT,SEROTONIN SYNDROME,7
IT,HYPONATRAEMIA,6
IT,LOSS OF CONSCIOUSNESS,6
IT,METABOLIC ACIDOSIS,6
IT,MYOPATHY,6
IT,PARAESTHESIA,6
IT,PYREXIA,6
IT,SOPOR,6
IT,ANURIA,5
IT,ARTHRALGIA,5
IT,BLOOD CREATININE INCREASED,5
IT,BRADYPHRENIA,5
IT,COGNITIVE DISORDER,5
IT,FOETAL EXPOSURE DURING PREGNANCY,5
IT,HYPOTENSION,5
IT,MUSCULAR WEAKNESS,5
IT,NAUSEA,5
IT,PROSTATE CANCER,5
IT,RASH,5
IT,RHABDOMYOLYSIS,5
IT,TOXICITY TO VARIOUS AGENTS,5
IT,VOMITING,5
IT,EMBOLISM VENOUS,4
IT,HYPERKALAEMIA,4
IT,OVERDOSE,4
IT,PAIN,4
IT,PRURITUS,4
IT,PURE WHITE CELL APLASIA,4
IT,SINUS BRADYCARDIA,4
IT,THROMBOCYTOPENIA,4
IT,VENOUS THROMBOSIS,4
IT,CARDIOGENIC SHOCK,3
IT,DYSPHEMIA,3
IT,EPILEPSY,3
IT,FOETAL MALFORMATION,3
IT,GAIT DISTURBANCE,3
IT,GENERAL PHYSICAL HEALTH DETERIORATION,3
IT,HEPATIC FUNCTION ABNORMAL,3
IT,HYPERTENSIVE CRISIS,3
IT,HYPOKALAEMIA,3
IT,INFUSION RELATED REACTION,3
IT,OEDEMA,3
IT,PNEUMONIA,3
IT,PROTEINURIA,3
IT,SUBARACHNOID HAEMORRHAGE,3
IT,THROAT TIGHTNESS,3
IT,TRANSIENT ISCHAEMIC ATTACK,3
IT,TREMOR,3
IT,UNIVENTRICULAR HEART,3
IT,VERTIGO,3
IT,AGGRESSION,2
IT,ANAEMIA,2
IT,ANGINA PECTORIS,2
IT,ATRIAL FIBRILLATION,2
IT,BLOOD PRESSURE DECREASED,2
IT,BRONCHITIS,2
IT,BRONCHOSPASM,2
IT,CARDIAC ARREST,2
IT,CONSTIPATION,2
IT,COUGH,2
IT,DEHYDRATION,2
IT,DEPRESSION,2
IT,DIABETES INSIPIDUS,2
IT,DIARRHOEA,2
IT,DRUG INEFFECTIVE,2
IT,FALL,2
IT,FEBRILE NEUTROPENIA,2
IT,FEELING HOT,2
IT,FLANK PAIN,2
IT,HEADACHE,2
IT,HEPATOCELLULAR INJURY,2
IT,HYPERALDOSTERONISM,2
IT,HYPERNATRAEMIA,2
IT,HYPERSENSITIVITY,2
IT,HYPOCHROMIC ANAEMIA,2
IT,HYPOMANIA,2
IT,INSOMNIA,2
IT,LACTIC ACIDOSIS,2
IT,LIP SWELLING,2
IT,MELAENA,2
IT,MULTIPLE ORGAN DYSFUNCTION SYNDROME,2
IT,MUSCLE SPASMS,2
IT,MYALGIA,2
IT,NEUTROPENIA,2
IT,ORBITAL OEDEMA,2
IT,PREMATURE BABY,2
IT,PULMONARY INFARCTION,2
IT,RENAL IMPAIRMENT,2
IT,SEPSIS,2
IT,WITHDRAWAL SYNDROME,2
IT,ABDOMINAL DISTENSION,1
IT,ABDOMINAL PAIN UPPER,1
IT,ABDOMINAL WALL HAEMATOMA,1
IT,ADRENAL INSUFFICIENCY,1
IT,AGITATION,1
IT,AGRANULOCYTOSIS,1
IT,ANGIOEDEMA,1
IT,AORTA HYPOPLASIA,1
IT,AORTIC ANEURYSM,1
IT,AORTIC STENOSIS,1
IT,APHASIA,1
IT,ASCITES,1
IT,BLADDER TRANSITIONAL CELL CARCINOMA,1
IT,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
IT,BLOOD SODIUM DECREASED,1
IT,BLOOD THYROID STIMULATING HORMONE ABNORMAL,1
IT,BRADYCARDIA,1
IT,BRAIN NATRIURETIC PEPTIDE ABNORMAL,1
IT,BUNDLE BRANCH BLOCK LEFT,1
IT,BUNDLE BRANCH BLOCK RIGHT,1
IT,C-REACTIVE PROTEIN ABNORMAL,1
IT,CARDIAC FAILURE CHRONIC,1
IT,CARDIOMEGALY,1
IT,CEREBRAL HAEMORRHAGE,1
IT,CEREBRAL SALT-WASTING SYNDROME,1
IT,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,1
IT,CONCOMITANT DISEASE AGGRAVATED,1
IT,CONDITION AGGRAVATED,1
IT,CONDUCTION DISORDER,1
IT,CONFUSIONAL STATE,1
IT,COPROLALIA,1
IT,DEATH,1
IT,DEEP VEIN THROMBOSIS,1
IT,DERMATOFIBROMA REMOVAL,1
IT,DISORIENTATION,1
IT,DIZZINESS,1
IT,DROP ATTACKS,1
IT,DRUG HYPERSENSITIVITY,1
IT,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
IT,DYSARTHRIA,1
IT,DYSENTERY,1
IT,DYSLIPIDAEMIA,1
IT,DYSPEPSIA,1
IT,DYSPHAGIA,1
IT,EJECTION FRACTION DECREASED,1
IT,ELECTROLYTE IMBALANCE,1
IT,EXTRAPULMONARY TUBERCULOSIS,1
IT,EXTRAPYRAMIDAL DISORDER,1
IT,FEMUR FRACTURE,1
IT,FRACTURED COCCYX,1
IT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
IT,GOITRE,1
IT,GRAVITATIONAL OEDEMA,1
IT,HAEMATEMESIS,1
IT,HAEMATOCHEZIA,1
IT,HAEMOLYTIC ANAEMIA,1
IT,HEMIPLEGIA,1
IT,HEPATIC FAILURE,1
IT,HYPERHOMOCYSTEINAEMIA,1
IT,HYPERTENSION,1
IT,HYPOCALCAEMIA,1
IT,HYPOCHLORAEMIA,1
IT,HYPOMAGNESAEMIA,1
IT,HYPOXIA,1
IT,INFLUENZA LIKE ILLNESS,1
IT,INJURY,1
IT,INTENTIONAL OVERDOSE,1
IT,INTERVERTEBRAL DISCITIS,1
IT,INTESTINAL HAEMORRHAGE,1
IT,INTRA-ABDOMINAL HAEMORRHAGE,1
IT,JAUNDICE,1
IT,JAUNDICE HEPATOCELLULAR,1
IT,LARYNGEAL DISCOMFORT,1
IT,LEFT VENTRICULAR DILATATION,1
IT,LEUKOPENIA,1
IT,LIMB IMMOBILISATION,1
IT,LIP OEDEMA,1
IT,MATERNAL EXPOSURE DURING PREGNANCY,1
IT,METABOLIC ALKALOSIS,1
IT,MITRAL VALVE ATRESIA,1
IT,MITRAL VALVE INCOMPETENCE,1
IT,NEUROLOGICAL DECOMPENSATION,1
IT,NUCHAL RIGIDITY,1
IT,OBSTRUCTIVE AIRWAYS DISORDER,1
IT,OEDEMA MOUTH,1
IT,OEDEMA PERIPHERAL,1
IT,OSTEITIS,1
IT,OXYGEN SATURATION INCREASED,1
IT,PACKED RED BLOOD CELL TRANSFUSION,1
IT,PANCYTOPENIA,1
IT,PARADOXICAL DRUG REACTION,1
IT,PERITONEAL HAEMORRHAGE,1
IT,PLEURAL EFFUSION,1
IT,POST PROCEDURAL HAEMORRHAGE,1
IT,PRESYNCOPE,1
IT,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
IT,PRURITUS GENERALISED,1
IT,PSYCHOMOTOR SKILLS IMPAIRED,1
IT,PULMONARY ARTERIAL PRESSURE ABNORMAL,1
IT,PULMONARY OEDEMA,1
IT,PULSELESS ELECTRICAL ACTIVITY,1
IT,QUADRIPLEGIA,1
IT,RASH ERYTHEMATOUS,1
IT,RESPIRATORY TRACT INFECTION,1
IT,RESTING TREMOR,1
IT,RESTLESSNESS,1
IT,SHOCK HAEMORRHAGIC,1
IT,SKIN DISCOLOURATION,1
IT,SKIN LESION,1
IT,SKIN ULCER,1
IT,SUBDURAL HAEMATOMA,1
IT,SYNCOPE,1
IT,TACHYCARDIA,1
IT,THROMBOPHLEBITIS SUPERFICIAL,1
IT,THROMBOSIS,1
IT,THYROIDITIS,1
IT,TONGUE OEDEMA,1
IT,TRANSAMINASES INCREASED,1
IT,TRANSFUSION,1
IT,TRICUSPID VALVE INCOMPETENCE,1
IT,TYPE 2 DIABETES MELLITUS,1
IT,URTICARIA,1
IT,VASCULITIS,1
IT,VASOPLEGIA SYNDROME,1
IT,VENOUS OCCLUSION,1
IT,VENTRICULAR EXTRASYSTOLES,1
IT,VENTRICULAR HYPOKINESIA,1
JP,PYREXIA,16
JP,DECREASED APPETITE,15
JP,MALIGNANT NEOPLASM PROGRESSION,15
JP,PLATELET COUNT DECREASED,12
JP,MALAISE,10
JP,ANAEMIA,9
JP,HYPERTENSION,8
JP,INTERSTITIAL LUNG DISEASE,8
JP,PNEUMONIA,8
JP,DIARRHOEA,7
JP,RASH,6
JP,STOMATITIS,6
JP,HYPOTENSION,5
JP,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,5
JP,WHITE BLOOD CELL COUNT DECREASED,5
JP,ATRIAL FIBRILLATION,4
JP,BLOOD CREATININE INCREASED,4
JP,BLOOD PRESSURE DECREASED,4
JP,DEATH,4
JP,DIABETES INSIPIDUS,4
JP,FATIGUE,4
JP,HAEMOGLOBIN DECREASED,4
JP,HEPATIC FUNCTION ABNORMAL,4
JP,HYPONATRAEMIA,4
JP,HYPOTHYROIDISM,4
JP,OEDEMA PERIPHERAL,4
JP,PNEUMONIA ASPIRATION,4
JP,SEROTONIN SYNDROME,4
JP,VOMITING,4
JP,ABDOMINAL DISTENSION,3
JP,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,3
JP,ADRENAL INSUFFICIENCY,3
JP,BONE MARROW FAILURE,3
JP,BRADYCARDIA,3
JP,CELLULITIS,3
JP,CEREBRAL INFARCTION,3
JP,CIRCULATORY COLLAPSE,3
JP,DEHYDRATION,3
JP,DIABETES MELLITUS,3
JP,DIZZINESS,3
JP,DRUG ERUPTION,3
JP,EOSINOPHIL COUNT INCREASED,3
JP,GLUCOSE TOLERANCE IMPAIRED,3
JP,HEADACHE,3
JP,HYPERKALAEMIA,3
JP,IMPAIRED HEALING,3
JP,LIVER DISORDER,3
JP,MUCOUS MEMBRANE DISORDER,3
JP,NAUSEA,3
JP,NEUTROPHIL COUNT DECREASED,3
JP,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,3
JP,PLEURAL EFFUSION,3
JP,THROMBOCYTOPENIA,3
JP,URINARY TRACT INFECTION,3
JP,URINE OUTPUT DECREASED,3
JP,ABDOMINAL DISCOMFORT,2
JP,ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE,2
JP,ACUTE HEPATIC FAILURE,2
JP,ACUTE MYELOID LEUKAEMIA RECURRENT,2
JP,ADRENOCORTICAL INSUFFICIENCY ACUTE,2
JP,ALTERED STATE OF CONSCIOUSNESS,2
JP,ARTERIAL HAEMORRHAGE,2
JP,ARTHRALGIA,2
JP,ASCITES,2
JP,ASPARTATE AMINOTRANSFERASE INCREASED,2
JP,ASTHENIA,2
JP,BASEDOW^S DISEASE,2
JP,BLOOD BILIRUBIN INCREASED,2
JP,BLOOD GLUCOSE INCREASED,2
JP,C-REACTIVE PROTEIN INCREASED,2
JP,CANDIDA TEST POSITIVE,2
JP,CARDIO-RESPIRATORY ARREST,2
JP,CHOLECYSTITIS,2
JP,CHRONIC GRAFT VERSUS HOST DISEASE,2
JP,COAGULATION TIME PROLONGED,2
JP,CONDITION AGGRAVATED,2
JP,CONSTIPATION,2
JP,CORYNEBACTERIUM SEPSIS,2
JP,CYTOMEGALOVIRUS INFECTION,2
JP,CYTOMEGALOVIRUS TEST POSITIVE,2
JP,DEPRESSED LEVEL OF CONSCIOUSNESS,2
JP,DIABETES MELLITUS INADEQUATE CONTROL,2
JP,DIABETIC KETOACIDOSIS,2
JP,DISSEMINATED INTRAVASCULAR COAGULATION,2
JP,DRUG EFFECT INCOMPLETE,2
JP,DRUG LEVEL INCREASED,2
JP,DRUG-INDUCED LIVER INJURY,2
JP,DYSPNOEA,2
JP,ERYTHEMA MULTIFORME,2
JP,FEBRILE NEUTROPENIA,2
JP,FOETAL EXPOSURE DURING PREGNANCY,2
JP,GASTROENTERITIS,2
JP,HEPATIC CIRRHOSIS,2
JP,HYPERTHYROIDISM,2
JP,HYPOAESTHESIA,2
JP,HYPOGLYCAEMIA,2
JP,HYPOKALAEMIA,2
JP,HYPOMAGNESAEMIA,2
JP,HYPOTHERMIA,2
JP,HYPOXIA,2
JP,INFLAMMATION,2
JP,INSOMNIA,2
JP,LEUKOPENIA,2
JP,MYCOBACTERIAL INFECTION,2
JP,NEUTROPENIA,2
JP,ORGANISING PNEUMONIA,2
JP,OSTEONECROSIS OF JAW,2
JP,PANCYTOPENIA,2
JP,PITUITARY CYST,2
JP,PNEUMOPERITONEUM,2
JP,PRURITUS,2
JP,RENAL DISORDER,2
JP,RENAL FAILURE,2
JP,RENAL IMPAIRMENT,2
JP,RESPIRATORY FAILURE,2
JP,RESPIRATORY SYNCYTIAL VIRUS INFECTION,2
JP,SECOND PRIMARY MALIGNANCY,2
JP,SEPSIS,2
JP,TACHYCARDIA,2
JP,TRANSAMINASES INCREASED,2
JP,TUMOUR LYSIS SYNDROME,2
JP,UMBILICAL CORD ABNORMALITY,2
JP,VERTIGO,2
JP,ABDOMINAL ABSCESS,1
JP,ABDOMINAL PAIN,1
JP,ABDOMINAL WOUND DEHISCENCE,1
JP,ABNORMAL FAECES,1
JP,ABORTION THREATENED,1
JP,ACIDOSIS,1
JP,ACROMEGALY,1
JP,ACUTE KIDNEY INJURY,1
JP,ALANINE AMINOTRANSFERASE INCREASED,1
JP,ALBUMINURIA,1
JP,AMNIOTIC BAND SYNDROME,1
JP,ANAPLASTIC LARGE-CELL LYMPHOMA,1
JP,ANXIETY,1
JP,AORTIC DISSECTION,1
JP,APHASIA,1
JP,APNOEA NEONATAL,1
JP,APPARENT DEATH,1
JP,APPENDICITIS,1
JP,ATRIOVENTRICULAR BLOCK COMPLETE,1
JP,AUTOIMMUNE THYROIDITIS,1
JP,AUTONOMIC NERVOUS SYSTEM IMBALANCE,1
JP,AUTONOMIC NEUROPATHY,1
JP,BACK PAIN,1
JP,BLADDER CANCER,1
JP,BLOOD ALBUMIN DECREASED,1
JP,BLOOD ALKALINE PHOSPHATASE INCREASED,1
JP,BLOOD CHOLESTEROL INCREASED,1
JP,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
JP,BLOOD IMMUNOGLOBULIN E INCREASED,1
JP,BLOOD LACTATE DEHYDROGENASE INCREASED,1
JP,BLOOD PRESSURE INCREASED,1
JP,BLOOD THYROID STIMULATING HORMONE INCREASED,1
JP,BLOOD UREA INCREASED,1
JP,CACHEXIA,1
JP,CANCER PAIN,1
JP,CARDIAC ARREST,1
JP,CARDIAC FAILURE,1
JP,CARDIAC VALVE DISEASE,1
JP,CEREBRAL ARTERY EMBOLISM,1
JP,CHEMICAL PERITONITIS,1
JP,CHOLANGITIS,1
JP,CHRONIC KIDNEY DISEASE,1
JP,CIRCULATORY FAILURE NEONATAL,1
JP,COLITIS ISCHAEMIC,1
JP,COLON CANCER,1
JP,COMPRESSION FRACTURE,1
JP,CONTRAST MEDIA ALLERGY,1
JP,CONTUSION,1
JP,CRUSH SYNDROME,1
JP,CYTOGENETIC ABNORMALITY,1
JP,CYTOPENIA,1
JP,DECUBITUS ULCER,1
JP,DELIRIUM,1
JP,DENTAL CARIES,1
JP,DEVICE RELATED INFECTION,1
JP,DIABETIC COMPLICATION,1
JP,DIFFUSE LARGE B-CELL LYMPHOMA,1
JP,DISSEMINATED TUBERCULOSIS,1
JP,DIVERTICULITIS,1
JP,DRUG DOSE OMISSION,1
JP,DRUG INEFFECTIVE,1
JP,DRUG WITHDRAWAL SYNDROME NEONATAL,1
JP,DUCTUS ARTERIOSUS STENOSIS FOETAL,1
JP,DYSGEUSIA,1
JP,DYSPEPSIA,1
JP,DYSPHAGIA,1
JP,ELECTROCARDIOGRAM QT PROLONGED,1
JP,EMOTIONAL DISORDER,1
JP,END STAGE RENAL DISEASE,1
JP,EOSINOPHILIA,1
JP,EPIGASTRIC DISCOMFORT,1
JP,EPILEPSY,1
JP,ERYTHEMA,1
JP,ERYTHROBLASTOSIS FOETALIS,1
JP,EXTRAPYRAMIDAL DISORDER,1
JP,FAECAL INCONTINENCE,1
JP,FAT EMBOLISM,1
JP,FEEDING DISORDER,1
JP,FEMUR FRACTURE,1
JP,FISTULA,1
JP,FOETAL HEART RATE DECREASED,1
JP,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
JP,GASTROINTESTINAL HAEMORRHAGE,1
JP,GASTROINTESTINAL NECROSIS,1
JP,GASTROINTESTINAL PERFORATION,1
JP,GASTROOESOPHAGEAL REFLUX DISEASE,1
JP,GENERAL PHYSICAL HEALTH DETERIORATION,1
JP,GENITAL CANDIDIASIS,1
JP,GINGIVAL BLEEDING,1
JP,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
JP,GOITRE,1
JP,GRAFT VERSUS HOST DISEASE,1
JP,GRANULOMA ANNULARE,1
JP,HAEMATEMESIS,1
JP,HAEMATOCRIT DECREASED,1
JP,HAEMORRHAGE,1
JP,HAEMORRHAGIC INFARCTION,1
JP,HAEMOSIDEROSIS,1
JP,HEART RATE DECREASED,1
JP,HEPATIC CANCER,1
JP,HEPATIC ENZYME INCREASED,1
JP,HEPATIC FAILURE,1
JP,HEPATITIS C RNA INCREASED,1
JP,HERPES ZOSTER,1
JP,HIATUS HERNIA,1
JP,HOT FLUSH,1
JP,HYPERAMMONAEMIA,1
JP,HYPERCALCAEMIA,1
JP,HYPERSOMNIA,1
JP,HYPERTHERMIA,1
JP,HYPERURICAEMIA,1
JP,HYPERVENTILATION,1
JP,HYPOAESTHESIA ORAL,1
JP,HYPOALBUMINAEMIA,1
JP,HYPOGLYCAEMIA NEONATAL,1
JP,HYPOPHYSITIS,1
JP,HYPOSPADIAS,1
JP,ILEUS,1
JP,IMMUNE THROMBOCYTOPENIC PURPURA,1
JP,INCARCERATED HERNIA,1
JP,INFECTION,1
JP,INJURY,1
JP,INTENTIONAL PRODUCT USE ISSUE,1
JP,INTERCAPILLARY GLOMERULOSCLEROSIS,1
JP,INTESTINAL ISCHAEMIA,1
JP,INTESTINAL OBSTRUCTION,1
JP,LACTIC ACIDOSIS,1
JP,LIVER FUNCTION TEST ABNORMAL,1
JP,LOW BIRTH WEIGHT BABY,1
JP,LUNG ABSCESS,1
JP,LUNG NEOPLASM MALIGNANT,1
JP,LYMPHANGIOSIS CARCINOMATOSA,1
JP,LYMPHOCYTE COUNT DECREASED,1
JP,MALLORY-WEISS SYNDROME,1
JP,MATERNAL DRUGS AFFECTING FOETUS,1
JP,MATERNAL EXPOSURE DURING PREGNANCY,1
JP,MEMORY IMPAIRMENT,1
JP,METABOLIC ACIDOSIS,1
JP,METASTASES TO BONE,1
JP,METASTASES TO LYMPH NODES,1
JP,MOUTH SWELLING,1
JP,MUSCULAR WEAKNESS,1
JP,MUSCULOSKELETAL STIFFNESS,1
JP,MYXOEDEMA COMA,1
JP,NASOPHARYNGITIS,1
JP,NECROTISING FASCIITIS,1
JP,NEONATAL RESPIRATORY DISTRESS SYNDROME,1
JP,NEOPLASM PROGRESSION,1
JP,NEOPLASM RECURRENCE,1
JP,OEDEMA,1
JP,OESOPHAGEAL CARCINOMA,1
JP,OESOPHAGEAL FISTULA,1
JP,ORAL CANDIDIASIS,1
JP,ORAL PAIN,1
JP,OROPHARYNGEAL PAIN,1
JP,OSTEITIS,1
JP,OSTEOCHONDROSIS,1
JP,OVERDOSE,1
JP,PACKED RED BLOOD CELL TRANSFUSION,1
JP,PALLOR,1
JP,PARAESTHESIA ORAL,1
JP,PATENT DUCTUS ARTERIOSUS,1
JP,PERICARDIAL EFFUSION,1
JP,PERICARDITIS,1
JP,PERIODONTITIS,1
JP,PERITONITIS,1
JP,PITUITARY HAEMORRHAGE,1
JP,PLASMA CELL MYELOMA,1
JP,PLATELET TRANSFUSION,1
JP,PLEURISY,1
JP,PNEUMATOSIS INTESTINALIS,1
JP,PNEUMOCYSTIS JIROVECII PNEUMONIA,1
JP,PNEUMONITIS,1
JP,PNEUMOTHORAX,1
JP,POLYDIPSIA,1
JP,POOR FEEDING INFANT,1
JP,PORTAL VEIN THROMBOSIS,1
JP,PORTAL VENOUS GAS,1
JP,POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER,1
JP,PREMATURE BABY,1
JP,PRIMARY ADRENAL INSUFFICIENCY,1
JP,PROCEDURAL HAEMORRHAGE,1
JP,PRODUCT USE IN UNAPPROVED INDICATION,1
JP,PROTEIN URINE PRESENT,1
JP,PSYCHIATRIC SYMPTOM,1
JP,PULMONARY FIBROSIS,1
JP,PULMONARY HYPERTENSION,1
JP,PULMONARY OEDEMA,1
JP,PULMONARY VENO-OCCLUSIVE DISEASE,1
JP,PUSTULAR PSORIASIS,1
JP,RASH PUSTULAR,1
JP,REBOUND EFFECT,1
JP,RECTAL ULCER,1
JP,RECURRENCE OF NEUROMUSCULAR BLOCKADE,1
JP,RED BLOOD CELL COUNT DECREASED,1
JP,RENAL FAILURE ACUTE,1
JP,RESPIRATORY ARREST,1
JP,RESPIRATORY DISORDER,1
JP,RESPIRATORY DISTRESS,1
JP,RETINOPATHY OF PREMATURITY,1
JP,RHABDOMYOLYSIS,1
JP,RHEUMATOID ARTHRITIS,1
JP,RICKETS,1
JP,SECONDARY ADRENOCORTICAL INSUFFICIENCY,1
JP,SINUS BRADYCARDIA,1
JP,SINUS TACHYCARDIA,1
JP,SKIN INFECTION,1
JP,SKIN ULCER,1
JP,SMALL INTESTINAL ULCER PERFORATION,1
JP,SOMNOLENCE,1
JP,SPINAL CORD COMPRESSION,1
JP,STILLBIRTH,1
JP,SUDDEN DEATH,1
JP,SUDDEN INFANT DEATH SYNDROME,1
JP,SUICIDE ATTEMPT,1
JP,SYNOVIAL CYST,1
JP,TACHYPNOEA,1
JP,THROMBOSIS,1
JP,THYROID ATROPHY,1
JP,THYROID HORMONES DECREASED,1
JP,TINEA INFECTION,1
JP,TONGUE DISCOLOURATION,1
JP,TOOTHACHE,1
JP,TRACHEOSTOMY INFECTION,1
JP,TRANSFUSION,1
JP,TREMOR,1
JP,TUMOUR HAEMORRHAGE,1
JP,TYPE 1 DIABETES MELLITUS,1
JP,UPPER GASTROINTESTINAL HAEMORRHAGE,1
JP,URINARY INCONTINENCE,1
JP,UTERINE CONTRACTIONS ABNORMAL,1
JP,VENTRICULAR EXTRASYSTOLES,1
JP,VENTRICULAR TACHYCARDIA,1
JP,WEIGHT INCREASED,1
JP,WITHDRAWAL SYNDROME,1
JP,WOUND,1
KR,DYSPNOEA,11
KR,PERICARDIAL EFFUSION,6
KR,PNEUMONIA,6
KR,CARDIAC FAILURE,5
KR,NAUSEA,5
KR,SURGERY,4
KR,ANAEMIA,3
KR,DIABETES MELLITUS,3
KR,DIARRHOEA,3
KR,DIZZINESS,3
KR,FEBRILE NEUTROPENIA,3
KR,NEUTROPENIA,3
KR,THROMBOCYTOPENIA,3
KR,ALANINE AMINOTRANSFERASE INCREASED,2
KR,ALOPECIA,2
KR,ARTHRITIS,2
KR,ASPARTATE AMINOTRANSFERASE INCREASED,2
KR,ASTHENIA,2
KR,ATRIAL FIBRILLATION,2
KR,CARDIAC ABLATION,2
KR,CHEST DISCOMFORT,2
KR,CHEST PAIN,2
KR,CHOLECYSTITIS,2
KR,CONSTIPATION,2
KR,COUGH,2
KR,CYSTITIS,2
KR,DYSPEPSIA,2
KR,HYPERTENSION,2
KR,HYPOCALCAEMIA,2
KR,HYPOPHAGIA,2
KR,INTERSTITIAL LUNG DISEASE,2
KR,LEUKOCYTOSIS,2
KR,NASOPHARYNGITIS,2
KR,NECROSIS,2
KR,PANCYTOPENIA,2
KR,PRURITUS,2
KR,PRURITUS GENERALISED,2
KR,RASH,2
KR,SUBDURAL HAEMORRHAGE,2
KR,THYROID CANCER,2
KR,URTICARIA,2
KR,VOMITING,2
KR,ABDOMINAL DISTENSION,1
KR,ABDOMINAL PAIN UPPER,1
KR,ACNE,1
KR,ACUTE KIDNEY INJURY,1
KR,AGEUSIA,1
KR,AMNESIA,1
KR,AMYLASE INCREASED,1
KR,ANAL ABSCESS,1
KR,ANGINA PECTORIS,1
KR,ANTIBODY TEST ABNORMAL,1
KR,ANXIETY,1
KR,ARRHYTHMIA,1
KR,ARTERIOSPASM CORONARY,1
KR,ARTHRALGIA,1
KR,ARTHROPATHY,1
KR,ASPIRATION,1
KR,BIOPSY BONE,1
KR,BLOOD CHOLESTEROL INCREASED,1
KR,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
KR,BONE PAIN,1
KR,BRAIN NATRIURETIC PEPTIDE INCREASED,1
KR,BREAST CANCER,1
KR,CARDIAC ARREST,1
KR,CARDIAC ENZYMES INCREASED,1
KR,CEREBRAL INFARCTION,1
KR,CHOLECYSTITIS ACUTE,1
KR,COMPRESSION FRACTURE,1
KR,CONCOMITANT DISEASE AGGRAVATED,1
KR,CONDITION AGGRAVATED,1
KR,DEEP VEIN THROMBOSIS,1
KR,DEHYDRATION,1
KR,DENTAL IMPLANTATION,1
KR,DYSPHAGIA,1
KR,DYSURIA,1
KR,ELECTROLYTE IMBALANCE,1
KR,ENTEROCOCCAL INFECTION,1
KR,ENTEROCOLITIS,1
KR,EXTRASYSTOLES,1
KR,FACIAL BONES FRACTURE,1
KR,FALL,1
KR,FATIGUE,1
KR,FEMUR FRACTURE,1
KR,FLANK PAIN,1
KR,FULL BLOOD COUNT ABNORMAL,1
KR,GASTRIC ULCER,1
KR,GASTRIC ULCER HELICOBACTER,1
KR,GASTRITIS,1
KR,GASTROINTESTINAL HAEMORRHAGE,1
KR,GASTROINTESTINAL TOXICITY,1
KR,GASTROOESOPHAGEAL REFLUX DISEASE,1
KR,GASTROSTOMY,1
KR,HAEMATOCHEZIA,1
KR,HEPATIC ENZYME INCREASED,1
KR,HEPATITIS ACUTE,1
KR,HYPERTENSIVE HYDROCEPHALUS,1
KR,HYPOKALAEMIA,1
KR,HYPONATRAEMIA,1
KR,HYPOTENSION,1
KR,HYPOXIA,1
KR,ILEUS,1
KR,INFECTION,1
KR,INTESTINAL PERFORATION,1
KR,IRRITABLE BOWEL SYNDROME,1
KR,LIPASE INCREASED,1
KR,LIVER FUNCTION TEST INCREASED,1
KR,LUPUS PNEUMONITIS,1
KR,MALIGNANT NEOPLASM PROGRESSION,1
KR,MANIA,1
KR,MUSCULOSKELETAL STIFFNESS,1
KR,MYALGIA,1
KR,NECK PAIN,1
KR,NEPHROTIC SYNDROME,1
KR,NEUTROPHIL COUNT DECREASED,1
KR,NONINFECTIVE GINGIVITIS,1
KR,OEDEMA,1
KR,OESOPHAGITIS,1
KR,OROPHARYNGEAL PAIN,1
KR,OSTEOSCLEROSIS,1
KR,OTITIS MEDIA,1
KR,OTITIS MEDIA CHRONIC,1
KR,OXYGEN SATURATION DECREASED,1
KR,PAIN IN EXTREMITY,1
KR,PALPITATIONS,1
KR,PANCREATITIS,1
KR,PANCREATITIS ACUTE,1
KR,PAPILLARY THYROID CANCER,1
KR,PARAESTHESIA,1
KR,PERICARDITIS,1
KR,PERIPHERAL ARTERIAL OCCLUSIVE DISEASE,1
KR,PERITONITIS,1
KR,PLEURAL EFFUSION,1
KR,POST PROCEDURAL HYPOTHYROIDISM,1
KR,PROCALCITONIN INCREASED,1
KR,PSEUDOMONAS INFECTION,1
KR,PULMONARY EMBOLISM,1
KR,PULMONARY OEDEMA,1
KR,PULMONARY TUBERCULOSIS,1
KR,PYREXIA,1
KR,RALES,1
KR,RASH ERYTHEMATOUS,1
KR,RASH GENERALISED,1
KR,RENAL ABSCESS,1
KR,RENAL FAILURE ACUTE,1
KR,RETINAL VASCULAR OCCLUSION,1
KR,SEPTIC SHOCK,1
KR,SKIN PLAQUE,1
KR,SKIN ULCER,1
KR,SOMNOLENCE,1
KR,SPINAL COMPRESSION FRACTURE,1
KR,SPONDYLOLISTHESIS,1
KR,STOMATITIS,1
KR,SWELLING,1
KR,SYNCOPE,1
KR,SYSTEMIC LUPUS ERYTHEMATOSUS,1
KR,UNDERDOSE,1
KR,UPPER RESPIRATORY TRACT INFECTION,1
KR,URINE OUTPUT DECREASED,1
KR,VERTEBROPLASTY,1
KR,VERTIGO,1
KR,WOUND,1
LB,DYSGEUSIA,1
LB,HAEMOGLOBIN DECREASED,1
LB,HEPATIC FAILURE,1
LB,HEPATITIS FULMINANT,1
LB,NAUSEA,1
LB,POLYURIA,1
LB,SALIVARY HYPERSECRETION,1
LB,TOXICITY TO VARIOUS AGENTS,1
LB,VOMITING,1
LS,ANAEMIA,1
LS,CONDITION AGGRAVATED,1
LS,COUGH,1
LS,FAILURE TO THRIVE,1
LS,HEPATIC ENZYME INCREASED,1
LS,PYREXIA,1
LS,VOMITING,1
LS,WEIGHT DECREASED,1
MX,DIZZINESS,2
MX,DRUG INEFFECTIVE,2
MX,EAR PAIN,2
MX,HEADACHE,2
MX,INFLAMMATION,2
MX,LOCALISED INFECTION,2
MX,LYMPHOEDEMA,2
MX,NAUSEA,2
MX,TOOTH DISORDER,2
MX,ABDOMINAL PAIN UPPER,1
MX,ADVERSE REACTION,1
MX,AGEUSIA,1
MX,ALOPECIA,1
MX,ANGINA PECTORIS,1
MX,ASTHENIA,1
MX,BACK PAIN,1
MX,BILE DUCT OBSTRUCTION,1
MX,BONE PAIN,1
MX,CHEST DISCOMFORT,1
MX,CHEST PAIN,1
MX,CHOLANGITIS,1
MX,CORONARY ARTERY DISEASE,1
MX,CORONARY ARTERY OCCLUSION,1
MX,COUGH,1
MX,DECREASED APPETITE,1
MX,DERMATITIS ACNEIFORM,1
MX,DIABETES MELLITUS,1
MX,DIARRHOEA,1
MX,DRUG PRESCRIBING ERROR,1
MX,DRY SKIN,1
MX,DYSPEPSIA,1
MX,DYSURIA,1
MX,EAR INFECTION,1
MX,EYE HAEMORRHAGE,1
MX,EYE IRRITATION,1
MX,EYE SWELLING,1
MX,FEEDING DISORDER,1
MX,FEELING OF DESPAIR,1
MX,FLUSHING,1
MX,GALLBLADDER DISORDER,1
MX,GENERAL PHYSICAL HEALTH DETERIORATION,1
MX,HEAD DEFORMITY,1
MX,HEART RATE INCREASED,1
MX,HEMIANOPIA,1
MX,HYPERTENSIVE CRISIS,1
MX,HYPOPHAGIA,1
MX,HYPOTENSION,1
MX,IMMOBILE,1
MX,INCORRECT DOSE ADMINISTERED,1
MX,KIDNEY INFECTION,1
MX,LACRIMAL DISORDER,1
MX,LACRIMATION INCREASED,1
MX,LIMB DISCOMFORT,1
MX,METASTASES TO LUNG,1
MX,MITRAL VALVE INCOMPETENCE,1
MX,MOBILITY DECREASED,1
MX,MUSCLE TIGHTNESS,1
MX,MUSCULAR WEAKNESS,1
MX,NAIL DISORDER,1
MX,NEOPLASM PROGRESSION,1
MX,ODYNOPHAGIA,1
MX,PHARYNGITIS,1
MX,PNEUMONIA,1
MX,PRESCRIBED OVERDOSE,1
MX,PRURITUS,1
MX,PRURITUS GENERALISED,1
MX,PULMONARY PAIN,1
MX,RASH ERYTHEMATOUS,1
MX,RASH GENERALISED,1
MX,SKIN LESION,1
MX,SWELLING FACE,1
MX,THYROID CANCER,1
MX,TINNITUS,1
MX,TRICUSPID VALVE INCOMPETENCE,1
MX,TUBERCULOSIS,1
MX,TYPE 1 DIABETES MELLITUS,1
MX,VISUAL ACUITY REDUCED,1
MX,VOMITING,1
MX,WEIGHT DECREASED,1
NL,ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS,4
NL,DEATH,3
NL,HYPERGLYCAEMIA,3
NL,MYOCARDIAL INFARCTION,3
NL,ARTHROPATHY,2
NL,BACK PAIN,2
NL,CARDIAC ARREST,2
NL,CHEST PAIN,2
NL,DYSPNOEA,2
NL,EAR DISORDER,2
NL,EPILEPSY,2
NL,GALLBLADDER DISORDER,2
NL,MALAISE,2
NL,PARKINSONISM,2
NL,PYREXIA,2
NL,UTERINE DISORDER,2
NL,ABASIA,1
NL,ABDOMINAL ABSCESS,1
NL,ABDOMINAL PAIN,1
NL,ABNORMAL FAECES,1
NL,ACUTE KIDNEY INJURY,1
NL,ADRENAL DISORDER,1
NL,ADRENAL INSUFFICIENCY,1
NL,ANAL INCONTINENCE,1
NL,ARRHYTHMIA,1
NL,ARTHRALGIA,1
NL,BINGE EATING,1
NL,BLOOD CREATINE PHOSPHOKINASE INCREASED,1
NL,BLOOD CREATININE INCREASED,1
NL,BLOOD GLUCOSE INCREASED,1
NL,BONE DISORDER,1
NL,BRADYCARDIA,1
NL,BRAIN ABSCESS,1
NL,BREAST RECONSTRUCTION,1
NL,CHILLS,1
NL,CHROMATURIA,1
NL,COGNITIVE DISORDER,1
NL,COLOUR BLINDNESS,1
NL,CORONARY ARTERY RESTENOSIS,1
NL,CORONARY ARTERY THROMBOSIS,1
NL,COUGH,1
NL,DEPRESSED MOOD,1
NL,DRUG ADMINISTRATION ERROR,1
NL,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
NL,DYSPEPSIA,1
NL,DYSTONIA,1
NL,FATIGUE,1
NL,FEELING ABNORMAL,1
NL,FEELING HOT,1
NL,FLUID RETENTION,1
NL,GENERAL PHYSICAL HEALTH DETERIORATION,1
NL,HEPATIC ENZYME INCREASED,1
NL,HEPATITIS,1
NL,HYPERKALAEMIA,1
NL,HYPERTHYROIDISM,1
NL,HYPNAGOGIC HALLUCINATION,1
NL,HYPOTENSION,1
NL,INCORRECT DRUG ADMINISTRATION DURATION,1
NL,INCREASED APPETITE,1
NL,INFLUENZA LIKE ILLNESS,1
NL,INJECTION SITE BRUISING,1
NL,INJECTION SITE DISCOLOURATION,1
NL,INJECTION SITE ERYTHEMA,1
NL,INJECTION SITE INDURATION,1
NL,INJECTION SITE INFLAMMATION,1
NL,INJECTION SITE PAIN,1
NL,IRIDOCYCLITIS,1
NL,ISCHAEMIC STROKE,1
NL,LOWER LIMB FRACTURE,1
NL,LUNG INFILTRATION,1
NL,MENSTRUAL DISORDER,1
NL,MICTURITION URGENCY,1
NL,MUSCLE SPASMS,1
NL,MUSCULAR WEAKNESS,1
NL,MYALGIA,1
NL,MYOCARDITIS,1
NL,MYOSITIS,1
NL,NEPHROGENIC SYSTEMIC FIBROSIS,1
NL,OEDEMA,1
NL,PAIN,1
NL,PALPITATIONS,1
NL,PANCREATITIS ACUTE,1
NL,PARAESTHESIA,1
NL,PELVIC DISCOMFORT,1
NL,PELVIC PAIN,1
NL,PERICARDIAL EFFUSION,1
NL,PHLEBITIS INFECTIVE,1
NL,PNEUMONIA ASPIRATION,1
NL,PROSTATE CANCER METASTATIC,1
NL,RASH ERYTHEMATOUS,1
NL,READING DISORDER,1
NL,RESTLESS LEGS SYNDROME,1
NL,SOCIAL AVOIDANT BEHAVIOUR,1
NL,STRESS URINARY INCONTINENCE,1
NL,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,1
NL,TREMOR,1
NL,TUBULOINTERSTITIAL NEPHRITIS,1
NL,TUNNEL VISION,1
NL,URETERIC STENOSIS,1
NL,URETHRAL OPERATION,1
NL,URINARY INCONTINENCE,1
NL,URINARY TRACT INFECTION,1
NL,UROSEPSIS,1
NL,VASCULAR OCCLUSION,1
NL,VEIN DISORDER,1
NL,VISION BLURRED,1
NZ,OSTEONECROSIS,2
NZ,ABDOMINAL DISCOMFORT,1
NZ,ABDOMINAL PAIN UPPER,1
NZ,BODY TEMPERATURE INCREASED,1
NZ,BONE PAIN,1
NZ,CEREBRAL THROMBOSIS,1
NZ,CHOLECYSTITIS,1
NZ,CONFUSIONAL STATE,1
NZ,CONGESTIVE CARDIOMYOPATHY,1
NZ,CRYING,1
NZ,DEPRESSED LEVEL OF CONSCIOUSNESS,1
NZ,DIARRHOEA HAEMORRHAGIC,1
NZ,DIZZINESS,1
NZ,DRUG EFFECT INCOMPLETE,1
NZ,EMOTIONAL DISORDER,1
NZ,FEELING ABNORMAL,1
NZ,FRACTURE,1
NZ,GENERALISED TONIC-CLONIC SEIZURE,1
NZ,GOUT,1
NZ,HEADACHE,1
NZ,HYPERREFLEXIA,1
NZ,HYPERTHYROIDISM,1
NZ,INFLUENZA LIKE ILLNESS,1
NZ,INTENTIONAL OVERDOSE,1
NZ,ISCHAEMIC STROKE,1
NZ,MALAISE,1
NZ,MYALGIA,1
NZ,NAUSEA,1
NZ,NECK PAIN,1
NZ,NYSTAGMUS,1
NZ,PAIN,1
NZ,PAIN IN EXTREMITY,1
NZ,PAIN IN JAW,1
NZ,PRODUCT QUALITY ISSUE,1
NZ,PRODUCT SUBSTITUTION ISSUE,1
NZ,RENAL FAILURE,1
NZ,SEPSIS,1
NZ,SOMNOLENCE,1
NZ,SUICIDAL IDEATION,1
NZ,TREMOR,1
NZ,VOMITING,1
NO,DRUG INEFFECTIVE,1
NO,DRUG RESISTANCE,1
NO,DRUG-INDUCED LIVER INJURY,1
NO,FEMORAL NECK FRACTURE,1
NO,FLATULENCE,1
NO,INFECTION,1
NO,RASH,1
NO,RHEUMATIC DISORDER,1
NO,SWELLING,1
NO,URTICARIA,1
NO,WHITE BLOOD CELL COUNT DECREASED,1
OM,HYPERSENSITIVITY VASCULITIS,1
PE,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
PE,BLOOD GLUCOSE FLUCTUATION,1
PE,DEHYDRATION,1
PE,HEART RATE INCREASED,1
PE,HEAT STROKE,1
PE,HEPATIC PAIN,1
PE,HYPERHIDROSIS,1
PE,KIDNEY INFECTION,1
PE,NAUSEA,1
PE,PERIHEPATIC DISCOMFORT,1
PE,PNEUMONIA,1
PE,PNEUMONIA BACTERIAL,1
PE,TREMOR,1
PE,URINARY TRACT INFLAMMATION,1
PL,COUGH,4
PL,OEDEMA PERIPHERAL,4
PL,ATRIAL FIBRILLATION,2
PL,CHEST PAIN,2
PL,CONFUSIONAL STATE,2
PL,DIARRHOEA,2
PL,DRUG INTOLERANCE,2
PL,DYSPNOEA,2
PL,EXERCISE TOLERANCE DECREASED,2
PL,FATIGUE,2
PL,HYPOTHYROIDISM,2
PL,LABILE BLOOD PRESSURE,2
PL,LIVE BIRTH,2
PL,MATERNAL EXPOSURE DURING PREGNANCY,2
PL,MUSCLE SPASMS,2
PL,MYALGIA,2
PL,OLIGURIA,2
PL,PALPITATIONS,2
PL,PNEUMONIA,2
PL,PREMATURE DELIVERY,2
PL,PULMONARY TOXICITY,2
PL,THROMBOCYTOPENIA,2
PL,TINNITUS,2
PL,VENTRICULAR ARRHYTHMIA,2
PL,ADHESION,1
PL,APPENDIX CANCER,1
PL,BLOOD GLUCOSE INCREASED,1
PL,CHOLECYSTITIS,1
PL,CHOLELITHIASIS,1
PL,CHRONIC KIDNEY DISEASE,1
PL,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
PL,ESCHERICHIA SEPSIS,1
PL,EYE PAIN,1
PL,GASTRIC ULCER HAEMORRHAGE,1
PL,GLOMERULAR FILTRATION RATE DECREASED,1
PL,HYPERTHYROIDISM,1
PL,MUSCULOSKELETAL PAIN,1
PL,NEPHROPATHY,1
PL,PHOTOPHOBIA,1
PL,PYELONEPHRITIS,1
PL,RENAL IMPAIRMENT,1
PL,TONGUE OEDEMA,1
PT,ACUTE KIDNEY INJURY,3
PT,COMA,3
PT,HYPERCHLORAEMIA,3
PT,HYPERNATRAEMIA,3
PT,MALAISE,3
PT,NAUSEA,3
PT,OVERDOSE,3
PT,RESPIRATORY DEPRESSION,3
PT,STRESS CARDIOMYOPATHY,3
PT,VOMITING,3
PT,ACUTE CORONARY SYNDROME,2
PT,CONVULSION,2
PT,DRUG SCREEN FALSE POSITIVE,2
PT,HYPONATRAEMIA,2
PT,ABDOMINAL PAIN,1
PT,ACQUIRED IMMUNODEFICIENCY SYNDROME,1
PT,AKINESIA,1
PT,ALANINE AMINOTRANSFERASE INCREASED,1
PT,ANGIOEDEMA,1
PT,ARTHRALGIA,1
PT,ASPARTATE AMINOTRANSFERASE INCREASED,1
PT,BACK PAIN,1
PT,BLOOD PRESSURE ABNORMAL,1
PT,BREAST CANCER,1
PT,CUSHING^S SYNDROME,1
PT,DEHYDRATION,1
PT,DELUSION,1
PT,DIABETES MELLITUS,1
PT,DIABETIC KETOACIDOSIS,1
PT,DIARRHOEA,1
PT,DIVERTICULITIS,1
PT,DIZZINESS,1
PT,DRUG HYPERSENSITIVITY,1
PT,DYSPNOEA,1
PT,ECCHYMOSIS,1
PT,ERYTHEMA,1
PT,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
PT,GASTROINTESTINAL HAEMORRHAGE,1
PT,GENERAL PHYSICAL HEALTH DETERIORATION,1
PT,HAEMATURIA,1
PT,HAEMORRHAGIC DISORDER,1
PT,HEPATIC PAIN,1
PT,HEPATITIS TOXIC,1
PT,HYPOTENSION,1
PT,INTESTINAL PERFORATION,1
PT,LOCALISED OEDEMA,1
PT,MALABSORPTION,1
PT,METABOLIC ACIDOSIS,1
PT,MUSCLE RIGIDITY,1
PT,MYOCARDIAL ISCHAEMIA,1
PT,PHOTODERMATOSIS,1
PT,PNEUMONIA,1
PT,PROTHROMBIN TIME PROLONGED,1
PT,PYREXIA,1
PT,RASH PRURITIC,1
PT,RECTAL HAEMORRHAGE,1
PT,SKIN LESION,1
PT,SKIN WOUND,1
PT,SWELLING FACE,1
PT,URTICARIA,1
PT,VISUAL IMPAIRMENT,1
PT,WEIGHT DECREASED,1
PR,INJECTION SITE PAIN,95
PR,NASOPHARYNGITIS,81
PR,PAIN,65
PR,DRUG INEFFECTIVE,62
PR,ARTHRALGIA,56
PR,HEADACHE,44
PR,URINARY TRACT INFECTION,39
PR,FATIGUE,37
PR,DIZZINESS,35
PR,ASTHMA,31
PR,PAIN IN EXTREMITY,31
PR,DIARRHOEA,30
PR,NAUSEA,30
PR,PYREXIA,28
PR,PSORIASIS,27
PR,BRONCHITIS,26
PR,MALAISE,26
PR,FALL,22
PR,VOMITING,21
PR,ASTHENIA,20
PR,COUGH,20
PR,HYPERTENSION,20
PR,INFLAMMATION,20
PR,OROPHARYNGEAL PAIN,20
PR,INJECTION SITE ERYTHEMA,19
PR,PRURITUS,19
PR,PHARYNGITIS,17
PR,BURNING SENSATION,16
PR,CHIKUNGUNYA VIRUS INFECTION,16
PR,DEPRESSION,16
PR,NASAL CONGESTION,16
PR,ARTHRITIS,14
PR,HAEMOGLOBIN DECREASED,14
PR,HYPERSENSITIVITY,14
PR,SINUSITIS,14
PR,ANXIETY,13
PR,RASH,13
PR,BACK PAIN,12
PR,WEIGHT DECREASED,12
PR,ABDOMINAL PAIN UPPER,11
PR,BLOOD GLUCOSE INCREASED,11
PR,DIABETES MELLITUS,11
PR,DYSPNOEA,11
PR,INJECTION SITE PRURITUS,11
PR,RHEUMATOID ARTHRITIS,11
PR,DIVERTICULITIS,10
PR,DYSPHONIA,10
PR,GAIT DISTURBANCE,10
PR,INJECTION SITE HAEMATOMA,10
PR,PERIPHERAL SWELLING,10
PR,ABDOMINAL PAIN,9
PR,BONE PAIN,9
PR,CATARACT,9
PR,CELLULITIS,9
PR,HYPOAESTHESIA,9
PR,MUSCULOSKELETAL PAIN,9
PR,OSTEOARTHRITIS,9
PR,PNEUMONIA,9
PR,ERYTHEMA,8
PR,HEPATIC ENZYME INCREASED,8
PR,INSOMNIA,8
PR,MUSCLE SPASMS,8
PR,ABDOMINAL DISCOMFORT,7
PR,ALOPECIA,7
PR,ANAEMIA,7
PR,DECREASED APPETITE,7
PR,DEHYDRATION,7
PR,HYPERCHOLESTEROLAEMIA,7
PR,INCORRECT DOSE ADMINISTERED,7
PR,INJECTION SITE RASH,7
PR,LOCAL SWELLING,7
PR,LOSS OF CONSCIOUSNESS,7
PR,RASH MACULAR,7
PR,URTICARIA,7
PR,BLOOD CHOLESTEROL INCREASED,6
PR,BLOOD GLUCOSE DECREASED,6
PR,DERMATITIS ALLERGIC,6
PR,DISCOMFORT,6
PR,DRUG PRESCRIBING ERROR,6
PR,DRY MOUTH,6
PR,HYPERHIDROSIS,6
PR,INFECTION,6
PR,INFLUENZA,6
PR,MUSCULAR WEAKNESS,6
PR,PRODUCTIVE COUGH,6
PR,TACHYCARDIA,6
PR,VAGINAL INFECTION,6
PR,VISUAL IMPAIRMENT,6
PR,VITAMIN D DEFICIENCY,6
PR,ARTHROPATHY,5
PR,BACTERIAL INFECTION,5
PR,CHEST PAIN,5
PR,CHILLS,5
PR,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,5
PR,CONTUSION,5
PR,DRUG EFFECT INCOMPLETE,5
PR,DRY EYE,5
PR,HAEMATOMA,5
PR,HEAD INJURY,5
PR,HYPOTHYROIDISM,5
PR,INJECTION SITE INFLAMMATION,5
PR,INJECTION SITE WARMTH,5
PR,JOINT SWELLING,5
PR,LARYNGITIS,5
PR,MUSCULOSKELETAL STIFFNESS,5
PR,MYOCARDIAL INFARCTION,5
PR,NECK PAIN,5
PR,VAGINAL HAEMORRHAGE,5
PR,BLOOD PRESSURE INCREASED,4
PR,CARPAL TUNNEL SYNDROME,4
PR,CONSTIPATION,4
PR,DRUG ADMINISTRATION ERROR,4
PR,DYSGEUSIA,4
PR,EAR INFECTION,4
PR,FEELING ABNORMAL,4
PR,HERPES ZOSTER,4
PR,HYPERTRIGLYCERIDAEMIA,4
PR,INJECTION SITE INDURATION,4
PR,INJECTION SITE URTICARIA,4
PR,INTESTINAL POLYP,4
PR,MUSCULOSKELETAL DISCOMFORT,4
PR,MUSCULOSKELETAL DISORDER,4
PR,NEOPLASM MALIGNANT,4
PR,NEUROPATHY PERIPHERAL,4
PR,NODULE,4
PR,PALPITATIONS,4
PR,PHLEBITIS,4
PR,PLATELET COUNT DECREASED,4
PR,PULMONARY OEDEMA,4
PR,RECTAL HAEMORRHAGE,4
PR,SLEEP APNOEA SYNDROME,4
PR,SOMNOLENCE,4
PR,SWELLING FACE,4
PR,THYROID CANCER,4
PR,THYROID MASS,4
PR,THYROID NEOPLASM,4
PR,TREMOR,4
PR,UNEVALUABLE EVENT,4
PR,UTERINE LEIOMYOMA,4
PR,VIRAL INFECTION,4
PR,WEIGHT INCREASED,4
PR,WHITE BLOOD CELL COUNT DECREASED,4
PR,WHITE BLOOD CELL COUNT INCREASED,4
PR,WRONG TECHNIQUE IN DRUG USAGE PROCESS,4
PR,ABDOMINAL DISTENSION,3
PR,APPENDICITIS,3
PR,BLINDNESS,3
PR,BLOOD URINE PRESENT,3
PR,CARDIAC ARREST,3
PR,CEREBROVASCULAR ACCIDENT,3
PR,CHEST DISCOMFORT,3
PR,CONDITION AGGRAVATED,3
PR,DEPRESSED MOOD,3
PR,DIVERTICULUM,3
PR,DRUG DOSE OMISSION,3
PR,DRUG HYPERSENSITIVITY,3
PR,DRY SKIN,3
PR,DYSPHAGIA,3
PR,DYSURIA,3
PR,EYE SWELLING,3
PR,FIBROMYALGIA,3
PR,GASTRITIS,3
PR,GINGIVITIS,3
PR,GOITRE,3
PR,GRIP STRENGTH DECREASED,3
PR,HAEMORRHOIDS,3
PR,HOSPITALISATION,3
PR,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,3
PR,INGROWING NAIL,3
PR,INJECTION SITE DISCOLOURATION,3
PR,INJECTION SITE DISCOMFORT,3
PR,INJECTION SITE OEDEMA,3
PR,INJECTION SITE SWELLING,3
PR,INJURY ASSOCIATED WITH DEVICE,3
PR,INTERVERTEBRAL DISC PROTRUSION,3
PR,LUNG NEOPLASM MALIGNANT,3
PR,MELANOCYTIC NAEVUS,3
PR,MIGRAINE,3
PR,MOBILITY DECREASED,3
PR,OEDEMA PERIPHERAL,3
PR,OROPHARYNGEAL DISCOMFORT,3
PR,OVARIAN CYST,3
PR,PAIN OF SKIN,3
PR,PARAESTHESIA,3
PR,PRURITUS GENERALISED,3
PR,PULMONARY EMBOLISM,3
PR,RESPIRATORY TRACT CONGESTION,3
PR,RHINORRHOEA,3
PR,SEIZURE,3
PR,SKIN DISCOLOURATION,3
PR,THROAT IRRITATION,3
PR,THYROID DISORDER,3
PR,TINNITUS,3
PR,VISION BLURRED,3
PR,WOUND,3
PR,ABASIA,2
PR,ACNE,2
PR,ANKLE FRACTURE,2
PR,ARTICULAR CALCIFICATION,2
PR,BALANCE DISORDER,2
PR,BLOOD TRIGLYCERIDES INCREASED,2
PR,BREAST CANCER,2
PR,BREAST CANCER FEMALE,2
PR,CEREBRAL INFARCTION,2
PR,CHEST X-RAY ABNORMAL,2
PR,CONFUSIONAL STATE,2
PR,CUTANEOUS LUPUS ERYTHEMATOSUS,2
PR,DENGUE FEVER,2
PR,DIABETES MELLITUS INADEQUATE CONTROL,2
PR,DIPLOPIA,2
PR,DRUG ADMINISTERED AT INAPPROPRIATE SITE,2
PR,DRUG EFFECT DECREASED,2
PR,DRUG INTOLERANCE,2
PR,EAR DISCOMFORT,2
PR,EAR PAIN,2
PR,EPISTAXIS,2
PR,EXOSTOSIS,2
PR,EYE INFLAMMATION,2
PR,EYE PRURITUS,2
PR,EYELID PTOSIS,2
PR,FEEDING DISORDER,2
PR,FEELING HOT,2
PR,FEELING OF DESPAIR,2
PR,FLUID RETENTION,2
PR,FOOT FRACTURE,2
PR,FUNGAL INFECTION,2
PR,FUNGAL SKIN INFECTION,2
PR,GALLBLADDER DISORDER,2
PR,GALLBLADDER OPERATION,2
PR,GASTRIC DISORDER,2
PR,GASTROINTESTINAL DISORDER,2
PR,GASTROINTESTINAL INFLAMMATION,2
PR,HAEMATOCHEZIA,2
PR,HAEMORRHAGE,2
PR,HAIR TEXTURE ABNORMAL,2
PR,HAND DEFORMITY,2
PR,HEART RATE DECREASED,2
PR,HELICOBACTER INFECTION,2
PR,HEPATIC STEATOSIS,2
PR,HERNIA,2
PR,HOT FLUSH,2
PR,HYPOGLYCAEMIA,2
PR,HYPOTENSION,2
PR,INFARCTION,2
PR,INJECTION SITE HAEMORRHAGE,2
PR,INJECTION SITE REACTION,2
PR,INTERVERTEBRAL DISC DISORDER,2
PR,INTESTINAL OBSTRUCTION,2
PR,INTRACRANIAL ANEURYSM,2
PR,JOINT DISLOCATION,2
PR,JOINT INJURY,2
PR,JOINT RANGE OF MOTION DECREASED,2
PR,KNEE ARTHROPLASTY,2
PR,LABORATORY TEST ABNORMAL,2
PR,LIVER DISORDER,2
PR,MEMORY IMPAIRMENT,2
PR,MENISCUS INJURY,2
PR,MENTAL DISORDER,2
PR,MYALGIA,2
PR,NEOPLASM,2
PR,NEOPLASM PROGRESSION,2
PR,ORAL FUNGAL INFECTION,2
PR,OROPHARYNGEAL PLAQUE,2
PR,OSTEOPENIA,2
PR,PANCREATITIS,2
PR,PERIPHERAL VENOUS DISEASE,2
PR,PLATELET COUNT INCREASED,2
PR,PRODUCT USE ISSUE,2
PR,RASH GENERALISED,2
PR,REACTION TO FOOD COLOURING,2
PR,RED BLOOD CELL SEDIMENTATION RATE DECREASED,2
PR,RED BLOOD CELL SEDIMENTATION RATE INCREASED,2
PR,RENAL IMPAIRMENT,2
PR,RESPIRATORY TRACT INFECTION,2
PR,ROAD TRAFFIC ACCIDENT,2
PR,SECRETION DISCHARGE,2
PR,SJOGREN^S SYNDROME,2
PR,SKIN EXFOLIATION,2
PR,SKIN ULCER,2
PR,SPINAL OPERATION,2
PR,STRESS,2
PR,SWELLING,2
PR,SYSTEMIC LUPUS ERYTHEMATOSUS,2
PR,TENDONITIS,2
PR,THROMBOPHLEBITIS,2
PR,TOOTH EXTRACTION,2
PR,TOOTH INFECTION,2
PR,TRANSIENT ISCHAEMIC ATTACK,2
PR,UTERINE HAEMORRHAGE,2
PR,VENOUS OCCLUSION,2
PR,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,2
PR,ABDOMINAL HERNIA,1
PR,ABDOMINAL RIGIDITY,1
PR,ABORTION SPONTANEOUS,1
PR,ABSCESS,1
PR,ABSCESS LIMB,1
PR,ABSCESS NECK,1
PR,ADVERSE DRUG REACTION,1
PR,ADVERSE EVENT,1
PR,ADVERSE REACTION,1
PR,AGITATION,1
PR,ALANINE AMINOTRANSFERASE INCREASED,1
PR,AMENORRHOEA,1
PR,ANAL FISSURE,1
PR,ANGINA PECTORIS,1
PR,ANORECTAL DISCOMFORT,1
PR,ANTI-THYROID ANTIBODY,1
PR,ANTIPHOSPHOLIPID ANTIBODIES POSITIVE,1
PR,APHONIA,1
PR,APTYALISM,1
PR,ARTERITIS,1
PR,ARTHROPOD BITE,1
PR,ASPARTATE AMINOTRANSFERASE INCREASED,1
PR,ASPIRATION PLEURAL CAVITY,1
PR,ASTHMATIC CRISIS,1
PR,ATRIAL FIBRILLATION,1
PR,AXILLARY MASS,1
PR,BACTERAEMIA,1
PR,BLISTER,1
PR,BLOOD CHOLESTEROL ABNORMAL,1
PR,BLOOD CREATINE INCREASED,1
PR,BLOOD CREATININE INCREASED,1
PR,BLOOD ELECTROLYTES DECREASED,1
PR,BLOOD GLUCOSE ABNORMAL,1
PR,BLOOD GLUCOSE FLUCTUATION,1
PR,BLOOD IMMUNOGLOBULIN G ABNORMAL,1
PR,BLOOD IRON DECREASED,1
PR,BLOOD POTASSIUM DECREASED,1
PR,BLOOD PRESSURE DECREASED,1
PR,BLOOD PRESSURE INADEQUATELY CONTROLLED,1
PR,BLOOD TRIGLYCERIDES ABNORMAL,1
PR,BLOOD UREA INCREASED,1
PR,BLOOD URIC ACID INCREASED,1
PR,BODY TEMPERATURE DECREASED,1
PR,BONE MARROW FAILURE,1
PR,BONE OPERATION,1
PR,BRAIN NEOPLASM MALIGNANT,1
PR,BREAST ABSCESS,1
PR,BREAST CANCER METASTATIC,1
PR,BREAST CELLULITIS,1
PR,BREAST CYST,1
PR,BREAST DISORDER,1
PR,BREAST MASS,1
PR,BREAST OPERATION,1
PR,BREAST RECONSTRUCTION,1
PR,BRONCHITIS CHRONIC,1
PR,BRONCHOSPASM,1
PR,C-REACTIVE PROTEIN INCREASED,1
PR,CARDIAC DISORDER,1
PR,CARDIAC FAILURE,1
PR,CARDIAC FAILURE CONGESTIVE,1
PR,CARDIAC MURMUR,1
PR,CARDIO-RESPIRATORY ARREST,1
PR,CARDIOVASCULAR DISORDER,1
PR,CERVICAL VERTEBRAL FRACTURE,1
PR,CHEILITIS,1
PR,CHEMICAL BURN OF SKIN,1
PR,CHEMOTHERAPY,1
PR,CHOLECYSTITIS ACUTE,1
PR,CHOLELITHIASIS,1
PR,COLITIS,1
PR,COLITIS ULCERATIVE,1
PR,COLON CANCER,1
PR,COLON OPERATION,1
PR,COLORECTAL CANCER,1
PR,CONJUNCTIVITIS,1
PR,CONVULSION,1
PR,COORDINATION ABNORMAL,1
PR,CRYING,1
PR,CYANOSIS,1
PR,CYST,1
PR,CYSTITIS,1
PR,CYSTITIS HAEMORRHAGIC,1
PR,DEATH,1
PR,DEMENTIA ALZHEIMER^S TYPE,1
PR,DERMAL CYST,1
PR,DERMATITIS,1
PR,DERMATITIS ACNEIFORM,1
PR,DERMATITIS CONTACT,1
PR,DEVICE ALLERGY,1
PR,DEVICE ISSUE,1
PR,DEVICE MALFUNCTION,1
PR,DISEASE RECURRENCE,1
PR,DISLOCATION OF VERTEBRA,1
PR,DRUG DISPENSING ERROR,1
PR,DRUG LEVEL DECREASED,1
PR,DUPUYTREN^S CONTRACTURE,1
PR,DYSARTHRIA,1
PR,DYSMENORRHOEA,1
PR,DYSPEPSIA,1
PR,DYSSTASIA,1
PR,EAR DISORDER,1
PR,ELBOW DEFORMITY,1
PR,EMBOLISM,1
PR,EMOTIONAL DISORDER,1
PR,EMOTIONAL DISTRESS,1
PR,ENDOMETRIAL CANCER,1
PR,EXPOSURE DURING PREGNANCY,1
PR,EXPOSURE TO COMMUNICABLE DISEASE,1
PR,EYE ABSCESS,1
PR,EYE DISORDER,1
PR,EYE HAEMORRHAGE,1
PR,EYE INFECTION,1
PR,EYE PAIN,1
PR,FACIAL BONES FRACTURE,1
PR,FEAR OF INJECTION,1
PR,FIBROMA,1
PR,FOLATE DEFICIENCY,1
PR,FOLLICULITIS,1
PR,FOOD POISONING,1
PR,FRACTURE,1
PR,FRACTURE DELAYED UNION,1
PR,FULL BLOOD COUNT DECREASED,1
PR,FURUNCLE,1
PR,GALLBLADDER NON-FUNCTIONING,1
PR,GALLBLADDER OEDEMA,1
PR,GASTROENTERITIS,1
PR,GASTROENTERITIS VIRAL,1
PR,GASTROINTESTINAL BACTERIAL INFECTION,1
PR,GASTROINTESTINAL PAIN,1
PR,GENITAL ABSCESS,1
PR,GENITAL DISCOMFORT,1
PR,GINGIVAL DISCOMFORT,1
PR,GINGIVAL INFECTION,1
PR,GINGIVAL PAIN,1
PR,GLAUCOMA,1
PR,GLOSSITIS,1
PR,HAEMORRHAGIC OVARIAN CYST,1
PR,HAEMORRHAGIC STROKE,1
PR,HAIR COLOUR CHANGES,1
PR,HAIR DISORDER,1
PR,HAND FRACTURE,1
PR,HEAD DISCOMFORT,1
PR,HEART RATE INCREASED,1
PR,HEAVY EXPOSURE TO ULTRAVIOLET LIGHT,1
PR,HEPATIC CIRRHOSIS,1
PR,HEPATIC MASS,1
PR,HEPATOCELLULAR CARCINOMA,1
PR,HIP ARTHROPLASTY,1
PR,HYPERKERATOSIS,1
PR,HYPERTHYROIDISM,1
PR,HYPOACUSIS,1
PR,HYPOKALAEMIA,1
PR,HYPOPHAGIA,1
PR,IMMUNE SYSTEM DISORDER,1
PR,IMMUNODEFICIENCY,1
PR,IMPAIRED HEALING,1
PR,IMPETIGO,1
PR,INCREASED APPETITE,1
PR,INFECTED SKIN ULCER,1
PR,INFLAMMATORY MARKER INCREASED,1
PR,INFLUENZA LIKE ILLNESS,1
PR,INJECTION SITE CELLULITIS,1
PR,INJECTION SITE HYPERSENSITIVITY,1
PR,INJECTION SITE PAPULE,1
PR,INJECTION SITE PARAESTHESIA,1
PR,INJURY,1
PR,INTERVERTEBRAL DISC OPERATION,1
PR,INTESTINAL MASS,1
PR,INTESTINAL PERFORATION,1
PR,IRRITABLE BOWEL SYNDROME,1
PR,JAW FRACTURE,1
PR,JOINT EFFUSION,1
PR,KERATITIS,1
PR,LACERATION,1
PR,LACRIMATION DECREASED,1
PR,LACRIMATION INCREASED,1
PR,LARGE INTESTINE POLYP,1
PR,LIGAMENT RUPTURE,1
PR,LIMB DISCOMFORT,1
PR,LIMB INJURY,1
PR,LIP SWELLING,1
PR,LIPOMA,1
PR,LOCALISED INFECTION,1
PR,LOW DENSITY LIPOPROTEIN INCREASED,1
PR,LOWER LIMB FRACTURE,1
PR,LUMBAR SPINAL STENOSIS,1
PR,LUNG DISORDER,1
PR,LUNG NEOPLASM,1
PR,LUPUS-LIKE SYNDROME,1
PR,LYMPH GLAND INFECTION,1
PR,LYMPHADENITIS,1
PR,LYMPHOMA,1
PR,MACULAR DEGENERATION,1
PR,MADAROSIS,1
PR,MALIGNANT NEOPLASM OF THORAX,1
PR,MENORRHAGIA,1
PR,MENTAL STATUS CHANGES,1
PR,METASTASES TO BONE,1
PR,MITE ALLERGY,1
PR,MOUTH SWELLING,1
PR,MULTIPLE CHEMICAL SENSITIVITY,1
PR,MUSCLE ATROPHY,1
PR,MUSCLE STRAIN,1
PR,MUSCULOSKELETAL CHEST PAIN,1
PR,MYOSITIS,1
PR,NAIL BED INFLAMMATION,1
PR,NAIL DISCOLOURATION,1
PR,NAIL INFECTION,1
PR,NASAL NEOPLASM,1
PR,NASAL TURBINATE HYPERTROPHY,1
PR,NEPHROLITHIASIS,1
PR,NERVE BLOCK,1
PR,NERVE COMPRESSION,1
PR,NONSPECIFIC REACTION,1
PR,OCULAR HYPERAEMIA,1
PR,OEDEMA,1
PR,ONYCHOCLASIS,1
PR,ONYCHOMADESIS,1
PR,ONYCHOMYCOSIS,1
PR,OPTIC NERVE DISORDER,1
PR,ORAL DISCOMFORT,1
PR,ORAL HERPES,1
PR,ORAL MUCOSAL BLISTERING,1
PR,ORAL PAIN,1
PR,ORAL SURGERY,1
PR,OVERDOSE,1
PR,OXYGEN SATURATION ABNORMAL,1
PR,OXYGEN SATURATION DECREASED,1
PR,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,1
PR,PANCREATIC DISORDER,1
PR,PANIC ATTACK,1
PR,PAPULE,1
PR,PEAU D^ORANGE,1
PR,PERIORBITAL OEDEMA,1
PR,PERIPHERAL ARTERY OCCLUSION,1
PR,PHARYNGEAL NEOPLASM,1
PR,PITYRIASIS ROSEA,1
PR,PLEURAL EFFUSION,1
PR,PNEUMONITIS,1
PR,PNEUMOTHORAX,1
PR,POLYDIPSIA,1
PR,POLYP,1
PR,POLYURIA,1
PR,POST PROCEDURAL CELLULITIS,1
PR,POST PROCEDURAL INFECTION,1
PR,POSTOPERATIVE WOUND COMPLICATION,1
PR,POSTOPERATIVE WOUND INFECTION,1
PR,PRESCRIBED OVERDOSE,1
PR,PRODUCT QUALITY ISSUE,1
PR,PRODUCT STORAGE ERROR,1
PR,PSYCHOMOTOR HYPERACTIVITY,1
PR,PULMONARY CONGESTION,1
PR,PULMONARY GRANULOMA,1
PR,PULMONARY HYPERTENSION,1
PR,PULMONARY PAIN,1
PR,PURULENT DISCHARGE,1
PR,RADICULOPATHY,1
PR,RADIUS FRACTURE,1
PR,RALES,1
PR,RASH PAPULAR,1
PR,RED BLOOD CELL COUNT DECREASED,1
PR,RENAL FAILURE,1
PR,RESPIRATORY DEPRESSION,1
PR,RESPIRATORY DISORDER,1
PR,RESPIRATORY DISTRESS,1
PR,RESPIRATORY RATE DECREASED,1
PR,RHONCHI,1
PR,SALIVARY HYPERSECRETION,1
PR,SCAB,1
PR,SCAR,1
PR,SENSORY LOSS,1
PR,SEPSIS,1
PR,SERUM FERRITIN DECREASED,1
PR,SKELETAL INJURY,1
PR,SKIN BURNING SENSATION,1
PR,SKIN CANCER,1
PR,SKIN DISORDER,1
PR,SKIN HYPERTROPHY,1
PR,SKIN MASS,1
PR,SKIN SENSITISATION,1
PR,SPEECH DISORDER,1
PR,SPINAL DISORDER,1
PR,SPINAL FRACTURE,1
PR,SPINAL OSTEOARTHRITIS,1
PR,SPINAL PAIN,1
PR,SPONDYLITIS,1
PR,STOMA SITE DISCHARGE,1
PR,STOMA SITE ERYTHEMA,1
PR,STOMATITIS,1
PR,SUBCUTANEOUS ABSCESS,1
PR,SUICIDAL IDEATION,1
PR,SURGERY,1
PR,SYNCOPE,1
PR,SYNOVIAL CYST,1
PR,TEMPERATURE INTOLERANCE,1
PR,TENDON INJURY,1
PR,TENDON RUPTURE,1
PR,TESTICULAR HAEMORRHAGE,1
PR,TESTICULAR OEDEMA,1
PR,THERAPEUTIC RESPONSE UNEXPECTED,1
PR,THERMAL BURN,1
PR,THROMBOSIS,1
PR,THYROID CANCER METASTATIC,1
PR,THYROID FUNCTION TEST ABNORMAL,1
PR,THYROID PAIN,1
PR,TIBIA FRACTURE,1
PR,TOE AMPUTATION,1
PR,TONGUE DISCOMFORT,1
PR,TONGUE DISORDER,1
PR,TOOTH FRACTURE,1
PR,TRANSFUSION,1
PR,TUBERCULIN TEST POSITIVE,1
PR,TUBERCULOSIS,1
PR,TYPE 2 DIABETES MELLITUS,1
PR,ULCER,1
PR,UMBILICAL HERNIA,1
PR,UNDERDOSE,1
PR,UPPER LIMB FRACTURE,1
PR,UPPER RESPIRATORY FUNGAL INFECTION,1
PR,URINARY RETENTION,1
PR,URINE OUTPUT DECREASED,1
PR,UTERINE DISORDER,1
PR,UTERINE INFLAMMATION,1
PR,UTERINE POLYP,1
PR,UVEITIS,1
PR,VAGINAL DISCHARGE,1
PR,VARICOSE VEIN,1
PR,VASCULAR INSUFFICIENCY,1
PR,VERTIGO,1
PR,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
PR,VITAMIN B12 DEFICIENCY,1
PR,VITAMIN D DECREASED,1
PR,VULVOVAGINAL PRURITUS,1
PR,WOUND DEHISCENCE,1
PR,WOUND INFECTION,1
PR,YELLOW SKIN,1
RO,DRUG EFFECT INCOMPLETE,1
RO,SPINAL FRACTURE,1
RO,WRIST FRACTURE,1
RU,ACUTE GRAFT VERSUS HOST DISEASE IN SKIN,1
RU,ALOPECIA,1
RU,APPENDICEAL ABSCESS,1
RU,BLOOD PRESSURE DECREASED,1
RU,BLOOD PRESSURE INCREASED,1
RU,CHRONIC GRAFT VERSUS HOST DISEASE,1
RU,CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE,1
RU,CHRONIC GRAFT VERSUS HOST DISEASE IN SKIN,1
RU,CORONARY ARTERY DISEASE,1
RU,CYTOKINE RELEASE SYNDROME,1
RU,DIABETIC KETOACIDOSIS,1
RU,DRUG INEFFECTIVE,1
RU,HAIR COLOUR CHANGES,1
RU,HEADACHE,1
RU,HYPERAEMIA,1
RU,SKIN EXFOLIATION,1
RU,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,1
SA,ACUTE KIDNEY INJURY,1
SA,CEREBROSPINAL FLUID LEAKAGE,1
SA,TUBULOINTERSTITIAL NEPHRITIS,1
RS,BLOOD POTASSIUM INCREASED,1
RS,BRADYCARDIA,1
RS,CARDIAC ARREST,1
RS,CIRCULATORY COLLAPSE,1
RS,HYPOTENSION,1
SG,ABDOMINAL DISTENSION,1
SG,ANKLE FRACTURE,1
SG,ANXIETY,1
SG,BALANCE DISORDER,1
SG,BURNING SENSATION,1
SG,DRUG DOSE OMISSION,1
SG,DRUG INEFFECTIVE,1
SG,HYPOAESTHESIA,1
SG,NAUSEA,1
SG,PNEUMONITIS,1
SG,PRE-EXISTING CONDITION IMPROVED,1
SG,SEPSIS,1
SG,TENSION,1
SG,THERAPEUTIC RESPONSE UNEXPECTED,1
SG,UPPER LIMB FRACTURE,1
SK,ALANINE AMINOTRANSFERASE INCREASED,1
SK,BLOOD CHOLESTEROL INCREASED,1
SK,C-REACTIVE PROTEIN INCREASED,1
SK,DYSPHAGIA,1
SK,LOCAL SWELLING,1
SK,SWELLING FACE,1
SI,ANGINA PECTORIS,1
SI,ARTHRALGIA,1
SI,BLADDER CANCER RECURRENT,1
SI,CORONARY ARTERY DISEASE,1
SI,COUGH,1
SI,DIARRHOEA,1
SI,DRY MOUTH,1
SI,DYSPEPSIA,1
SI,EPISTAXIS,1
SI,GASTRITIS EROSIVE,1
SI,HAEMATEMESIS,1
SI,JOINT SWELLING,1
SI,NAUSEA,1
SI,PERIPHERAL SWELLING,1
SI,RASH,1
SI,SWELLING FACE,1
ZA,BLOOD THYROID STIMULATING HORMONE DECREASED,1
ES,DIARRHOEA,8
ES,ASTHENIA,7
ES,VOMITING,7
ES,NAUSEA,6
ES,DECREASED APPETITE,5
ES,DEPRESSED LEVEL OF CONSCIOUSNESS,5
ES,FEELING ABNORMAL,5
ES,HYPOCALCAEMIA,5
ES,HYPOMAGNESAEMIA,5
ES,CONFUSIONAL STATE,4
ES,DYSGEUSIA,4
ES,HYPERTONIA,4
ES,PAROSMIA,4
ES,PNEUMONIA,4
ES,DYSPHAGIA,3
ES,HEPATITIS,3
ES,HYPOTHYROIDISM,3
ES,NEUTROPENIA,3
ES,APLASTIC ANAEMIA,2
ES,FALL,2
ES,FEBRILE NEUTROPENIA,2
ES,HYPOKALAEMIA,2
ES,IMMUNE-MEDIATED NECROTISING MYOPATHY,2
ES,OEDEMA,2
ES,PANCYTOPENIA,2
ES,PYREXIA,2
ES,RENAL FAILURE,2
ES,RENAL FAILURE ACUTE,2
ES,THROMBOCYTOPENIA,2
ES,ABDOMINAL DISCOMFORT,1
ES,ABDOMINAL DISTENSION,1
ES,ACID BASE BALANCE ABNORMAL,1
ES,ACUTE MYOCARDIAL INFARCTION,1
ES,ADRENAL INSUFFICIENCY,1
ES,ALLODYNIA,1
ES,AMYOTROPHY,1
ES,ANGIOEDEMA,1
ES,AREFLEXIA,1
ES,ARTHRALGIA,1
ES,ASPHYXIA,1
ES,ATRIOVENTRICULAR BLOCK,1
ES,BACK PAIN,1
ES,BLOOD PRESSURE INCREASED,1
ES,BRADYCARDIA,1
ES,BRONCHOSPASM,1
ES,CAESAREAN SECTION,1
ES,CARDIOVASCULAR DISORDER,1
ES,CHRONIC KIDNEY DISEASE,1
ES,COMPLEX REGIONAL PAIN SYNDROME,1
ES,CONGENITAL CENTRAL NERVOUS SYSTEM ANOMALY,1
ES,CONGESTIVE CARDIOMYOPATHY,1
ES,CONJUNCTIVAL HAEMORRHAGE,1
ES,DEHYDRATION,1
ES,DRUG INEFFECTIVE,1
ES,DRUG WITHDRAWAL SYNDROME,1
ES,DYSAESTHESIA,1
ES,DYSPNOEA,1
ES,DYSPNOEA EXERTIONAL,1
ES,ELECTROCARDIOGRAM QT PROLONGED,1
ES,EYE DISORDER,1
ES,FATIGUE,1
ES,FEMORAL NECK FRACTURE,1
ES,FOETAL EXPOSURE DURING PREGNANCY,1
ES,GASTRITIS,1
ES,GASTROINTESTINAL MALFORMATION,1
ES,GENERALISED OEDEMA,1
ES,HEPATIC FAILURE,1
ES,HEPATIC FUNCTION ABNORMAL,1
ES,HEPATOTOXICITY,1
ES,HERNIA,1
ES,HIP FRACTURE,1
ES,HYPERBILIRUBINAEMIA,1
ES,HYPERKALAEMIA,1
ES,HYPONATRAEMIA,1
ES,HYPOTENSION,1
ES,ILEUS PARALYTIC,1
ES,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,1
ES,LIVE BIRTH,1
ES,LIVER DISORDER,1
ES,LUPUS-LIKE SYNDROME,1
ES,LYMPHADENOPATHY,1
ES,MALAISE,1
ES,METABOLIC ACIDOSIS,1
ES,METASTASES TO LUNG,1
ES,MILK-ALKALI SYNDROME,1
ES,MUCORMYCOSIS,1
ES,MULTI-ORGAN FAILURE,1
ES,MUSCLE SPASMS,1
ES,MUSCLE SPASTICITY,1
ES,MUSCULOSKELETAL PAIN,1
ES,MYOCARDITIS,1
ES,NASOPHARYNGITIS,1
ES,NERVOUSNESS,1
ES,NEUROTOXICITY,1
ES,OEDEMA PERIPHERAL,1
ES,OPTIC NEURITIS,1
ES,PAIN,1
ES,PAIN IN EXTREMITY,1
ES,PERIPHERAL SWELLING,1
ES,PETECHIAE,1
ES,PLEURAL EFFUSION,1
ES,PNEUMOCOCCAL INFECTION,1
ES,PNEUMONIA ASPIRATION,1
ES,POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME,1
ES,PSORIASIS,1
ES,PULMONARY FIBROSIS,1
ES,PULMONARY OEDEMA,1
ES,RENAL APLASIA,1
ES,RESPIRATORY FAILURE,1
ES,RESPIRATORY TRACT INFECTION,1
ES,SEPSIS,1
ES,SEPTIC SHOCK,1
ES,SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS,1
ES,TACHYCARDIA,1
ES,TACHYPNOEA,1
ES,TENDON RUPTURE,1
ES,TREMOR,1
ES,TROUSSEAU^S SYNDROME,1
ES,VISUAL ACUITY REDUCED,1
ES,WITHDRAWAL SYNDROME,1
ES,WOUND,1
SE,DIZZINESS,3
SE,HYPERTENSION,3
SE,HEADACHE,2
SE,SYNCOPE,2
SE,ABNORMAL FAECES,1
SE,ALOPECIA,1
SE,ANXIETY,1
SE,APHASIA,1
SE,CHEST PAIN,1
SE,CHOLELITHIASIS,1
SE,CHROMATURIA,1
SE,DRY MOUTH,1
SE,DYSPNOEA,1
SE,EAR INFECTION,1
SE,FATIGUE,1
SE,FEELING ABNORMAL,1
SE,FLUSHING,1
SE,GASTRIC INFECTION,1
SE,GASTROINTESTINAL MOTILITY DISORDER,1
SE,HEART RATE INCREASED,1
SE,HYPERHIDROSIS,1
SE,HYPERSEXUALITY,1
SE,INTERVERTEBRAL DISC COMPRESSION,1
SE,LIP SQUAMOUS CELL CARCINOMA,1
SE,LIP SWELLING,1
SE,MUSCLE TWITCHING,1
SE,MUSCULOSKELETAL DISCOMFORT,1
SE,ORAL DISCOMFORT,1
SE,PANIC ATTACK,1
SE,RED BLOOD CELL COUNT DECREASED,1
SE,RESTLESSNESS,1
SE,SOMATIC DELUSION,1
SE,SWOLLEN TONGUE,1
SE,TREMOR,1
SE,URINE ODOUR ABNORMAL,1
SE,WEIGHT DECREASED,1
SE,WHITE BLOOD CELL COUNT DECREASED,1
CH,DEEP VEIN THROMBOSIS,3
CH,GASTROINTESTINAL HAEMORRHAGE,3
CH,ACUTE MYOCARDIAL INFARCTION,2
CH,DRUG INEFFECTIVE,2
CH,DYSPNOEA,2
CH,FALL,2
CH,FOETAL EXPOSURE DURING PREGNANCY,2
CH,HAEMOLYTIC ANAEMIA,2
CH,HYPOCHROMIC ANAEMIA,2
CH,JAUNDICE ACHOLURIC,2
CH,LOSS OF CONSCIOUSNESS,2
CH,MATERNAL DRUGS AFFECTING FOETUS,2
CH,OVERDOSE,2
CH,PULMONARY EMBOLISM,2
CH,RENAL INFARCT,2
CH,SOMNOLENCE,2
CH,WEIGHT DECREASED,2
CH,ABNORMAL BEHAVIOUR,1
CH,ACUTE RESPIRATORY DISTRESS SYNDROME,1
CH,AMNESIA,1
CH,ANAEMIA,1
CH,ANGIOEDEMA,1
CH,APHASIA,1
CH,APNOEA,1
CH,ASTHMATIC CRISIS,1
CH,BLOOD PRESSURE SYSTOLIC INCREASED,1
CH,BRADYCARDIA,1
CH,BRONCHOSPASM,1
CH,CARDIO-RESPIRATORY ARREST,1
CH,CELLULITIS,1
CH,CHEST DISCOMFORT,1
CH,CHROMATOPSIA,1
CH,COGNITIVE DISORDER,1
CH,CONFUSIONAL STATE,1
CH,CONGENITAL MEGACOLON,1
CH,DEHYDRATION,1
CH,DELIRIUM,1
CH,DEPRESSED LEVEL OF CONSCIOUSNESS,1
CH,DEPRESSION,1
CH,DIARRHOEA,1
CH,DISTURBANCE IN ATTENTION,1
CH,DIZZINESS,1
CH,DRUG EFFECT INCREASED,1
CH,EXECUTIVE DYSFUNCTION,1
CH,FATIGUE,1
CH,GLYCOSYLATED HAEMOGLOBIN INCREASED,1
CH,HEART RATE INCREASED,1
CH,HYPERGLYCAEMIA,1
CH,HYPERKALAEMIA,1
CH,HYPERSENSITIVITY,1
CH,HYPERTHYROIDISM,1
CH,HYPOGLYCAEMIA,1
CH,HYPONATRAEMIA,1
CH,HYPOTHYROIDISM,1
CH,IMPAIRED HEALING,1
CH,INTESTINAL ATRESIA,1
CH,KETONURIA,1
CH,LACTIC ACIDOSIS,1
CH,LIP OEDEMA,1
CH,LOCALISED INFECTION,1
CH,LOCALISED OEDEMA,1
CH,MEMORY IMPAIRMENT,1
CH,METABOLIC ACIDOSIS,1
CH,MOTOR DYSFUNCTION,1
CH,MUCOSAL DRYNESS,1
CH,MYOCARDIAL INFARCTION,1
CH,MYOCLONUS,1
CH,NAUSEA,1
CH,NEURODEGENERATIVE DISORDER,1
CH,OXYGEN SATURATION DECREASED,1
CH,PALPITATIONS,1
CH,PANCREATITIS,1
CH,PARAPARESIS,1
CH,PNEUMONIA,1
CH,POLYDIPSIA,1
CH,PRURITUS,1
CH,PYOGENIC GRANULOMA,1
CH,RENAL FAILURE,1
CH,RENAL FAILURE ACUTE,1
CH,RESPIRATORY ACIDOSIS,1
CH,RESPIRATORY FAILURE,1
CH,SEPTIC SHOCK,1
CH,SPEECH DISORDER,1
CH,THERAPEUTIC RESPONSE INCREASED,1
CH,THROMBOCYTOPENIA,1
CH,TOXIC ENCEPHALOPATHY,1
CH,TOXIC SKIN ERUPTION,1
CH,TYPE 1 DIABETES MELLITUS,1
CH,VOMITING,1
TW,ACUTE KIDNEY INJURY,3
TW,OLIGURIA,2
TW,COARCTATION OF THE AORTA,1
TW,DIZZINESS,1
TW,EJECTION FRACTION DECREASED,1
TW,HEPATITIS ACUTE,1
TW,HYPERTENSION,1
TW,LEFT VENTRICULAR HYPERTROPHY,1
TW,MENTAL STATUS CHANGES,1
TW,PNEUMOTHORAX,1
TW,RENAL IMPAIRMENT,1
TW,RESPIRATORY ACIDOSIS,1
TH,HEPATITIS,2
TH,ABDOMINAL PAIN,1
TH,DIARRHOEA,1
TH,FEBRILE NEUTROPENIA,1
TH,MYALGIA,1
TR,TYPE I HYPERSENSITIVITY,4
TR,BONE TUBERCULOSIS,2
TR,DRUG HYPERSENSITIVITY,2
TR,HAEMOGLOBIN DECREASED,2
TR,HYPERCALCAEMIA,2
TR,PANCYTOPENIA,2
TR,RENAL FAILURE,2
TR,SKIN NECROSIS,2
TR,ANAEMIA,1
TR,ANAPHYLACTIC REACTION,1
TR,BLOOD CREATINE INCREASED,1
TR,BLOOD TRIGLYCERIDES INCREASED,1
TR,CEREBRAL ISCHAEMIA,1
TR,CONFUSIONAL STATE,1
TR,DEATH,1
TR,DECREASED APPETITE,1
TR,DRUG INEFFECTIVE,1
TR,EMBOLISM,1
TR,ENDOMETRIAL HYPERPLASIA,1
TR,FATIGUE,1
TR,GASTROINTESTINAL HAEMORRHAGE,1
TR,GINGIVAL BLEEDING,1
TR,HAEMATOCRIT DECREASED,1
TR,HEADACHE,1
TR,HEPATITIS TOXIC,1
TR,HYPERTHYROIDISM,1
TR,INTERNATIONAL NORMALISED RATIO INCREASED,1
TR,IRRITABILITY,1
TR,LOW DENSITY LIPOPROTEIN INCREASED,1
TR,MUTISM,1
TR,OVERDOSE,1
TR,PALPITATIONS,1
TR,PITUITARY HAEMORRHAGE,1
TR,SEPSIS,1
TR,SLEEP DISORDER,1
TR,SUICIDE ATTEMPT,1
TR,URTICARIA,1
TR,UTERINE HAEMORRHAGE,1
TR,VERTIGO,1
TR,VOMITING,1
TR,WEIGHT INCREASED,1
UA,LOBAR PNEUMONIA,1
UA,PLEURISY,1
GB,MALAISE,69
GB,FATIGUE,66
GB,DIZZINESS,61
GB,DYSPNOEA,58
GB,HEADACHE,53
GB,NAUSEA,51
GB,CONFUSIONAL STATE,49
GB,ACUTE KIDNEY INJURY,44
GB,VOMITING,43
GB,LOWER RESPIRATORY TRACT INFECTION,35
GB,TREMOR,33
GB,DIARRHOEA,31
GB,ARTHRALGIA,30
GB,ASTHENIA,29
GB,MYALGIA,29
GB,SEIZURE,29
GB,PAIN,28
GB,CONSTIPATION,27
GB,PARAESTHESIA,27
GB,ABDOMINAL PAIN,26
GB,HYPONATRAEMIA,26
GB,BACK PAIN,25
GB,ABDOMINAL PAIN UPPER,24
GB,DRUG INEFFECTIVE,23
GB,MUSCLE SPASMS,22
GB,TOXICITY TO VARIOUS AGENTS,22
GB,ANXIETY,21
GB,CHILLS,21
GB,DECREASED APPETITE,21
GB,DISTURBANCE IN ATTENTION,21
GB,DYSGEUSIA,21
GB,PALPITATIONS,21
GB,HALLUCINATION,20
GB,LIVER FUNCTION TEST ABNORMAL,20
GB,BRADYCARDIA,19
GB,INSOMNIA,19
GB,RENAL FAILURE,19
GB,SOMNOLENCE,19
GB,WEIGHT DECREASED,19
GB,DEHYDRATION,18
GB,FEELING ABNORMAL,18
GB,HYPERHIDROSIS,18
GB,PAIN IN EXTREMITY,18
GB,SWELLING FACE,18
GB,VISION BLURRED,18
GB,AGITATION,17
GB,HYPOAESTHESIA,17
GB,JAUNDICE,17
GB,LETHARGY,17
GB,CHEST PAIN,16
GB,DRUG WITHDRAWAL SYNDROME,16
GB,GENERAL PHYSICAL HEALTH DETERIORATION,16
GB,HYPERKALAEMIA,16
GB,PERIPHERAL SWELLING,16
GB,PRURITUS,16
GB,RASH,16
GB,ANAEMIA,15
GB,CONDITION AGGRAVATED,15
GB,COUGH,15
GB,DEPRESSED MOOD,15
GB,ATRIAL FIBRILLATION,14
GB,DISORIENTATION,14
GB,FALL,14
GB,HYPOTENSION,14
GB,PANCYTOPENIA,14
GB,RENAL FAILURE ACUTE,14
GB,SEPSIS,14
GB,SLEEP DISORDER,14
GB,VERTIGO,14
GB,ABDOMINAL DISTENSION,13
GB,ADDISON^S DISEASE,13
GB,AMNESIA,13
GB,EOSINOPHILIA,13
GB,EYE PAIN,13
GB,GAIT DISTURBANCE,13
GB,ORTHOSTATIC HYPOTENSION,13
GB,PYREXIA,13
GB,RESTLESSNESS,13
GB,WEIGHT INCREASED,13
GB,ABDOMINAL DISCOMFORT,12
GB,AGGRESSION,12
GB,ALANINE AMINOTRANSFERASE INCREASED,12
GB,BALANCE DISORDER,12
GB,GASTROINTESTINAL HAEMORRHAGE,12
GB,MIGRAINE,12
GB,PULMONARY EMBOLISM,12
GB,ACUTE CORONARY SYNDROME,11
GB,BLISTER,11
GB,BLOOD CREATINE PHOSPHOKINASE INCREASED,11
GB,BLOOD CREATININE INCREASED,11
GB,BLOOD PRESSURE DECREASED,11
GB,CONTUSION,11
GB,HYPERTENSION,11
GB,MUSCULAR WEAKNESS,11
GB,NEUTROPENIA,11
GB,OVERDOSE,11
GB,PANCREATITIS ACUTE,11
GB,SYNCOPE,11
GB,THROMBOCYTOPENIA,11
GB,URINARY TRACT INFECTION,11
GB,ALOPECIA,10
GB,ATRIOVENTRICULAR BLOCK,10
GB,DRY MOUTH,10
GB,HAEMOGLOBIN DECREASED,10
GB,HEAD DISCOMFORT,10
GB,HYPERSENSITIVITY,10
GB,INTERNATIONAL NORMALISED RATIO INCREASED,10
GB,IRRITABILITY,10
GB,NECK PAIN,10
GB,PNEUMONIA,10
GB,PRESYNCOPE,10
GB,SPEECH DISORDER,10
GB,SUICIDAL IDEATION,10
GB,ABNORMAL BEHAVIOUR,9
GB,AUTONOMIC NERVOUS SYSTEM IMBALANCE,9
GB,CARDIAC FAILURE,9
GB,CHEST DISCOMFORT,9
GB,DIABETES MELLITUS INADEQUATE CONTROL,9
GB,HEART RATE INCREASED,9
GB,INFECTION,9
GB,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,9
GB,MUSCLE TWITCHING,9
GB,RENAL IMPAIRMENT,9
GB,RHABDOMYOLYSIS,9
GB,BLOOD ALKALINE PHOSPHATASE INCREASED,8
GB,BLOOD BILIRUBIN INCREASED,8
GB,BLOOD PRESSURE INCREASED,8
GB,DYSKINESIA,8
GB,FOOD REFUSAL,8
GB,GLOMERULAR FILTRATION RATE DECREASED,8
GB,HAEMATEMESIS,8
GB,JOINT SWELLING,8
GB,LOSS OF LIBIDO,8
GB,SKIN TIGHTNESS,8
GB,UNRESPONSIVE TO STIMULI,8
GB,URTICARIA,8
GB,VISUAL IMPAIRMENT,8
GB,AORTIC ANEURYSM,7
GB,CELLULITIS,7
GB,CHOLELITHIASIS,7
GB,COMA SCALE ABNORMAL,7
GB,DEATH,7
GB,DEPRESSION,7
GB,DERMATITIS ALLERGIC,7
GB,HAEMORRHAGE INTRACRANIAL,7
GB,JOINT STIFFNESS,7
GB,MUCOSAL ULCERATION,7
GB,NIGHTMARE,7
GB,PHOTOSENSITIVITY REACTION,7
GB,PSYCHOMOTOR HYPERACTIVITY,7
GB,RECTAL HAEMORRHAGE,7
GB,RHINORRHOEA,7
GB,SWOLLEN TONGUE,7
GB,TENDONITIS,7
GB,TINNITUS,7
GB,ACUTE MYOCARDIAL INFARCTION,6
GB,BURNING SENSATION,6
GB,DIABETIC KETOACIDOSIS,6
GB,DRY EYE,6
GB,DYSARTHRIA,6
GB,DYSPHAGIA,6
GB,FAECES DISCOLOURED,6
GB,FLUSHING,6
GB,GASTROINTESTINAL DISORDER,6
GB,GASTROINTESTINAL MOTILITY DISORDER,6
GB,HEMIPARESIS,6
GB,HEPATITIS,6
GB,HYPOGLYCAEMIA,6
GB,HYPOPHAGIA,6
GB,HYPOTHYROIDISM,6
GB,HYPOXIA,6
GB,LOCAL SWELLING,6
GB,MUSCULOSKELETAL PAIN,6
GB,NIGHT SWEATS,6
GB,OESOPHAGITIS,6
GB,PAIN OF SKIN,6
GB,PALLOR,6
GB,PARANOIA,6
GB,PROTEINURIA,6
GB,SUBARACHNOID HAEMORRHAGE,6
GB,SUBDURAL HAEMORRHAGE,6
GB,TACHYCARDIA,6
GB,THROAT IRRITATION,6
GB,TOOTHACHE,6
GB,TUBULOINTERSTITIAL NEPHRITIS,6
GB,WHEEZING,6
GB,WHITE BLOOD CELL COUNT INCREASED,6
GB,WITHDRAWAL SYNDROME,6
GB,ABNORMAL LOSS OF WEIGHT,5
GB,ACUTE SINUSITIS,5
GB,ASTHMA,5
GB,BILE DUCT STENOSIS,5
GB,BREATH ODOUR,5
GB,C-REACTIVE PROTEIN INCREASED,5
GB,CEREBROVASCULAR ACCIDENT,5
GB,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,5
GB,CIRCULATORY COLLAPSE,5
GB,DEAFNESS UNILATERAL,5
GB,DEEP VEIN THROMBOSIS,5
GB,DELIRIUM,5
GB,ELECTROCARDIOGRAM T WAVE ABNORMAL,5
GB,ERYTHEMA,5
GB,HEPATIC PAIN,5
GB,HYPOMAGNESAEMIA,5
GB,LABILE HYPERTENSION,5
GB,LACTIC ACIDOSIS,5
GB,MELAENA,5
GB,NEUROPATHY PERIPHERAL,5
GB,OEDEMA,5
GB,ONYCHOCLASIS,5
GB,OSTEONECROSIS OF JAW,5
GB,OXYGEN SATURATION DECREASED,5
GB,PANCREATITIS,5
GB,PERITONITIS,5
GB,PSYCHIATRIC SYMPTOM,5
GB,RASH GENERALISED,5
GB,RASH PRURITIC,5
GB,RESPIRATORY DISORDER,5
GB,RETCHING,5
GB,TEARFULNESS,5
GB,TOOTH DISORDER,5
GB,ABNORMAL DREAMS,4
GB,ACUTE INTERSTITIAL PNEUMONITIS,4
GB,AMYLASE INCREASED,4
GB,ANAPHYLACTIC REACTION,4
GB,ANGIOEDEMA,4
GB,ANORGASMIA,4
GB,ASPARTATE AMINOTRANSFERASE INCREASED,4
GB,BLOOD LACTATE DEHYDROGENASE INCREASED,4
GB,COGNITIVE DISORDER,4
GB,COLD SWEAT,4
GB,CONVULSION,4
GB,DEAFNESS,4
GB,DISCOMFORT,4
GB,DRUG ERUPTION,4
GB,DRY SKIN,4
GB,ELECTROCARDIOGRAM QT PROLONGED,4
GB,EPISTAXIS,4
GB,GENERALISED TONIC-CLONIC SEIZURE,4
GB,HAEMATURIA,4
GB,HEPATIC FUNCTION ABNORMAL,4
GB,HYPERGLYCAEMIA,4
GB,HYPOACUSIS,4
GB,HYPOKALAEMIA,4
GB,HYPOMANIA,4
GB,INFLUENZA,4
GB,ISCHAEMIC STROKE,4
GB,LIBIDO DECREASED,4
GB,LOSS OF CONSCIOUSNESS,4
GB,LUNG NEOPLASM MALIGNANT,4
GB,MARITAL PROBLEM,4
GB,MORBID THOUGHTS,4
GB,MUSCLE ATROPHY,4
GB,MYOCARDIAL INFARCTION,4
GB,NEURALGIA,4
GB,OCULAR DISCOMFORT,4
GB,PANCREATIC CARCINOMA,4
GB,POTENTIATING DRUG INTERACTION,4
GB,PRODUCT QUALITY ISSUE,4
GB,PRURITUS GENERALISED,4
GB,PSORIASIS,4
GB,QUADRIPLEGIA,4
GB,RESPIRATORY FAILURE,4
GB,SCIATICA,4
GB,SHOCK SYMPTOM,4
GB,SPINAL CORD HAEMORRHAGE,4
GB,STEVENS-JOHNSON SYNDROME,4
GB,TENDON RUPTURE,4
GB,TRANSIENT ISCHAEMIC ATTACK,4
GB,TYPE 2 DIABETES MELLITUS,4
GB,ABNORMAL WEIGHT GAIN,3
GB,ACTIVITIES OF DAILY LIVING IMPAIRED,3
GB,APHASIA,3
GB,APHTHOUS ULCER,3
GB,BLOOD PRESSURE DIASTOLIC DECREASED,3
GB,BUNDLE BRANCH BLOCK RIGHT,3
GB,CALCIPHYLAXIS,3
GB,CARDIAC DISORDER,3
GB,CEREBRAL HAEMORRHAGE,3
GB,COMPARTMENT SYNDROME,3
GB,CRYING,3
GB,DIVERTICULUM,3
GB,DRUG DEPENDENCE,3
GB,DYSPHONIA,3
GB,DYSPNOEA EXERTIONAL,3
GB,EYE SWELLING,3
GB,FLATULENCE,3
GB,GASTRIC ULCER PERFORATION,3
GB,GASTRITIS,3
GB,GASTROENTERITIS NOROVIRUS,3
GB,HAEMORRHAGE,3
GB,HALLUCINATION_ VISUAL,3
GB,HYPONATRAEMIC SEIZURE,3
GB,IMMOBILE,3
GB,INAPPROPRIATE PRESCRIBING,3
GB,INCREASED TENDENCY TO BRUISE,3
GB,INTRACRANIAL PRESSURE INCREASED,3
GB,LEFT VENTRICULAR DYSFUNCTION,3
GB,LIMB DISCOMFORT,3
GB,MEMORY IMPAIRMENT,3
GB,METABOLIC ACIDOSIS,3
GB,MOOD ALTERED,3
GB,MOOD SWINGS,3
GB,MUSCULOSKELETAL STIFFNESS,3
GB,NASAL DRYNESS,3
GB,NASOPHARYNGITIS,3
GB,NEUROLEPTIC MALIGNANT SYNDROME,3
GB,NEUTROPENIC SEPSIS,3
GB,NEUTROPHIL COUNT INCREASED,3
GB,OEDEMA PERIPHERAL,3
GB,PERSONALITY CHANGE,3
GB,PHOBIA,3
GB,PRODUCT SUBSTITUTION ISSUE,3
GB,PULMONARY FIBROSIS,3
GB,RASH ERYTHEMATOUS,3
GB,RESPIRATORY TRACT INFECTION,3
GB,SELF-INJURIOUS IDEATION,3
GB,SEXUAL INHIBITION,3
GB,SKIN EXFOLIATION,3
GB,SKIN NECROSIS,3
GB,SMALL CELL LUNG CANCER METASTATIC,3
GB,STOMATITIS,3
GB,THROAT TIGHTNESS,3
GB,TROPONIN INCREASED,3
GB,UNEVALUABLE EVENT,3
GB,UROSEPSIS,3
GB,VIITH NERVE PARALYSIS,3
GB,ABDOMINAL PAIN LOWER,2
GB,ABORTION SPONTANEOUS,2
GB,ADVERSE EVENT,2
GB,AFFECTIVE DISORDER,2
GB,ANAL INCONTINENCE,2
GB,ANGER,2
GB,AORTIC RUPTURE,2
GB,ARTERIOSCLEROSIS,2
GB,ARTHRITIS,2
GB,ASTHMA LATE ONSET,2
GB,ATYPICAL FRACTURE,2
GB,BIPOLAR DISORDER,2
GB,BLADDER CANCER,2
GB,BLINDNESS,2
GB,BLOOD GLUCOSE INCREASED,2
GB,BONE PAIN,2
GB,BOWEN^S DISEASE,2
GB,BRUXISM,2
GB,CARDIAC ARREST,2
GB,CARTILAGE INJURY,2
GB,CHROMATURIA,2
GB,COLITIS MICROSCOPIC,2
GB,COORDINATION ABNORMAL,2
GB,CYSTOCELE,2
GB,DEMYELINATION,2
GB,DEPRESSED LEVEL OF CONSCIOUSNESS,2
GB,DIFFERENTIAL WHITE BLOOD CELL COUNT ABNORMAL,2
GB,DISORGANISED SPEECH,2
GB,DRUG DISPENSING ERROR,2
GB,DRUG EFFECT DECREASED,2
GB,DRUG HYPERSENSITIVITY,2
GB,DRUG PRESCRIBING ERROR,2
GB,DYSPEPSIA,2
GB,DYSURIA,2
GB,EATING DISORDER,2
GB,EMOTIONAL DISORDER,2
GB,EOSINOPHIL COUNT INCREASED,2
GB,EPILEPSY,2
GB,ESCHERICHIA SEPSIS,2
GB,EYE DISORDER,2
GB,EYE PRURITUS,2
GB,FACIAL PARALYSIS,2
GB,FEELING COLD,2
GB,FEMUR FRACTURE,2
GB,FINE MOTOR SKILL DYSFUNCTION,2
GB,GENITAL SWELLING,2
GB,GLASSY EYES,2
GB,HAEMATOMA,2
GB,HAEMOPTYSIS,2
GB,HEART RATE IRREGULAR,2
GB,HYPOCALCAEMIA,2
GB,HYPOTONIA,2
GB,INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION,2
GB,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,2
GB,INJECTION SITE PAIN,2
GB,INTERNATIONAL NORMALISED RATIO FLUCTUATION,2
GB,INTERSTITIAL LUNG DISEASE,2
GB,IRIDOCYCLITIS,2
GB,LACRIMATION INCREASED,2
GB,LICHEN PLANUS,2
GB,LOWER GASTROINTESTINAL HAEMORRHAGE,2
GB,MEDICATION ERROR,2
GB,MENTAL IMPAIRMENT,2
GB,MOTOR NEURONE DISEASE,2
GB,MOUTH SWELLING,2
GB,MUCOSAL INFLAMMATION,2
GB,MUSCULOSKELETAL CHEST PAIN,2
GB,MYELODYSPLASTIC SYNDROME,2
GB,MYOCARDIAL ISCHAEMIA,2
GB,MYOCLONUS,2
GB,OEDEMA MOUTH,2
GB,ORAL CANDIDIASIS,2
GB,ORAL MUCOSAL EXFOLIATION,2
GB,ORAL PAIN,2
GB,PANIC ATTACK,2
GB,PAPILLOEDEMA,2
GB,PAROSMIA,2
GB,PERIPHERAL ARTERY THROMBOSIS,2
GB,PERIPHERAL SENSORIMOTOR NEUROPATHY,2
GB,POLLAKIURIA,2
GB,POST PROCEDURAL HAEMORRHAGE,2
GB,PRURITUS GENITAL,2
GB,PSYCHOTIC DISORDER,2
GB,PULMONARY PAIN,2
GB,PULSE ABNORMAL,2
GB,PULSELESS ELECTRICAL ACTIVITY,2
GB,RASH MACULAR,2
GB,RASH MACULO-PAPULAR,2
GB,REACTION TO DRUG EXCIPIENTS,2
GB,RESPIRATORY RATE DECREASED,2
GB,RHEUMATOID ARTHRITIS,2
GB,SALIVARY HYPERSECRETION,2
GB,SEROTONIN SYNDROME,2
GB,SKIN ABRASION,2
GB,SKIN INFECTION,2
GB,SNEEZING,2
GB,SNORING,2
GB,STAPHYLOCOCCAL INFECTION,2
GB,STARING,2
GB,SUICIDE ATTEMPT,2
GB,SUPRAVENTRICULAR TACHYCARDIA,2
GB,SWELLING,2
GB,TACHYPNOEA,2
GB,TARDIVE DYSKINESIA,2
GB,TEMPORAL ARTERITIS,2
GB,UPPER RESPIRATORY TRACT INFECTION,2
GB,VISUAL ACUITY REDUCED,2
GB,VULVAL DISORDER,2
GB,WOUND SECRETION,2
GB,ABASIA,1
GB,ABDOMINAL INFECTION,1
GB,ABDOMINAL LYMPHADENOPATHY,1
GB,ABDOMINAL SEPSIS,1
GB,ACCIDENTAL OVERDOSE,1
GB,ACUTE MOTOR-SENSORY AXONAL NEUROPATHY,1
GB,ACUTE MYELOID LEUKAEMIA,1
GB,ACUTE PULMONARY OEDEMA,1
GB,ADRENAL DISORDER,1
GB,AGORAPHOBIA,1
GB,ALLERGIC COUGH,1
GB,ALLERGIC OEDEMA,1
GB,ALTERED STATE OF CONSCIOUSNESS,1
GB,AMENORRHOEA,1
GB,ANAPHYLACTIC SHOCK,1
GB,ANGINA PECTORIS,1
GB,ANGIOPATHY,1
GB,ANGLE CLOSURE GLAUCOMA,1
GB,ANTINEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE,1
GB,ANTIPHOSPHOLIPID ANTIBODIES POSITIVE,1
GB,AORTIC ANEURYSM RUPTURE,1
GB,AORTIC VALVE DISEASE,1
GB,APPENDICITIS PERFORATED,1
GB,APPETITE DISORDER,1
GB,APPLICATION SITE PAIN,1
GB,APPLICATION SITE PARAESTHESIA,1
GB,ARRHYTHMIA,1
GB,ARTHRITIS BACTERIAL,1
GB,ARTHROPATHY,1
GB,ASPIRATION,1
GB,ATRIAL FLUTTER,1
GB,ATRIOVENTRICULAR BLOCK COMPLETE,1
GB,ATYPICAL FEMUR FRACTURE,1
GB,AUTOIMMUNE PANCREATITIS,1
GB,AUTOPHONY,1
GB,BABINSKI REFLEX TEST,1
GB,BASAL CELL CARCINOMA,1
GB,BASAL GANGLIA INFARCTION,1
GB,BENIGN PROSTATIC HYPERPLASIA,1
GB,BLADDER NEOPLASM,1
GB,BLOOD ALKALINE PHOSPHATASE ABNORMAL,1
GB,BLOOD CHOLESTEROL INCREASED,1
GB,BLOOD CREATINE INCREASED,1
GB,BLOOD DISORDER,1
GB,BLOOD ELECTROLYTES ABNORMAL,1
GB,BLOOD PHOSPHORUS DECREASED,1
GB,BLOOD POTASSIUM DECREASED,1
GB,BLOOD POTASSIUM INCREASED,1
GB,BLOOD UREA ABNORMAL,1
GB,BLOOD UREA INCREASED,1
GB,BODY MASS INDEX DECREASED,1
GB,BODY TEMPERATURE INCREASED,1
GB,BRAIN HERNIATION,1
GB,BRAIN OEDEMA,1
GB,BREAST DISCOMFORT,1
GB,BRONCHOPNEUMONIA,1
GB,BUNDLE BRANCH BLOCK LEFT,1
GB,BURSITIS,1
GB,CALCULUS URETERIC,1
GB,CANDIDA INFECTION,1
GB,CARDIAC FAILURE CONGESTIVE,1
GB,CARDIAC MURMUR,1
GB,CAROTID ARTERY STENOSIS,1
GB,CELLS IN URINE,1
GB,CEREBELLAR INFARCTION,1
GB,CEREBRAL VENTRICLE DILATATION,1
GB,CERVICOGENIC HEADACHE,1
GB,CHANGE OF BOWEL HABIT,1
GB,CHEST CRUSHING,1
GB,CHOKING,1
GB,CHOKING SENSATION,1
GB,CHOLANGITIS,1
GB,CHOLECYSTITIS,1
GB,CHROMATOPSIA,1
GB,CHRONIC KIDNEY DISEASE,1
GB,CLAUDICATION OF JAW MUSCLES,1
GB,CLOSTRIDIUM DIFFICILE INFECTION,1
GB,COELIAC DISEASE,1
GB,COLITIS,1
GB,COLOSTOMY,1
GB,CONJUNCTIVAL HAEMORRHAGE,1
GB,CONSCIOUSNESS FLUCTUATING,1
GB,CONTRAINDICATED PRODUCT ADMINISTERED,1
GB,CORONARY ARTERY EMBOLISM,1
GB,CUSHING^S SYNDROME,1
GB,CYANOSIS,1
GB,CYSTITIS,1
GB,DEFAECATION URGENCY,1
GB,DEMENTIA,1
GB,DEREALISATION,1
GB,DEVICE DEPLOYMENT ISSUE,1
GB,DIABETIC RETINOPATHY,1
GB,DISCOLOURED VOMIT,1
GB,DISEASE PROGRESSION,1
GB,DISSOCIATION,1
GB,DISTURBANCE IN SEXUAL AROUSAL,1
GB,DIVERTICULITIS,1
GB,DIVERTICULUM INTESTINAL HAEMORRHAGIC,1
GB,DRAIN PLACEMENT,1
GB,DRUG ADMINISTERED AT INAPPROPRIATE SITE,1
GB,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,1
GB,DRUG INTOLERANCE,1
GB,DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS,1
GB,DRUG RESISTANCE,1
GB,DRUG-INDUCED LIVER INJURY,1
GB,DRY LUNG SYNDROME,1
GB,DUODENAL ULCER PERFORATION,1
GB,DYSGRAPHIA,1
GB,DYSMENORRHOEA,1
GB,DYSSTASIA,1
GB,EAR CONGESTION,1
GB,EAR DISCOMFORT,1
GB,EAR PAIN,1
GB,EJACULATION DISORDER,1
GB,ELECTROCARDIOGRAM T WAVE INVERSION,1
GB,EMBOLISM VENOUS,1
GB,EMOTIONAL DISTRESS,1
GB,ENCEPHALOCELE,1
GB,ENDOCARDITIS,1
GB,ENDOCRINE HYPERTENSION,1
GB,ENDOMETRIAL ADENOCARCINOMA,1
GB,ENDOMETRIOSIS,1
GB,ENTERITIS,1
GB,ERECTILE DYSFUNCTION,1
GB,ERUCTATION,1
GB,ESCHERICHIA URINARY TRACT INFECTION,1
GB,ESSENTIAL HYPERTENSION,1
GB,EXFOLIATIVE RASH,1
GB,EXTRA DOSE ADMINISTERED,1
GB,EYE IRRITATION,1
GB,EYELID PTOSIS,1
GB,FACIAL ASYMMETRY,1
GB,FACIAL PARESIS,1
GB,FAECALOMA,1
GB,FEBRILE NEUTROPENIA,1
GB,FEELING DRUNK,1
GB,FEELING HOT,1
GB,FEELING OF BODY TEMPERATURE CHANGE,1
GB,FIBROMYALGIA,1
GB,FIBULA FRACTURE,1
GB,FOCAL DYSCOGNITIVE SEIZURES,1
GB,FOOD CRAVING,1
GB,FOOD INTERACTION,1
GB,FOREIGN BODY SENSATION IN EYES,1
GB,FRACTURE,1
GB,FREQUENT BOWEL MOVEMENTS,1
GB,FURUNCLE,1
GB,GAMMA-GLUTAMYLTRANSFERASE INCREASED,1
GB,GASTRIC BYPASS,1
GB,GASTRIC DILATATION,1
GB,GASTROENTERITIS,1
GB,GASTROINTESTINAL CARCINOMA,1
GB,GASTROINTESTINAL PAIN,1
GB,GASTROOESOPHAGEAL REFLUX DISEASE,1
GB,GENERAL PHYSICAL CONDITION ABNORMAL,1
GB,GENERALISED ANXIETY DISORDER,1
GB,GINGIVAL SWELLING,1
GB,GLUCOSE TOLERANCE IMPAIRED,1
GB,GOUT,1
GB,HAEMANGIOMA OF SKIN,1
GB,HAEMARTHROSIS,1
GB,HAEMORRHAGIC STROKE,1
GB,HAEMORRHOIDS,1
GB,HAIR GROWTH ABNORMAL,1
GB,HALLUCINATION_ AUDITORY,1
GB,HALLUCINATIONS_ MIXED,1
GB,HANGOVER,1
GB,HEAD INJURY,1
GB,HEMIPLEGIA,1
GB,HEPATIC FAILURE,1
GB,HEPATIC FIBROSIS,1
GB,HEPATIC STEATOSIS,1
GB,HEPATITIS CHOLESTATIC,1
GB,HEPATITIS E,1
GB,HEPATOTOXICITY,1
GB,HERPES ZOSTER,1
GB,HORMONE REPLACEMENT THERAPY,1
GB,HOT FLUSH,1
GB,HYDROCEPHALUS,1
GB,HYDROSALPINX,1
GB,HYPERCALCAEMIA,1
GB,HYPERLIPIDAEMIA,1
GB,HYPERNATRAEMIA,1
GB,HYPEROSMOLAR HYPERGLYCAEMIC STATE,1
GB,HYPERTENSIVE CRISIS,1
GB,HYPERTHYROIDISM,1
GB,HYPERTONIA,1
GB,HYPERTONIC BLADDER,1
GB,HYPOAESTHESIA ORAL,1
GB,HYPOKINESIA,1
GB,HYPOVOLAEMIA,1
GB,HYSTERECTOMY,1
GB,IDIOSYNCRATIC DRUG REACTION,1
GB,ILIOTIBIAL BAND SYNDROME,1
GB,IMPAIRED GASTRIC EMPTYING,1
GB,IMPLANT SITE BRUISING,1
GB,INCORRECT DOSE ADMINISTERED,1
GB,INCORRECT DRUG ADMINISTRATION DURATION,1
GB,INCREASED APPETITE,1
GB,INFECTIVE EXACERBATION OF CHRONIC OBSTRUCTIVE AIRWAYS DISEASE,1
GB,INFLAMMATORY MARKER INCREASED,1
GB,INFLUENZA LIKE ILLNESS,1
GB,INJECTION SITE ERYTHEMA,1
GB,INJECTION SITE HAEMORRHAGE,1
GB,INJECTION SITE INDURATION,1
GB,INJECTION SITE RASH,1
GB,INJECTION SITE REACTION,1
GB,INJECTION SITE SWELLING,1
GB,INJECTION SITE ULCER,1
GB,INJECTION SITE WARMTH,1
GB,INTENTIONAL OVERDOSE,1
GB,INTESTINAL OBSTRUCTION,1
GB,INTESTINAL PERFORATION,1
GB,INTRACRANIAL MASS,1
GB,INTRAOCULAR PRESSURE INCREASED,1
GB,INTRAVENTRICULAR HAEMORRHAGE,1
GB,INVESTIGATION,1
GB,IRIS ADHESIONS,1
GB,IRIS DISORDER,1
GB,IRRITABLE BOWEL SYNDROME,1
GB,JAUNDICE CHOLESTATIC,1
GB,JESSNER^S LYMPHOCYTIC INFILTRATION,1
GB,JOINT LOCK,1
GB,KIDNEY ENLARGEMENT,1
GB,KIDNEY INFECTION,1
GB,LABILE BLOOD PRESSURE,1
GB,LABYRINTHINE FISTULA,1
GB,LARGE INTESTINE POLYP,1
GB,LEARNING DISORDER,1
GB,LICHEN SCLEROSUS,1
GB,LIMB ASYMMETRY,1
GB,LIMB MASS,1
GB,LIP BLISTER,1
GB,LIP DISCOLOURATION,1
GB,LIP DISORDER,1
GB,LIP PAIN,1
GB,LIP SWELLING,1
GB,LIVER ABSCESS,1
GB,LIVER DISORDER,1
GB,LIVER FUNCTION TEST INCREASED,1
GB,LIVER INJURY,1
GB,LOCALISED OEDEMA,1
GB,LONG QT SYNDROME,1
GB,LOOSE TOOTH,1
GB,LUNG INFECTION,1
GB,LUPUS-LIKE SYNDROME,1
GB,LYMPH NODE PALPABLE,1
GB,LYMPHANGITIS,1
GB,LYMPHOMA,1
GB,MALIGNANT NEOPLASM OF UNKNOWN PRIMARY SITE,1
GB,MALIGNANT NEOPLASM PROGRESSION,1
GB,MASS,1
GB,MEDICAL DEVICE COMPLICATION,1
GB,MEDICAL DEVICE REMOVAL,1
GB,MENORRHAGIA,1
GB,METASTASES TO BONE,1
GB,METASTASES TO KIDNEY,1
GB,METASTASES TO LIVER,1
GB,METASTASES TO LUNG,1
GB,METASTASIS,1
GB,METASTATIC MALIGNANT MELANOMA,1
GB,MICTURITION URGENCY,1
GB,MIDDLE INSOMNIA,1
GB,MIOSIS,1
GB,MOBILITY DECREASED,1
GB,MUSCLE RIGIDITY,1
GB,MYELOFIBROSIS,1
GB,MYELOPATHY,1
GB,MYOCARDITIS,1
GB,NARCOLEPSY,1
GB,NASAL CONGESTION,1
GB,NEGATIVE THOUGHTS,1
GB,NEPHRITIS,1
GB,NEPHROGENIC DIABETES INSIPIDUS,1
GB,NEPHROLITHIASIS,1
GB,NEPHROPATHY,1
GB,NERVOUSNESS,1
GB,NIPPLE PAIN,1
GB,NITRITE URINE,1
GB,NOCTURIA,1
GB,NODULE,1
GB,NUCLEAR MAGNETIC RESONANCE IMAGING SPINAL ABNORMAL,1
GB,NYSTAGMUS,1
GB,OCULAR HYPERAEMIA,1
GB,OCULOGYRIC CRISIS,1
GB,OESOPHAGEAL CARCINOMA,1
GB,OESOPHAGEAL PERFORATION,1
GB,OESOPHAGEAL STENT INSERTION,1
GB,OESOPHAGEAL ULCER,1
GB,ORAL MUCOSAL BLISTERING,1
GB,OROPHARYNGEAL PAIN,1
GB,ORTHOPNOEA,1
GB,OSTEOARTHRITIS,1
GB,OSTEOPOROSIS,1
GB,OVARIAN CYST,1
GB,OVARIAN EPITHELIAL CANCER,1
GB,OXYGEN SATURATION ABNORMAL,1
GB,PAIN IN JAW,1
GB,PANCREATIC CARCINOMA METASTATIC,1
GB,PANCREATIC DISORDER,1
GB,PANCREATIC MASS,1
GB,PANCREATITIS CHRONIC,1
GB,PATHOLOGICAL FRACTURE,1
GB,PEAK EXPIRATORY FLOW RATE DECREASED,1
GB,PELVIC MASS,1
GB,PENILE SIZE REDUCED,1
GB,PERICARDIAL HAEMORRHAGE,1
GB,PERIPHERAL COLDNESS,1
GB,PERIPHERAL SENSORY NEUROPATHY,1
GB,PERITONEAL DIALYSIS COMPLICATION,1
GB,PERITONITIS BACTERIAL,1
GB,PHOTOPHOBIA,1
GB,PIGMENTATION DISORDER,1
GB,PLATELET COUNT INCREASED,1
GB,PLEOMORPHIC ADENOMA,1
GB,PLEURAL EFFUSION,1
GB,PLEURISY,1
GB,POLYMYALGIA RHEUMATICA,1
GB,POST PROCEDURAL INFECTION,1
GB,POST STROKE SEIZURE,1
GB,POST VIRAL FATIGUE SYNDROME,1
GB,POSTOPERATIVE WOUND INFECTION,1
GB,PROCEDURAL HAEMORRHAGE,1
GB,PRODUCT COLOUR ISSUE,1
GB,PRODUCT PACKAGING CONFUSION,1
GB,PRODUCT USE IN UNAPPROVED INDICATION,1
GB,PRODUCT USE ISSUE,1
GB,PRODUCTIVE COUGH,1
GB,PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY,1
GB,PROLAPSE REPAIR,1
GB,PROSTATOMEGALY,1
GB,PSEUDOPOLYPOSIS,1
GB,PUBIS FRACTURE,1
GB,PULMONARY MASS,1
GB,PULMONARY OEDEMA,1
GB,PUPILLARY REFLEX IMPAIRED,1
GB,PYELONEPHRITIS,1
GB,RASH VESICULAR,1
GB,RED MAN SYNDROME,1
GB,RENAL PAIN,1
GB,RESTLESS LEGS SYNDROME,1
GB,RETINOPATHY,1
GB,REVERSED HOT-COLD SENSATION,1
GB,SALIVARY GLAND ADENOMA,1
GB,SCALLOPED TONGUE,1
GB,SCLERAL DISCOLOURATION,1
GB,SCLERODERMA-LIKE REACTION,1
GB,SEASONAL ALLERGY,1
GB,SEDATION,1
GB,SEIZURE CLUSTER,1
GB,SENSATION OF FOREIGN BODY,1
GB,SEVERE ACUTE RESPIRATORY SYNDROME,1
GB,SINUS HEADACHE,1
GB,SJOGREN^S SYNDROME,1
GB,SKIN BURNING SENSATION,1
GB,SKIN DISCOLOURATION,1
GB,SKIN PLAQUE,1
GB,SLEEP APNOEA SYNDROME,1
GB,SLEEP TERROR,1
GB,SMALL INTESTINAL OBSTRUCTION,1
GB,SPINAL COLUMN STENOSIS,1
GB,SPINAL FRACTURE,1
GB,SPUTUM CULTURE POSITIVE,1
GB,SPUTUM DISCOLOURED,1
GB,SQUAMOUS CELL CARCINOMA,1
GB,STREPTOCOCCAL URINARY TRACT INFECTION,1
GB,STRESS CARDIOMYOPATHY,1
GB,STRIDOR,1
GB,SUDDEN DEATH,1
GB,SUSPICIOUSNESS,1
GB,TACHYPHRENIA,1
GB,TENDERNESS,1
GB,THERAPEUTIC PRODUCT INEFFECTIVE,1
GB,THERMAL BURN,1
GB,THIRST,1
GB,THROMBOSIS,1
GB,THYROID CANCER,1
GB,THYROIDITIS,1
GB,TONGUE BITING,1
GB,TONGUE DISCOLOURATION,1
GB,TONGUE DRY,1
GB,TONGUE OEDEMA,1
GB,TOOTH ABSCESS,1
GB,TOOTH INFECTION,1
GB,TOOTH LOSS,1
GB,TORSADE DE POINTES,1
GB,TRANSAMINASES INCREASED,1
GB,TRICHORRHEXIS,1
GB,TYPE 1 DIABETES MELLITUS,1
GB,UNINTENDED PREGNANCY,1
GB,UPPER GASTROINTESTINAL HAEMORRHAGE,1
GB,UPPER-AIRWAY COUGH SYNDROME,1
GB,URETHRAL CARUNCLE,1
GB,URETHRAL PAIN,1
GB,URINARY BLADDER HAEMORRHAGE,1
GB,URINARY RETENTION,1
GB,VARICES OESOPHAGEAL,1
GB,VASCULAR STENT THROMBOSIS,1
GB,VASCULITIC RASH,1
GB,VASODILATATION,1
GB,VENTRICULAR FIBRILLATION,1
GB,VIOLENCE-RELATED SYMPTOM,1
GB,VIRAL UPPER RESPIRATORY TRACT INFECTION,1
GB,VISUAL BRIGHTNESS,1
GB,VISUAL FIELD DEFECT,1
GB,VULVOVAGINAL DRYNESS,1
GB,VULVOVAGINAL RASH,1
GB,WEIGHT BEARING DIFFICULTY,1
GB,WRONG TECHNIQUE IN DRUG USAGE PROCESS,1
US,FATIGUE,5687
US,DRUG INEFFECTIVE,5677
US,NAUSEA,4643
US,DIARRHOEA,4033
US,HEADACHE,3847
US,PAIN,3352
US,DIZZINESS,3165
US,DYSPNOEA,3021
US,MALAISE,2872
US,ASTHENIA,2606
US,FALL,2436
US,ARTHRALGIA,2397
US,FEELING ABNORMAL,2257
US,INSOMNIA,2208
US,PAIN IN EXTREMITY,2112
US,RASH,2086
US,WEIGHT DECREASED,2023
US,VOMITING,1999
US,ANXIETY,1956
US,WEIGHT INCREASED,1955
US,ALOPECIA,1914
US,DRUG DOSE OMISSION,1914
US,PRURITUS,1834
US,BACK PAIN,1710
US,CONSTIPATION,1645
US,COUGH,1619
US,DEPRESSION,1612
US,PNEUMONIA,1611
US,MUSCLE SPASMS,1513
US,GAIT DISTURBANCE,1356
US,HYPERTENSION,1356
US,DECREASED APPETITE,1341
US,DEATH,1339
US,ABDOMINAL PAIN UPPER,1271
US,URINARY TRACT INFECTION,1253
US,INJECTION SITE PAIN,1248
US,CHEST PAIN,1214
US,PRODUCT QUALITY ISSUE,1206
US,ABDOMINAL PAIN,1192
US,PYREXIA,1175
US,PALPITATIONS,1122
US,ABDOMINAL DISCOMFORT,1113
US,TREMOR,1100
US,ANAEMIA,1092
US,MYALGIA,1086
US,SOMNOLENCE,1082
US,PERIPHERAL SWELLING,1069
US,PRODUCT USE ISSUE,1063
US,PARAESTHESIA,1034
US,HYPOAESTHESIA,1031
US,CONDITION AGGRAVATED,1030
US,HYPERSENSITIVITY,996
US,DRUG HYPERSENSITIVITY,986
US,BLOOD PRESSURE INCREASED,980
US,SINUSITIS,973
US,NASOPHARYNGITIS,942
US,GASTROOESOPHAGEAL REFLUX DISEASE,913
US,INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION,908
US,DEHYDRATION,884
US,MEMORY IMPAIRMENT,883
US,URTICARIA,857
US,DYSPEPSIA,839
US,MUSCULAR WEAKNESS,833
US,CONTUSION,822
US,VISION BLURRED,822
US,ERYTHEMA,820
US,GASTROINTESTINAL HAEMORRHAGE,807
US,BLOOD GLUCOSE INCREASED,805
US,HYPERHIDROSIS,803
US,INCORRECT DOSE ADMINISTERED,802
US,ABDOMINAL DISTENSION,792
US,BALANCE DISORDER,771
US,OEDEMA PERIPHERAL,771
US,CONFUSIONAL STATE,768
US,HYPOTENSION,760
US,HYPOTHYROIDISM,750
US,BRONCHITIS,720
US,DYSGEUSIA,708
US,HEART RATE INCREASED,707
US,ARTHRITIS,703
US,OROPHARYNGEAL PAIN,703
US,JOINT SWELLING,690
US,DRY MOUTH,679
US,FLUSHING,672
US,ATRIAL FIBRILLATION,671
US,DYSPHAGIA,665
US,CEREBROVASCULAR ACCIDENT,664
US,BLOOD THYROID STIMULATING HORMONE INCREASED,654
US,CHILLS,632
US,PULMONARY EMBOLISM,619
US,CHEST DISCOMFORT,614
US,NEUROPATHY PERIPHERAL,610
US,MIGRAINE,601
US,VISUAL IMPAIRMENT,598
US,DRY SKIN,587
US,INTENTIONAL PRODUCT MISUSE,581
US,INJECTION SITE ERYTHEMA,578
US,UNEVALUABLE EVENT,578
US,INFLUENZA,576
US,HOT FLUSH,562
US,WHITE BLOOD CELL COUNT DECREASED,561
US,HAEMOGLOBIN DECREASED,556
US,DYSPHONIA,553
US,WRONG TECHNIQUE IN PRODUCT USAGE PROCESS,549
US,DEEP VEIN THROMBOSIS,543
US,THERAPEUTIC RESPONSE UNEXPECTED,538
US,OSTEOARTHRITIS,537
US,CARDIAC FAILURE CONGESTIVE,536
US,PSORIASIS,523
US,MYOCARDIAL INFARCTION,520
US,EPISTAXIS,517
US,LOSS OF CONSCIOUSNESS,512
US,NERVOUSNESS,511
US,DRUG EFFECT DECREASED,510
US,MUSCULOSKELETAL PAIN,509
US,RHEUMATOID ARTHRITIS,506
US,INFLUENZA LIKE ILLNESS,503
US,SWELLING,497
US,ASTHMA,495
US,SYNCOPE,493
US,INJECTION SITE BRUISING,484
US,INJURY,476
US,NECK PAIN,476
US,BURNING SENSATION,473
US,INFECTION,466
US,CATARACT,464
US,DRUG INTOLERANCE,455
US,FLATULENCE,452
US,MUSCULOSKELETAL STIFFNESS,452
US,FLUID RETENTION,439
US,PLATELET COUNT DECREASED,438
US,STOMATITIS,437
US,HAEMORRHAGE,436
US,BLOOD CHOLESTEROL INCREASED,429
US,OSTEOPOROSIS,416
US,THROMBOSIS,413
US,RENAL FAILURE,409
US,VERTIGO,409
US,ADVERSE EVENT,403
US,DIABETES MELLITUS,403
US,FEELING HOT,403
US,AMNESIA,399
US,CHRONIC OBSTRUCTIVE PULMONARY DISEASE,398
US,UPPER RESPIRATORY TRACT INFECTION,398
US,CELLULITIS,397
US,DRUG EFFECT INCOMPLETE,397
US,NASAL CONGESTION,396
US,SWELLING FACE,395
US,BONE PAIN,394
US,SEPSIS,387
US,IRRITABILITY,384
US,ARTHROPATHY,383
US,FEMUR FRACTURE,381
US,SEIZURE,381
US,LETHARGY,380
US,STRESS,380
US,DISEASE PROGRESSION,379
US,RHINORRHOEA,376
US,ADVERSE DRUG REACTION,374
US,ACUTE KIDNEY INJURY,373
US,OEDEMA,373
US,THYROID DISORDER,360
US,CARDIAC DISORDER,358
US,OVERDOSE,354
US,POLLAKIURIA,354
US,SLEEP DISORDER,348
US,RASH PRURITIC,347
US,DRY EYE,338
US,HERPES ZOSTER,335
US,THYROID FUNCTION TEST ABNORMAL,329
US,INCORRECT DRUG ADMINISTRATION DURATION,328
US,DISTURBANCE IN ATTENTION,326
US,BLISTER,322
US,INJECTION SITE HAEMORRHAGE,322
US,GASTROINTESTINAL DISORDER,320
US,LOCAL SWELLING,320
US,MOBILITY DECREASED,320
US,INJECTION SITE PRURITUS,319
US,UNDERDOSE,313
US,WRONG TECHNIQUE IN DRUG USAGE PROCESS,311
US,BLOOD THYROID STIMULATING HORMONE DECREASED,309
US,PLEURAL EFFUSION,309
US,EYE PAIN,306
US,COELIAC DISEASE,304
US,EMOTIONAL DISTRESS,304
US,INTENTIONAL PRODUCT USE ISSUE,304
US,MULTIPLE SCLEROSIS RELAPSE,304
US,THROAT IRRITATION,296
US,RECTAL HAEMORRHAGE,295
US,WHEEZING,294
US,AGITATION,292
US,MALIGNANT NEOPLASM PROGRESSION,292
US,DRUG WITHDRAWAL SYNDROME,288
US,SUICIDAL IDEATION,288
US,HALLUCINATION,284
US,NEPHROLITHIASIS,284
US,PRODUCT USE IN UNAPPROVED INDICATION,282
US,EYE IRRITATION,280
US,CYSTITIS,279
US,FEELING JITTERY,279
US,HEPATIC ENZYME INCREASED,277
US,CRYING,275
US,TINNITUS,275
US,ORAL PAIN,274
US,BLOOD GLUCOSE DECREASED,272
US,ROAD TRAFFIC ACCIDENT,272
US,THROMBOCYTOPENIA,272
US,NIGHT SWEATS,271
US,RESPIRATORY FAILURE,271
US,TACHYCARDIA,271
US,DEPRESSED MOOD,270
US,SKIN EXFOLIATION,269
US,THERAPY CESSATION,269
US,SKIN DISCOLOURATION,268
US,VAGINAL HAEMORRHAGE,267
US,BLOOD PRESSURE DECREASED,266
US,GASTRIC DISORDER,266
US,DRUG ADMINISTRATION ERROR,265
US,SLEEP APNOEA SYNDROME,264
US,FIBROMYALGIA,263
US,INTERVERTEBRAL DISC PROTRUSION,262
US,EYE SWELLING,260
US,HOSPITALISATION,259
US,BLOOD POTASSIUM DECREASED,255
US,PRODUCTIVE COUGH,255
US,ACTIVITIES OF DAILY LIVING IMPAIRED,253
US,SPEECH DISORDER,253
US,INJECTION SITE REACTION,251
US,INJECTION SITE SWELLING,251
US,BODY HEIGHT DECREASED,250
US,DRUG INEFFECTIVE FOR UNAPPROVED INDICATION,250
US,BLOOD CREATININE INCREASED,246
US,BREAST CANCER,246
US,HIP FRACTURE,246
US,DISCOMFORT,245
US,DYSURIA,244
US,GENERAL PHYSICAL HEALTH DETERIORATION,244
US,VITAMIN D DEFICIENCY,243
US,DYSPNOEA EXERTIONAL,241
US,PRURITUS GENERALISED,241
US,FEELING COLD,236
US,FOOT FRACTURE,235
US,TRANSIENT ISCHAEMIC ATTACK,234
US,ABASIA,233
US,IMPAIRED HEALING,233
US,LIMB DISCOMFORT,233
US,PAIN IN JAW,232
US,NO ADVERSE EVENT,231
US,FUNGAL INFECTION,228
US,HAEMORRHOIDS,224
US,OSTEOPENIA,222
US,OCULAR HYPERAEMIA,221
US,HAEMATOCHEZIA,219
US,DEVICE ISSUE,218
US,PANIC ATTACK,218
US,PRODUCT SUBSTITUTION ISSUE,217
US,SWOLLEN TONGUE,217
US,SURGERY,216
US,CHOLELITHIASIS,215
US,SKIN DISORDER,215
US,HEAD INJURY,213
US,NEUTROPENIA,213
US,HYPERSOMNIA,211
US,PRE-EXISTING CONDITION IMPROVED,211
US,THERAPEUTIC RESPONSE DECREASED,211
US,TOOTH DISORDER,211
US,URINARY INCONTINENCE,211
US,RIB FRACTURE,210
US,BLOOD THYROID STIMULATING HORMONE ABNORMAL,209
US,RASH GENERALISED,209
US,GASTRITIS,207
US,HYPONATRAEMIA,207
US,DEVICE MALFUNCTION,206
US,DIVERTICULITIS,206
US,VISUAL ACUITY REDUCED,205
US,PLASMA CELL MYELOMA,202
US,APPLICATION SITE ERYTHEMA,200
US,BONE DISORDER,200
US,LYMPHADENOPATHY,200
US,CONVULSION,199
US,HAEMATURIA,198
US,HYPERTHYROIDISM,198
US,RASH ERYTHEMATOUS,198
US,IRRITABLE BOWEL SYNDROME,197
US,DISORIENTATION,195
US,EXPIRED PRODUCT ADMINISTERED,195
US,LIP SWELLING,195
US,HAEMORRHAGIC ANAEMIA,194
US,STAPHYLOCOCCAL INFECTION,194
US,RENAL IMPAIRMENT,193
US,INTERVERTEBRAL DISC DEGENERATION,192
US,RENAL DISORDER,192
US,SINUS DISORDER,192
US,ACNE,191
US,JOINT STIFFNESS,191
US,SPINAL OSTEOARTHRITIS,191
US,HAIR TEXTURE ABNORMAL,190
US,HEART RATE DECREASED,189
US,LABORATORY TEST ABNORMAL,189
US,MUSCULOSKELETAL DISCOMFORT,189
US,HYPOACUSIS,188
US,HYPOKALAEMIA,187
US,WHITE BLOOD CELL COUNT INCREASED,187
US,LACRIMATION INCREASED,186
US,PANCREATITIS,186
US,ARRHYTHMIA,181
US,COGNITIVE DISORDER,180
US,FULL BLOOD COUNT DECREASED,179
US,JOINT INJURY,179
US,RED BLOOD CELL COUNT DECREASED,179
US,DYSSTASIA,177
US,HEART RATE IRREGULAR,177
US,LACERATION,177
US,EYE DISORDER,176
US,MENTAL STATUS CHANGES,176
US,CARDIAC ARREST,175
US,HIATUS HERNIA,175
US,CLOSTRIDIUM DIFFICILE INFECTION,174
US,DEVICE DISLOCATION,173
US,HYPERLIPIDAEMIA,173
US,POOR QUALITY SLEEP,173
US,CARPAL TUNNEL SYNDROME,171
US,ROTATOR CUFF SYNDROME,171
US,WITHDRAWAL SYNDROME,170
US,TYPE 2 DIABETES MELLITUS,169
US,ANGER,168
US,PULMONARY OEDEMA,168
US,RESTLESS LEGS SYNDROME,168
US,DRUG PRESCRIBING ERROR,167
US,LUNG DISORDER,167
US,THROAT TIGHTNESS,167
US,CROHN^S DISEASE,166
US,UPPER LIMB FRACTURE,166
US,APPLICATION SITE PRURITUS,165
US,CORONARY ARTERY DISEASE,165
US,SKIN BURNING SENSATION,165
US,RETCHING,164
US,CARDIAC FAILURE,163
US,MULTIPLE SCLEROSIS,163
US,RASH MACULAR,163
US,VIRAL INFECTION,162
US,COAGULOPATHY,161
US,TOXICITY TO VARIOUS AGENTS,161
US,EYE PRURITUS,160
US,MENTAL DISORDER,160
US,PHARYNGEAL OEDEMA,160
US,GLOSSODYNIA,159
US,MALABSORPTION,159
US,PRODUCT ADHESION ISSUE,159
US,SKIN ULCER,159
US,URINARY RETENTION,159
US,BURSITIS,158
US,DYSARTHRIA,158
US,INFLAMMATION,158
US,INJECTION SITE MASS,158
US,DYSKINESIA,157
US,HYPOGLYCAEMIA,157
US,LIMB INJURY,157
US,LOW TURNOVER OSTEOPATHY,157
US,RENAL FAILURE ACUTE,156
US,MOOD SWINGS,155
US,NEURALGIA,155
US,PRODUCT PHYSICAL ISSUE,154
US,EAR INFECTION,153
US,EAR PAIN,153
US,EXPOSURE DURING PREGNANCY,153
US,PANCYTOPENIA,153
US,TREATMENT NONCOMPLIANCE,153
US,APHASIA,152
US,MEDICATION ERROR,152
US,MENTAL IMPAIRMENT,151
US,NIGHTMARE,151
US,GALLBLADDER DISORDER,150
US,INTENTIONAL DRUG MISUSE,150
US,PULMONARY MASS,149
US,DENTAL CARIES,148
US,OSTEONECROSIS OF JAW,148
US,RESTLESSNESS,148
US,VITAMIN D DECREASED,148
US,HYPOXIA,145
US,PSORIATIC ARTHROPATHY,145
US,THINKING ABNORMAL,145
US,THYROID CANCER,145
US,TOOTHACHE,145
US,INCREASED TENDENCY TO BRUISE,144
US,COLITIS,143
US,GASTROENTERITIS VIRAL,143
US,HAEMATOMA,143
US,MOOD ALTERED,143
US,MOVEMENT DISORDER,143
US,NEOPLASM MALIGNANT,143
US,OXYGEN SATURATION DECREASED,142
US,SKIN LESION,142
US,ANKLE FRACTURE,141
US,GOUT,141
US,INTRAMEDULLARY ROD INSERTION,141
US,SPINAL FRACTURE,140
US,TEMPERATURE INTOLERANCE,140
US,HAIR COLOUR CHANGES,138
US,KNEE ARTHROPLASTY,138
US,ABNORMAL BEHAVIOUR,137
US,BACK DISORDER,137
US,BLINDNESS,137
US,EMOTIONAL DISORDER,137
US,MUSCLE TIGHTNESS,137
US,PRESYNCOPE,137
US,INCREASED APPETITE,136
US,ABNORMAL DREAMS,135
US,BLOOD COUNT ABNORMAL,135
US,FEAR,135
US,GLYCOSYLATED HAEMOGLOBIN INCREASED,135
US,WRIST FRACTURE,135
US,ALANINE AMINOTRANSFERASE INCREASED,134
US,EXTRA DOSE ADMINISTERED,134
US,GLAUCOMA,134
US,HAEMATOCRIT DECREASED,134
US,HAEMOPTYSIS,134
US,MUSCULOSKELETAL CHEST PAIN,134
US,PULMONARY HYPERTENSION,134
US,SCIATICA,134
US,SINUS CONGESTION,134
US,AGEUSIA,133
US,DIPLOPIA,133
US,INTESTINAL OBSTRUCTION,133
US,DEMENTIA,132
US,OSTEOMYELITIS,132
US,WOUND,131
US,ACUTE RESPIRATORY FAILURE,130
US,BRADYCARDIA,130
US,CHRONIC KIDNEY DISEASE,130
US,SNEEZING,130
US,TOOTH FRACTURE,130
US,SKIN IRRITATION,129
US,ASPARTATE AMINOTRANSFERASE INCREASED,128
US,PELVIC PAIN,128
US,PRODUCT TASTE ABNORMAL,128
US,SPINAL COLUMN STENOSIS,128
US,HYPOPHAGIA,127
US,LOWER LIMB FRACTURE,127
US,PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME,127
US,SEASONAL ALLERGY,127
US,DEAFNESS,125
US,ERUCTATION,125
US,MUSCLE TWITCHING,125
US,CHROMATURIA,124
US,PERICARDIAL EFFUSION,124
US,CHOKING,123
US,DIVERTICULUM,122
US,HEAD DISCOMFORT,122
US,LOCALISED INFECTION,122
US,RESPIRATORY TRACT INFECTION,122
US,SYSTEMIC LUPUS ERYTHEMATOSUS,122
US,INJECTION SITE RASH,121
US,LIVER FUNCTION TEST ABNORMAL,121
US,ABDOMINAL PAIN LOWER,120
US,LOWER GASTROINTESTINAL HAEMORRHAGE,120
US,PRESCRIBED OVERDOSE,120
US,BLOOD PRESSURE ABNORMAL,119
US,COMPLETED SUICIDE,119
US,FREQUENT BOWEL MOVEMENTS,119
US,GOITRE,119
US,APPLICATION SITE PAIN,118
US,BLOOD SODIUM DECREASED,118
US,BLOOD TRIGLYCERIDES INCREASED,118
US,CEREBRAL HAEMORRHAGE,118
US,FEEDING DISORDER,118
US,HERNIA,118
US,KIDNEY INFECTION,118
US,CHOLECYSTECTOMY,117
US,DRUG DISPENSING ERROR,117
US,BLOOD POTASSIUM INCREASED,116
US,FAECES DISCOLOURED,116
US,TENDERNESS,116
US,BLOOD URINE PRESENT,115
US,CARDIAC MURMUR,115
US,MENORRHAGIA,115
US,NEOPLASM PROGRESSION,115
US,THIRST,115
US,BLOOD PRESSURE FLUCTUATION,114
US,CANDIDA INFECTION,114
US,TOOTH INFECTION,114
US,ACUTE MYOCARDIAL INFARCTION,113
US,ATELECTASIS,113
US,INTERNATIONAL NORMALISED RATIO INCREASED,113
US,ONYCHOCLASIS,112
US,EATING DISORDER,111
US,FLUID OVERLOAD,111
US,ORAL DISCOMFORT,111
US,PSYCHOMOTOR HYPERACTIVITY,111
US,INCORRECT PRODUCT STORAGE,110
US,TENDONITIS,110
US,DEVICE EXPULSION,109
US,RESPIRATORY TRACT CONGESTION,109
US,UPPER GASTROINTESTINAL HAEMORRHAGE,109
US,HYPERGLYCAEMIA,108
US,ILL-DEFINED DISORDER,108
US,INJECTION SITE WARMTH,108
US,ACCIDENTAL EXPOSURE TO PRODUCT,107
US,ECZEMA,107
US,HAIR DISORDER,107
US,NOCTURIA,107
US,POOR QUALITY DRUG ADMINISTERED,107
US,ANAPHYLACTIC REACTION,106
US,ASCITES,106
US,AUTOIMMUNE THYROIDITIS,106
US,EXOSTOSIS,106
US,INCORRECT ROUTE OF DRUG ADMINISTRATION,106
US,MACULAR DEGENERATION,106
US,MIDDLE INSOMNIA,106
US,SENSORY DISTURBANCE,106
US,GASTRIC ULCER,105
US,AGGRESSION,104
US,LARYNGITIS,104
US,MICTURITION URGENCY,104
US,SLUGGISHNESS,104
US,HYPERCHOLESTEROLAEMIA,103
US,MUSCULOSKELETAL DISORDER,103
US,BLOOD CALCIUM INCREASED,102
US,NERVOUS SYSTEM DISORDER,102
US,RASH PAPULAR,102
US,BASAL CELL CARCINOMA,101
US,MENISCUS INJURY,101
US,HEPATIC STEATOSIS,100
US,LIGAMENT SPRAIN,100
US,MITRAL VALVE INCOMPETENCE,100
US,SCAR,100
US,SKIN CANCER,100
US,TOOTH ABSCESS,100
US,BLOOD TESTOSTERONE DECREASED,99
US,CARDIOMEGALY,99
US,INJECTION SITE URTICARIA,99
US,MADAROSIS,99
US,ANGINA PECTORIS,98
US,DRUG ADMINISTERED AT INAPPROPRIATE SITE,98
US,CORONARY ARTERY OCCLUSION,97
US,INJECTION SITE NODULE,97
US,LEUKOCYTOSIS,97
US,SCOLIOSIS,97
US,COLD SWEAT,96
US,CYST,96
US,IMPAIRED DRIVING ABILITY,96
US,LARGE INTESTINE POLYP,96
US,TRICUSPID VALVE INCOMPETENCE,96
US,HUNGER,94
US,ANHEDONIA,93
US,APHONIA,93
US,CENTRAL NERVOUS SYSTEM LESION,93
US,PRESCRIBED UNDERDOSE,93
US,WEIGHT FLUCTUATION,93
US,EYELID OEDEMA,92
US,FOETAL EXPOSURE DURING PREGNANCY,92
US,PHOTOPHOBIA,92
US,EYE HAEMORRHAGE,91
US,HYSTERECTOMY,91
US,MASS,91
US,MOUTH ULCERATION,91
US,RESPIRATORY DISORDER,91
US,HYPERKALAEMIA,90
US,INTERNAL HAEMORRHAGE,90
US,BIPOLAR DISORDER,89
US,BLOOD CALCIUM DECREASED,89
US,BLOOD GLUCOSE ABNORMAL,89
US,DRY THROAT,89
US,HYPOAESTHESIA ORAL,89
US,INFUSION RELATED REACTION,89
US,LUNG NEOPLASM MALIGNANT,89
US,HIP ARTHROPLASTY,88
US,OBESITY,88
US,PAIN OF SKIN,88
US,PARAESTHESIA ORAL,88
US,ULCER,88
US,BLOOD IRON DECREASED,86
US,NODULE,86
US,OPEN REDUCTION OF FRACTURE,86
US,ORTHOSTATIC HYPOTENSION,86
US,UPPER-AIRWAY COUGH SYNDROME,86
US,FEBRILE NEUTROPENIA,85
US,GINGIVAL PAIN,85
US,MALNUTRITION,85
US,PERIPHERAL COLDNESS,85
US,BLOOD TEST ABNORMAL,84
US,DEVICE FAILURE,84
US,HAIR GROWTH ABNORMAL,84
US,IMPAIRED WORK ABILITY,84
US,METASTASES TO BONE,84
US,ORAL CANDIDIASIS,84
US,SKIN HAEMORRHAGE,84
US,SUBDURAL HAEMATOMA,84
US,TRANSFUSION,84
US,DIABETIC KETOACIDOSIS,83
US,FOOT DEFORMITY,83
US,PROCEDURAL PAIN,83
US,TOOTH EXTRACTION,83
US,COLITIS ULCERATIVE,82
US,LUMBAR SPINAL STENOSIS,82
US,LUNG INFECTION,82
US,MUSCLE SPASTICITY,82
US,NERVE COMPRESSION,82
US,NEUTROPHIL COUNT DECREASED,82
US,PALLOR,82
US,BLOOD ALKALINE PHOSPHATASE INCREASED,81
US,BONE DENSITY DECREASED,81
US,IRON DEFICIENCY ANAEMIA,81
US,MUSCLE STRAIN,81
US,PAPILLARY THYROID CANCER,81
US,PRODUCT ODOUR ABNORMAL,81
US,SPINAL COMPRESSION FRACTURE,81
US,EAR DISCOMFORT,80
US,ABORTION SPONTANEOUS,79
US,DERMATITIS,79
US,LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES,79
US,LYMPHOEDEMA,79
US,RENAL CYST,79
US,STRESS FRACTURE,78
US,GROIN PAIN,77
US,HEPATIC CIRRHOSIS,77
US,LEUKOPENIA,77
US,LIVER DISORDER,77
US,METRORRHAGIA,77
US,SEDATION,77
US,SEPTIC SHOCK,77
US,VENTRICULAR EXTRASYSTOLES,77
US,ABNORMAL LOSS OF WEIGHT,76
US,CONCUSSION,76
US,EYE DISCHARGE,76
US,MENSTRUATION IRREGULAR,76
US,PHARYNGITIS STREPTOCOCCAL,76
US,PSYCHOLOGICAL TRAUMA,76
US,REACTION TO DRUG EXCIPIENTS,76
US,RHINITIS ALLERGIC,76
US,ANGIOEDEMA,75
US,APPLICATION SITE RASH,75
US,EYE INFECTION,75
US,FOOD ALLERGY,75
US,HAND FRACTURE,75
US,ORAL HERPES,75
US,PNEUMONIA ASPIRATION,75
US,RESPIRATORY DISTRESS,75
US,ADVERSE REACTION,74
US,BLOOD BILIRUBIN INCREASED,74
US,THROMBOPHLEBITIS SUPERFICIAL,74
US,BLADDER DISORDER,73
US,BLOOD UREA INCREASED,73
US,CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR,73
US,GINGIVAL BLEEDING,73
US,HAEMATEMESIS,73
US,HYPOKINESIA,73
US,METASTASES TO LIVER,73
US,MUSCLE DISORDER,73
US,NAIL DISORDER,73
US,ORAL DISORDER,73
US,PULMONARY ARTERIAL HYPERTENSION,73
US,UNRESPONSIVE TO STIMULI,73
US,INITIAL INSOMNIA,72
US,ACCIDENTAL OVERDOSE,71
US,CATARACT OPERATION,71
US,COORDINATION ABNORMAL,71
US,ENERGY INCREASED,71
US,EYELID PTOSIS,71
US,IMMUNE SYSTEM DISORDER,71
US,MUSCLE ATROPHY,71
US,NASAL DISCOMFORT,71
US,PLATELET COUNT INCREASED,71
US,PRODUCT PACKAGING ISSUE,71
US,ABSCESS,70
US,ESSENTIAL HYPERTENSION,70
US,FACIAL PAIN,70
US,HAEMORRHAGIC STROKE,70
US,INTRAOCULAR PRESSURE INCREASED,70
US,JOINT DISLOCATION,70
US,LIBIDO DECREASED,70
US,MUCOSAL INFLAMMATION,70
US,SYNOVIAL CYST,70
US,UTERINE PERFORATION,70
US,WALKING AID USER,70
US,DISABILITY,69
US,IMPAIRED GASTRIC EMPTYING,69
US,OVARIAN CYST,69
US,SINUS HEADACHE,69
US,SKIN FISSURES,69
US,SPINAL PAIN,69
US,SUICIDE ATTEMPT,69
US,THYROID NEOPLASM,69
US,VITREOUS FLOATERS,69
US,LYMPHOCYTE COUNT DECREASED,68
US,PARANOIA,68
US,PULMONARY CONGESTION,68
US,THYROIDECTOMY,68
US,TOOTH LOSS,68
US,BLOOD GLUCOSE FLUCTUATION,67
US,CARDIOMYOPATHY,67
US,DEVICE RELATED INFECTION,67
US,EMPHYSEMA,67
US,JOINT RANGE OF MOTION DECREASED,67
US,PSYCHOTIC DISORDER,67
US,VIRAL UPPER RESPIRATORY TRACT INFECTION,67
US,DEPRESSED LEVEL OF CONSCIOUSNESS,66
US,HAEMORRHAGE INTRACRANIAL,66
US,OESOPHAGITIS,66
US,SPINAL DISORDER,66
US,TENDON RUPTURE,66
US,ARTERIOSCLEROSIS,65
US,ATRIAL FLUTTER,65
US,BACK INJURY,65
US,ISCHAEMIC STROKE,65
US,MATERNAL EXPOSURE DURING PREGNANCY,65
US,PARKINSON^S DISEASE,65
US,PHOTOSENSITIVITY REACTION,65
US,PNEUMONITIS,65
US,SPLENOMEGALY,65
US,ADRENAL INSUFFICIENCY,64
US,BODY TEMPERATURE INCREASED,64
US,CHOLECYSTITIS,64
US,DEVICE BREAKAGE,64
US,FRACTURE,64
US,GLUCOSE TOLERANCE IMPAIRED,64
US,HYPERAESTHESIA,64
US,RENAL FAILURE CHRONIC,64
US,BEDRIDDEN,63
US,BONE LESION,63
US,CLOSTRIDIUM DIFFICILE COLITIS,63
US,DECREASED INTEREST,63
US,ELECTROLYTE IMBALANCE,63
US,FOREIGN BODY,63
US,HYPERKERATOSIS,63
US,INTERSTITIAL LUNG DISEASE,63
US,UTERINE LEIOMYOMA,63
US,ARTHROPOD BITE,62
US,BLOOD MAGNESIUM DECREASED,62
US,CARDIO-RESPIRATORY ARREST,62
US,HEMIPARESIS,62
US,INCONTINENCE,62
US,INTERVERTEBRAL DISC DISORDER,62
US,MULTIPLE FRACTURES,62
US,NERVE INJURY,62
US,SPINAL OPERATION,62
US,COMA,61
US,ELECTROCARDIOGRAM QT PROLONGED,61
US,FEELING DRUNK,61
US,HYPERCALCAEMIA,61
US,PULMONARY FIBROSIS,61
US,SMALL INTESTINAL OBSTRUCTION,61
US,DECUBITUS ULCER,60
US,DELIRIUM,60
US,DERMATITIS CONTACT,60
US,GASTROENTERITIS,60
US,MEDICATION RESIDUE PRESENT,60
US,PELVIC FRACTURE,60
US,VARICOSE VEIN,60
US,APPETITE DISORDER,59
US,ATAXIA,59
US,COMPRESSION FRACTURE,59
US,DRUG DEPENDENCE,59
US,FEELING OF BODY TEMPERATURE CHANGE,59
US,HEARING IMPAIRED,59
US,INJECTION SITE DISCOLOURATION,59
US,OSTEONECROSIS,59
US,PHARYNGITIS,59
US,QUALITY OF LIFE DECREASED,59
US,SJOGREN^S SYNDROME,59
US,SUPRAVENTRICULAR TACHYCARDIA,59
US,BREAST CANCER FEMALE,58
US,DISEASE RECURRENCE,58
US,HYPOCALCAEMIA,58
US,MANIA,58
US,POLYP,58
US,WEIGHT LOSS POOR,58
US,CHOLECYSTITIS CHRONIC,57
US,DYSLIPIDAEMIA,57
US,GAIT INABILITY,57
US,LOWER RESPIRATORY TRACT INFECTION,57
US,SCAB,57
US,SPONDYLOLISTHESIS,57
US,TRIGGER FINGER,57
US,HUMERUS FRACTURE,56
US,PANCREATITIS ACUTE,56
US,PULMONARY THROMBOSIS,56
US,RHABDOMYOLYSIS,56
US,SQUAMOUS CELL CARCINOMA,56
US,AFFECT LABILITY,55
US,APPLICATION SITE IRRITATION,55
US,BACTERIAL INFECTION,55
US,BREAST PAIN,55
US,ENCEPHALOPATHY,55
US,MALIGNANT MELANOMA,55
US,METASTASES TO LUNG,55
US,NASAL DRYNESS,55
US,PARANASAL SINUS HYPERSECRETION,55
US,SECRETION DISCHARGE,55
US,ABNORMAL FAECES,54
US,DIABETIC NEUROPATHY,54
US,DRUG EFFECT DELAYED,54
US,ECCHYMOSIS,54
US,INJECTION SITE EXTRAVASATION,54
US,JAUNDICE,54
US,PETECHIAE,54
US,TONGUE DISORDER,54
US,TREATMENT FAILURE,54
US,ERECTILE DYSFUNCTION,53
US,HEREDITARY ANGIOEDEMA,53
US,MELAENA,53
US,METABOLIC ACIDOSIS,53
US,ORAL MUCOSAL BLISTERING,53
US,PANCREATIC CARCINOMA,53
US,SNORING,53
US,WRONG DRUG ADMINISTERED,53
US,AORTIC ANEURYSM,52
US,BARRETT^S OESOPHAGUS,52
US,CARDIAC FLUTTER,52
US,CONJUNCTIVITIS,52
US,DIABETES MELLITUS INADEQUATE CONTROL,52
US,FLANK PAIN,52
US,FORMICATION,52
US,HEPATIC FAILURE,52
US,LUNG INFILTRATION,52
US,SOMNAMBULISM,52
US,TRICHORRHEXIS,52
US,ANAEMIA POSTOPERATIVE,51
US,APATHY,51
US,DEVICE USE ERROR,51
US,EXTRASYSTOLES,51
US,JAW DISORDER,51
US,METASTASES TO LYMPH NODES,51
US,POST PROCEDURAL HAEMORRHAGE,51
US,BREAST MASS,50
US,FACE OEDEMA,50
US,LIGAMENT RUPTURE,50
US,NO THERAPEUTIC RESPONSE,50
US,POST PROCEDURAL COMPLICATION,50
US,PRODUCT FORMULATION ISSUE,50
US,BLINDNESS UNILATERAL,49
US,DELUSION,49
US,GASTROINTESTINAL PAIN,49
US,MENSTRUAL DISORDER,49
US,PARALYSIS,49
US,PERIPHERAL VASCULAR DISORDER,49
US,PNEUMOTHORAX,49
US,VULVOVAGINAL BURNING SENSATION,49
US,VULVOVAGINAL PRURITUS,49
US,BONE LOSS,48
US,DIZZINESS POSTURAL,48
US,EXPOSED BONE IN JAW,48
US,FAILURE TO THRIVE,48
US,KNEE OPERATION,48
US,RED BLOOD CELL SEDIMENTATION RATE INCREASED,48
US,SKIN ATROPHY,48
US,THERAPY NON-RESPONDER,48
US,VAGINAL DISCHARGE,48
US,VULVOVAGINAL DRYNESS,48
US,WOUND INFECTION,48
US,BOWEL MOVEMENT IRREGULARITY,47
US,CHOKING SENSATION,47
US,ELECTROCARDIOGRAM ABNORMAL,47
US,FAECAL INCONTINENCE,47
US,GENERALISED OEDEMA,47
US,HALLUCINATION_ VISUAL,47
US,LOW DENSITY LIPOPROTEIN INCREASED,47
US,LYMPHOMA,47
US,MULTIPLE ALLERGIES,47
US,RENAL CANCER,47
US,URINE ODOUR ABNORMAL,47
US,EJECTION FRACTION DECREASED,46
US,ERYTHEMA OF EYELID,46
US,INTENTIONAL OVERDOSE,46
US,JOINT EFFUSION,46
US,LACTOSE INTOLERANCE,46
US,MYELODYSPLASTIC SYNDROME,46
US,PRODUCT COLOUR ISSUE,46
US,ROSACEA,46
US,SCRATCH,46
US,STENT PLACEMENT,46
US,VITAMIN B12 DEFICIENCY,46
US,AMENORRHOEA,45
US,APHAGIA,45
US,BLOOD CREATINE PHOSPHOKINASE INCREASED,45
US,COLON CANCER,45
US,DECREASED ACTIVITY,45
US,GLOMERULAR FILTRATION RATE DECREASED,45
US,HAEMORRHOIDAL HAEMORRHAGE,45
US,INTENTIONAL UNDERDOSE,45
US,LIVER FUNCTION TEST INCREASED,45
US,SKIN INFECTION,45
US,TENDON DISORDER,45
US,TIBIA FRACTURE,45
US,URINE OUTPUT DECREASED,45
US,ANAL INCONTINENCE,44
US,ARTERIOSCLEROSIS CORONARY ARTERY,44
US,CARDIAC PACEMAKER INSERTION,44
US,CARDIOVASCULAR DISORDER,44
US,DYSGRAPHIA,44
US,GASTROINTESTINAL INFECTION,44
US,OSTEOSCLEROSIS,44
US,SENSATION OF FOREIGN BODY,44
US,UROSEPSIS,44
US,ANOSMIA,43
US,CHRONIC SINUSITIS,43
US,ENDOMETRIOSIS,43
US,FAECES SOFT,43
US,FURUNCLE,43
US,ILEUS,43
US,INJECTION SITE INDURATION,43
US,OESOPHAGEAL PAIN,43
US,PAROSMIA,43
US,PERONEAL NERVE PALSY,43
US,SINUS TACHYCARDIA,43
US,SKIN WARM,43
US,TRI-IODOTHYRONINE DECREASED,43
US,ACCIDENT,42
US,AORTIC ARTERIOSCLEROSIS,42
US,EXPIRED DRUG ADMINISTERED,42
US,FRACTURE NONUNION,42
US,GLUTEN SENSITIVITY,42
US,HEPATOMEGALY,42
US,LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR,42
US,LOOSE TOOTH,42
US,MOTOR DYSFUNCTION,42
US,MOUTH HAEMORRHAGE,42
US,ONYCHOMYCOSIS,42
US,PERSONALITY CHANGE,42
US,PLANTAR FASCIITIS,42
US,POST PROCEDURAL INFECTION,42
US,RHINITIS,42
US,RIGHT VENTRICULAR FAILURE,42
US,SINUS BRADYCARDIA,42
US,THERAPY CHANGE,42
US,VENTRICULAR TACHYCARDIA,42
US,BLADDER CANCER,41
US,BLOOD PRESSURE INADEQUATELY CONTROLLED,41
US,BREAST CANCER METASTATIC,41
US,DEFORMITY,41
US,FACIAL PARALYSIS,41
US,HORMONE LEVEL ABNORMAL,41
US,HYPOMAGNESAEMIA,41
US,OESOPHAGEAL DISORDER,41
US,PHOTOPSIA,41
US,PROSTATIC SPECIFIC ANTIGEN INCREASED,41
US,RESPIRATORY ARREST,41
US,RETINAL DETACHMENT,41
US,SKIN ABRASION,41
US,ULCER HAEMORRHAGE,41
US,URINE ABNORMALITY,41
US,APPENDICECTOMY,40
US,ARTERIAL OCCLUSIVE DISEASE,40
US,ASPIRATION,40
US,BLOOD CHOLESTEROL ABNORMAL,40
US,BRUXISM,40
US,DEMENTIA ALZHEIMER^S TYPE,40
US,DIVERTICULUM INTESTINAL,40
US,DRUG EFFECT INCREASED,40
US,FAECALOMA,40
US,FOREIGN BODY SENSATION IN EYES,40
US,GASTRIC HAEMORRHAGE,40
US,MEDICAL DEVICE COMPLICATION,40
US,PRODUCT SIZE ISSUE,40
US,PROTEINURIA,40
US,TRANSAMINASES INCREASED,40
US,VULVOVAGINAL DISCOMFORT,40
US,ANORECTAL DISCOMFORT,39
US,APPLICATION SITE VESICLES,39
US,ATRIAL SEPTAL DEFECT,39
US,BRAIN INJURY,39
US,FACIAL BONES FRACTURE,39
US,FOOT OPERATION,39
US,GENERALISED TONIC-CLONIC SEIZURE,39
US,HEPATIC CYST,39
US,INCREASED UPPER AIRWAY SECRETION,39
US,LUMBAR RADICULOPATHY,39
US,MOUTH SWELLING,39
US,NEOPLASM,39
US,SUBARACHNOID HAEMORRHAGE,39
US,BODY TEMPERATURE DECREASED,38
US,C-REACTIVE PROTEIN INCREASED,38
US,DYSMENORRHOEA,38
US,EXERCISE TOLERANCE DECREASED,38
US,GINGIVITIS,38
US,HAEMORRHAGIC DIATHESIS,38
US,HEART RATE ABNORMAL,38
US,IMMUNODEFICIENCY,38
US,JOINT CREPITATION,38
US,KYPHOSIS,38
US,LIP DRY,38
US,MYOSITIS,38
US,RADICULOPATHY,38
US,THYROID MASS,38
US,VEIN DISORDER,38
US,VULVOVAGINAL PAIN,38
US,WRONG PATIENT RECEIVED MEDICATION,38
US,ANAPHYLACTIC SHOCK,37
US,AORTIC VALVE INCOMPETENCE,37
US,BLOOD PRESSURE SYSTOLIC INCREASED,37
US,BREAST TENDERNESS,37
US,DIALYSIS,37
US,DIARRHOEA HAEMORRHAGIC,37
US,ENDODONTIC PROCEDURE,37
US,EUPHORIC MOOD,37
US,FIBULA FRACTURE,37
US,MULTI-ORGAN FAILURE,37
US,PEPTIC ULCER,37
UM,CHEST PAIN,1
UM,HEART RATE IRREGULAR,1
UM,PALPITATIONS,1
UY,DIARRHOEA,2
UY,NAUSEA,2
UY,AFFECTIVE DISORDER,1
UY,BLOOD PRESSURE FLUCTUATION,1
UY,COUGH,1
UY,DECREASED APPETITE,1
UY,DYSPEPSIA,1
UY,FEELING HOT,1
UY,GASTROENTERITIS VIRAL,1
UY,HEADACHE,1
UY,INSOMNIA,1
UY,LACTOSE INTOLERANCE,1
UY,LIVER DISORDER,1
UY,PULSE ABNORMAL,1
UY,TACHYCARDIA,1
UY,VOMITING,1
UY,WEIGHT DECREASED,1
VE,ARTHRALGIA,1
VE,DISCOMFORT,1
VE,HAEMORRHAGIC TRANSFORMATION STROKE,1
VE,ISCHAEMIC STROKE,1
VE,MYALGIA,1
VE,PALPITATIONS,1
VE,PHOTOSENSITIVITY REACTION,1
VE,PYREXIA,1
VE,TACHYCARDIA,1
